Vasti madhumeha pk011-gdg
-
Upload
ayurmitra-ksrprasad -
Category
Documents
-
view
1.405 -
download
28
description
Transcript of Vasti madhumeha pk011-gdg
By
D.S.Swami
Dissertation Submitted to the Rajiv Gandhi University Of Health Sciences,Karnataka, Bangalore.
In partial fulfillment of the requirements for the degree of
AYURVEDA VACHASPATHI M.D.
In
PANCHAKARMA
Under the guidance of
Dr. G. Purushothamacharyulu,M.D. (Ayu)
And co-guidance of
Dr. Shashidhar.H. Doddamani,M.D. (Ayu)
Post graduate department of Panchakarma, Shri D. G. Melmalagi Ayurvedic Medical College,
Gadag – 582103.
2006.
Evaluation of efficacy of Madhutailaka BastikarmaEvaluation of efficacy of Madhutailaka BastikarmaEvaluation of efficacy of Madhutailaka BastikarmaEvaluation of efficacy of Madhutailaka BastikarmaEvaluation of efficacy of Madhutailaka Bastikarma
in the management of Madhumeha (NIDDM)in the management of Madhumeha (NIDDM)in the management of Madhumeha (NIDDM)in the management of Madhumeha (NIDDM)in the management of Madhumeha (NIDDM)
Rajiv Gandhi University Of Health Sciences, Karnataka, Bangalore.
DECLARATION BY THE CANDIDATE
hereby declare that this dissertation / thesis entitled “““““EEEEEvaluationvaluationvaluationvaluationvaluation
of of of of of the Efficacy of Madhutailika Bastikarama in the management ofthe Efficacy of Madhutailika Bastikarama in the management ofthe Efficacy of Madhutailika Bastikarama in the management ofthe Efficacy of Madhutailika Bastikarama in the management ofthe Efficacy of Madhutailika Bastikarama in the management of
Madhumeha (NIDDM)Madhumeha (NIDDM)Madhumeha (NIDDM)Madhumeha (NIDDM)Madhumeha (NIDDM)””””” is a bonafide and genuine research work carried out
by me under the guidance of Dr. G. Purushothamacharyulu, M.D. (Ayu), Pro-
fessor and H.O.D, Post-graduate department of Panchakarma and co-guid-
ance of Dr. Shashidhar. H. Doddamani, M.D.(Ayu), Assistant Professor, Post
graduate department of Panchakarma.
Date:Place: D.S.Swami
I
CERTIFICATE BY THE GUIDE
This is to certify that the dissertation entitled “Evaluation of
the Efficacy of Madhutailika Bastikarama in the management of Madhumeha
(NIDDM)” is a bonafide research work done by D.S.Swami in partial fulfillment
of the requirement for the degree of Ayurveda Vachaspathi. M.D.
(Panchakarma).
Date:
Place: Dr. G. Purushothamacharyulu, M.D. (Ayu).
Professor & H.O.D
Post graduate department of Panchakarma.
ENDORSEMENT BY THE H.O.D AND PRINCIPAL OF
THE INSTITUTION
This is to certify that the dissertation entitled “Evaluation of
the Efficacy of Madhutailika Bastikarama in the management of
Madhumeha (NIDDM)” is a bonafide research work done by D.S.Swami
under the guidance of Dr.G. Purushothamacharyulu, M.D. (Ayu), Professor and
H.O.D, Postgraduate department of Panchakarma and co-guidance of Dr.
Shashidhar.H. Doddamani, M.D. (Ayu), Assistant Professor, Post graduate de-
partment of Panchakarma.
Dr. G. Purushothamacharyulu, M.D. (Ayu) Dr. G. B. Patil.
Professor & H.O.D, Principal.
Post graduate department of Panchakarma.
CERTIFICATE BY THE CO- GUIDE
This is to certify that the dissertation entitled “Evaluation of
the Efficacy of Madhutailika Bastikarama in the management of
Madhumeha (NIDDM)” is a bonafide research work done by D.S.Swami
in partial fulfillment of the requirement for the degree of Ayurveda
Vachaspathi. M.D. (Panchakarma).
Date: Dr. Shashidhar.H. Doddamani, M.D. (Ayu).
Place: Assistant Professor,
Post graduate Department of Panchakarma.
COPYRIGHT
Declaration by the candidate
I hereby declare that the Rajiv Gandhi University of Health
Sciences, Karnataka shall have the rights to preserve, use and dissemi-
nate this dissertation / thesis in print or electronic format for academic /
research purpose.
Date: D.S.Swami
Place:
© Rajiv Gandhi University of Health Sciences, Karnataka.
I
Acknowledgement
By the grace of god, bless of eiders I take this opportunity to express my
regards to the persons who helped in completing this work.
I express my deep sense of gratitude to his great holiness Jagadguru Shri
Abhinava Shivananda mahaswamiji for their divine blessings.
Words fail miserably when I try to express my gratitude to my mentor, my
guide Dr.G.Purushottamacharylu M.D (Ayu), H.O.D of P.G.Department of Panchakarma.
For his incessant, untiring, round the clock guidance with all the diligence. His
sustained fostering and encouragement instilled considerable impetus in me enabling
to achieve this milestone which otherwise would have lacked this particular finish.
Indeed, I will cherish the affectionate guidance of my co-guide Dr.Shashidhar
H.Doddamani M.D (Ayu), Asst professor of P.G.Department of Panchakarm. For his
invincible and radical thinking were very valuable in achieving this research work
invoking scientific spirit throughout the course of the study.
I express my sincere and deep gratitude to Dr.G.B.Patil, Principal, D.G.M.A.M.C,
Gadag, for his wholehearted encouragement as well as providing all necessary facilities
for this research work.
I express my sincere gratitude to Dr.P.Shivaramudu M.D (Ayu), Assistant Professor and Dr.
Santhosh.N.Belavadi MD (Ayu), Lecturer of P.G.Department of Panchakarma for his
excellent advices.
I also express my sincere gratitude to Dr.S.D.Yargeri R.M.O. for his moral
support and special care in providing the all the facilities during this trail work.
I express my sincere gratitude to Dr.G.S.Hiremath, Dr. Anjaneya murthy
Dr.V.Varadacharyulu, Dr.M.C.Patil, Dr. Mulgund, Dr.Dilip Kumar, Dr.R.V.Shetter,
Dr.Basavaraj Hadapada,Dr. K.S.R.Prasad, Dr.G.Danappa Gowdar, Dr. Kuber Sankh,
II
Dr.J.G.Mitti, Dr.Shakanath.Nidagundi, and other PG staff for their constant
encouragement.
I thank Dr.U.V.Purad, Dr.S.H.Radder, Dr.B.M,Mulkipatil and other
undergraduate teachers for their support in the clinical work. I thank to Shri. Nandakumar
(Statistician), Shri.V.M.Mundinamani (Librarian), Mr.Surebana and other hospital and
office staff for their kind support during my study.
Indeed, I will cherish the affectionate of my Father, my elder brother Mr.
V.S.Kendadmath, and all my family members who has been a source of inspiration for
my entire carrier.
I express my sincere thanks to my friends Dr.H.T.Sangamesh, Dr.Basavaraj R.
Channappagoudar, Dr.Prakasha.Gunjal, Dr.shrikanth, Dr.Santhosh.L.Y, Dr.V.M.Hugar,
Dr.Jayaraj Basarigidad, Dr.Shivakumar.Sajjanar, Dr.Ashok.Bingi, Dr.B.H.Venkaraddi,
Dr.B.L.Kalmath, Dr.P.Chandramouleeswaran, Dr.Shaila.B. Dr.Uday Kumar, Dr.Ratna
Kumar, Dr.Ghanti, Dr.Pradeep, Dr.Babu.Sobagin, Dr.Suresh.Hakkandi,
Dr.Manjunath.Akki, Dr.Gavi, Dr.AshwinDev, Dr.V.S.Hiremath, Dr.L.M.Biradar,
Dr.Jagadisha.H., Dr.Sharanu, Dr.Anand, Dr.Umesh, Dr.Suvarna, Dr.Devendrappa,
Dr.Sibaprasad, Dr.Madhushree, Dr.Ashok.M.J, Dr.Payappagoudar, and other post
graduate scholars for their support.
I would like to mention the support and inspiration provided by my uncle
Shri.Shivashankarayya.S.Hiremath & family for their support and encouragement during
my stay at Gadag.
I acknowledge my patients for their wholehearted consent to participate in this
clinical trial. I express my thanks to all the persons who have helped me directly and
indirectly with apologies for my inability to identify them individually.
Finally I dedicate this work to my respected patients who are the prime reasons
for this study.
Date : Signature of the scholar
Place : (Dr. D.S.Swami)
III
ABSTRACT The study “Evaluation of the efficacy of Madhutailika Bastikarma in the
management of Madhumeha (NIDDM)” is focused on an important form of an siddha
basti and a common disease Madhumeha. Madhutailika basti is believed to have a note
worthy role in the management of such impaired metabolic condition by importing
equilibrium state of doshasa, nourishes the dhatu and maintains the blood sugar level.
Panchakarma is the popular term for shodhana chikitsa, among that Bastikarma is an
important one. In this the doshas are made to pass through the adhomarga i.e.
Gudamarga. In the Bastikarma doshas even from the all over body are removed through
gudamarga.
In the treatment of Sthoola Madhumeha Bastikarma has great importance
according to Ayurveda. In the modern system of medicine Madhumeha can be compared
to diabetes mellitus. And it can be classified as insulin dependent, non insulin dependent,
malnutrition related and other types of diabetes mellitus associated with certain
conditions and syndromes. Among this non-insulin dependent diabetes mellitus
constitutes 85 % or more of all cases of diabetes. Diabetes has become the disease of the
masses. Over 20 million people are reported to be suffering from this “Sweet Disease”.
Between 1995 and 2005 India will have about 2-3 crore diabetic patients.
Even though the scientific world has conducted extensive studies but couldn’t
find a safe and effective therapy or medicine for this disease. In Ayurveda we can offer
several treatment modalities among that Bastikarma is a good, result oriented and
economical therapy which can control the blood sugar level and prevent further
complications without any serious side effects.
BastiKarma is advised in Madhumeha patients having good body strength and
those who are sthoola in nature. The objective of this study was to assess the efficacy of
BastiKarma in such patients. The study was designed as a prospective clinical trial and 30
patients were selected and given Madhutailika Bastikarm
The treatment contains the following steps.
01. Deepana pachana
02. Sthanika Abhyanga and mridu sweda by Moorchita tila taila.
IV
03. Madhutailika basti in yogabasti pattern.
04. Sixteen days Parihara kala.
05. Follow-up for one month.
As a result of the proper administration of Madhutailika basti it was noted that, it
gives immediate and lasting results, both in sugar levels as well as in other complaints.
Among the 30 patients taken for the study, 17 patients (56.6%) responded well, 11
patients (36.6%), responded moderately and 2 patient’s (6.6%) showed poor response. A
close perusal of observation and inference that can be drawn leads to the conclusions
such as, Madhutailika basti is an effective treatment in Sthoola Madhuneha and it also
shows lasting results. In mild and moderate type of Sthoola Madhumeha classical
Madhutailika basti alone is enough to control it. Even though only Virechana was
administered in this study, it was also noted that along with Madhutailika basti,
administration of pathya ahara vihara and shamanoushadis might help more.
Key words –
Shodhana karma ; Madhutailik Bastikarma ; Sthoola Madhumeha ; Prameha ;
Diabetes mellitus ; Insulin resistance ; Obesity; Blood sugar.
V
LIST OF ABBREVIATIONS
⇒ C. S _ Charaka Samhitha.
⇒ A. H. – Ashtanga Hridaya.
⇒ B. P. – Bhavaprakasha
⇒ K.S _ Kashyapa Samhita
⇒ G. R. – Good response.
⇒ M. R. – Moderate response.
⇒ N. R. – No response.
⇒ P. R. – Poor response.
⇒ S. S. – Sushruta Samhita.
VI
TABLE OF CONTENTS
Chapters Page No.
1. Introduction 1-4
2. Objectives 5-7
3. Review of literature 8-108
4. Drug review 109-114
5. Methodology 115-121
6. Results 122 -139
7. Discussion 140-152
8. Conclusion 153-154
9. Summary 155 - 156
10. Bibliography 157- 170
11. Annexure 171 - 178
VII
LIST OF TABLES Page No.
1. Table showing patients showing indicated for matrabasti 37
2. Table showing showing ingredients of madhutailika basti 42
3. Table showing Measurements of Bastiyantra 45
4. Table showing Netra dosha and Putaka dosha. 46
5. Table showing patients showing indicated for anasthapya 47
6. Table showing patients showing indicated for asthapya 49
7. Table showing patients showing contra indicated for Anuvasana. 50
8. Table showing proper dose according to age 52
9. Table showing ahara samandi nidanas 70
10. Table showing vihara sambandi nidanas 70
11. Table showing the types kaphaja prameha 76
12. Table showing the types pittaja prameha 77
13. Table showing the types vataja prameha 77
14. Table showing the poorvaroopa of prameha 82
15. Table showing the roopa of prameha 85
16. Table showing the Prameha pidakas 106
15. Table showing the grades of blood sugar level 121
Table showing the Data of Age Group Incidence and Response 125
18. Table showing the distribution of sex group Incidence and Response 126
19. Table showing the Chronicity and response 127
20. Table showing the incidence of religion and response 128
21. Table showing the socioeconomic status and response 129
22. Table showing the incidence of religion and response 130
23. Table showing the incidence of occupation and response 131
24. Table showing the Family history and response 132
25. Table showing the Treatment history and response 133
26. Table showing the habits of the patients and response 134
27. Table showing the Nature of mala pravrithi and response 135
28. Table showing the Nidana status and response 136
29. Table showing the Nature of kostha and response 137
30. Table showing the Status of agni and reponse 138
VIII
31. Table showing the Prakruti of patient and response 139
32. Table showing the Statistical data 0f the study 140
LIST OF FIGURES, PHOTOGRAPHS
Title Page No.
1. Figure showing dilated anatomy of the rectum and anus 18
2. Figure grass anatomy of large intestine 20
3. Figure grass anatomy of intestinal villi 20
4. Figure grass anatomy of Pancreas 23
5. Figure anatomy and orientation of Pitutary 27
6. Figure grass anatomy of Adrenalin gland 29
7. Figure grass anatomy of liver 30
8. Photo of drugs used in Mdhutailika Bastikarma 118
LIST OF GRAPHS
Title Page No. 1. Graph showing distribution of age 125 2. Graph showing distribution of sex 126 3. Graph showing distribution of Chronicity and response 127 4. Graph showing distribution of religion and response 128 5. Graph showing distribution of socioeconomic status and response 129 6. Graph showing distribution of religion and response 130 7. Graph showing distribution of occupation and response 131 8. Graph showing distribution of Family history and response 132 9. Graph showing distribution of Treatment history and response 133 10. Graph showing distribution of habits of the patients and response 134 11. Graph showing distribution of Nature of mala pravrithi and response 135 12. Graph showing distribution of Nidana status and response 136 13. Graph showing distribution of Nature of kostha and response 137 14. Graph showing Status of agni and reponse 138 15. Graph showing Prakruti of patient and response 139
Introduction
INTRODUCTION
Ayurveda the life science; embedded with the treasure of ancient knowledge
unfolding the mystery of health and disease. It is a compilation of observation,
experience and research of so many mentors, and moreover it is a cross section of the
scientific thoughts of many generations. Due to its simplicity and scientific nature,
Ayurveda has drawn the attention of the global population. It is well known for its role in
the management of the chronic and incurable diseases. It survived all the downfalls and
fought with unfavorable conditions, flourished during favorable time and still holds its
place in the mainstream.
Research begins with doubts and ends with facts; facts which serve as new data to
be verified again. Thus the process of research never ends, but at the end of it the
researcher would have become wiser with plans to counter newer challenges. Recurrent
modeling and remodeling by time is inevitable for the fulfillment of this destination.
Ayurveda is one such attainment by the perspiration of many eminent Acharyas of the
past. The time tested science Ayurveda has its own everlasting principles regarding both
life and disease. It is applicable in every facet of human life, with its own unique
principles in understanding a disease by both preventive and curative view. This may be
the fact due to which this science is persisting through centuries beginning from time
immemorial.
Scientific and technological progress has made man highly sensitive and critical;
they’re by giving rise to different types of health problems. The advancement of
industrialization and communication is contributing towards sedentary life styles, in turn
causing chronic non- communicable diseases like diabetes mellitus, etc. In fact it is the
first life science, which identified diagnosed and managed diabetes (the Greek word for
siphon) while claiming it is incurable much earlier to famous Greek physician Aerated
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
1
Introduction
(1-2 AD). In spite of all sorts of advancement of science man is not able to stay himself
in the boat of happy and healthy life, so it is a disadvantage rather than an asset; of the
individual by imposing an extra burden on all the systems of body. Then the persons are
very much likely to acquire an infirmity by name: Madhumeha; Mother’s name: Kapha;
Father’s name: Vata; Ancestry: Sahaja & Apathya nimittaja; Qualification: Mahagada;
Character: Anushangi; Expertise: Dhatu karshana; Identification with: Prabhoota Avila
mootrata and tanu madhurya; Status: impairment in multi systems of the body;
complexity Vidradi, Alaji etc; ultimate result: Pranahani.
Madhumeha is a disease known to the mankind since Vedic period and it is
mentioned as one of the 20 obstinate urinary disorders. It is the present burning issue
alarming the world. With synonym of Richman’s disease,’ it is present particularly the
persons who are able to enjoy the pleasure of life with a machine power. Most of the
srotas are involved in the manifestation of the madhumeha. At the outset it becomes
pertinent to discuss the following issues related to Madhumeha. Whether Madhumeha &
Prameha are synonyms? Yes. Charaka has used the words Prameha & Madhumeha as
synonyms and Chakrapani has clarified this fact more than once. The term Prameha has a
broader connotation, indicating the increased quantity and quality of urination whereas
Madhumeha more specifically means a condition where the patient passes urine like
honey. Yet, both the terms convey the nature of the same disease. Madhumeha is an
Anushangi vyadhi, which means it is punarbhavi. In other words the disease has a
tendency to re-occur. It is sadhya vyadhi only in the initial stages where Vata is still
anubandha (secondarily associated) and Kapha is dominant, in a sthoola and balavan rogi.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
2
Introduction
It is asadhya when Vata begins to dominate either as a result of beeja upatapa or as a
sequel to a long-standing, Kapha pradhana Madhumeha.
In Ayurveda chikitsa has been explained under two folds; they are langhana and
brimhana, due to Shodhana in nature Panchakarma comes under the langhana category.
Panchashodhanas well known and effective treatment modalities in the management of
many chronic diseases like Madhumeha, Kustha, etc shodhana techniques are acts as a
weapon’s, due to its simplicity panchakarmas will helps in attaining both the aim of
Ayurveda i.e. Swasthasya urjaskara and arthasya roganut again the treatment is broadly
divided into two categories: Shodhana and Shamana. Curing the disease by cleaning out
the impurities is called Shodhana chikitsa, which is the principle of Panchakarma. It
involves the clearing of vitiated doshas (vata, pitta and kapha) which cause the disease
and thereby the restoration of equilibrium of doshas.
Vamana Virechana, Bastikarma, Nasya karma and Raktamokshana are considered
as the five folded theropies.In brief the term panch means “Vistara” or mangalakar that is
elaborate .In classics our Acharyas have given prime importance to Basti karma. Basti is
a prosses by which doshas are eliminated through the Adhomarga.Acharyas also given
prime importance to it. Even it termed as Ardhachikitsa and it removes the vitiated
doshas from all systems of the body.
Though Basti has been indicated for almost all the disease, some specific types of
Basti have been explained in the management of Madhumeha. As the vata dosha is one of
the main contributing factors. The best way to analyze Bastikarma is by checking its
effect over multisystemic dissordes like Madhumeha.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
3
Introduction
The whole study has been distributed into two major divisions - the conceptual
study & the clinical study. The conceptual study is grouped into a literary review of
(Basti and Madhumeha) drug review; the clinical study contains the Observations,
Results, Discussion and Conclusion and Bibliography.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
4
NEED FOR STUDY
Diabetes mellitus is the third largest killer in the world behind the cardiac
ailments and cancer. It is becoming a great national catastrophe with a current prevalence
rate of 2.4% to 11.6% in urban dwellers.
The danger of this epidemic disease is not only confined to individual’s mortality
and morbidity but also extends to affect the national health care system and economy.
In spite of many advances in contemporary science, the management of diabetes
is still unsatisfactory. Consequent to such projections alarm bell are already ringing in the
circle of health care institutions. In spite of more and more chemical molecules flooding
the market with claims of better efficiency in the management of diabetes mellitus, but
the over all treatment scenario is not of confidant, drug related resistance and toxicity etc
are creating a opinion for provision of safe anti-diabetics. There is no doubt that attention
is coming back to our ancient Indian heritage of Ayurveda to explore its rich literature
and come out with some efficacious remedies, to co-fight the challenge of diabetes.
Among that madhutailik vasti is one of the jewel of Ayurveda, which gives tremendous
result in many diseases including madhumeha (Stoola Madhumeha), Even though it is
classified under Niroohabasti, Siddabasti. In this types of vasti patients need not follow
much restriction as in the case of Niroohabasti.
OBJECTIVES
Number of research works has already been conducted on evaluation of the effect
of some indigenous drugs on madhumeha. Only few research works have been
conducted on efficacy of Samshodhana karmas in the management of Madhumeha. It is
one of the multi systemic disorders where the maximum numbers of Srotases are
involved in the manifestation of the disease. So treating such disease with some time
tested and effective therapies like vasti is the better option. No studies are conducted on
the effect of madhutailika vasti in the management of sthoola madhumeha so for.
THE AIMS AND OBJECTIVES OF THE STUDY
To evaluate the efficacy of madhutailika vasti in the management of
madhumeha.
To evaluate the hypoglycemic effect of Madhutailika vasti.
INCIDENCE AND PREVELENCE
Diabetes is a disease of the masses. The incidence and prevalence rate of diabetes
itself suggests that it is burning issue alarming the world. As per recent WHO assessment
there are 150 million people are reported to be suffering from this Rich man’s sweet
disease. Among them 35% are living in India (>55 million). It is reported that at the end
of 2025, the incidence of diabetes in Indian continent is rising very fast at a rate of >3
times the entire world.
The disease prevalence was 2.4% in rural and 4% -11.6% in urban dwellers.
In world: -150 million persons are now affected and the expected prevalence will be
5.4% by the year 2025.
There are 50% in developed countries 10% in developing countries.
In India: - There were 102000 persons died because of this disease in the
Year
1997.
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
8
Historical view
REVIEW OF LITERATURE
History in other words a function of a historian is neither to love the past nor to
emancipate himself from the past, but to master and understanding of the present. E. H. Carr
History of medicine in India in ancient period is actually the history of science of life
developed by the ancient seers & later systematized into carefully woven treatises
A careful insight into ancient treasure of knowledge makes a good beginning for any
study since we become proud to belong to be part of a heritage, which traces its roots into
times immemorial. Historical background itself base and back bone for the present
progressive development of Ayurveda.
A critical review of the history from the primitive stage to the new millennium
assists one to understand the future in a better way. Struggle and attempt made by a man
for the better future can achieve only with good prospective past and present experiences,
truths and planned in a proper time. History helps to reveal the hidden facts and ideas of
the concerned subject.
BASTI KARMA
Vyadhi has been defined as the state in which imbalance of three Dosha-
the three basic constituents of the living body, saptha dhatu and three malas. The
measures undertaken to restore these Doshika equilibrium is called as Chikitsa.1 the
ayurvedic approach to the treatment of a disease comprises mainly under the two folds
viz
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
9
• Shodhana
• Shamana
Shodhana Chikitsa is supposed to eliminate vitiated Doshas completely and thus prevents
the recurring of the diseases. On the other hand Shamana is the conservative treatment as
it doesn’t eliminate vitiated Dosha but it farcifies them. It is believed that there is no
possibility of relapse of the disease cured by Shodhana Chikitsa if followed proper
samsarjana karmas and pathyapathya during parihara kala, while the disease cured by
Shamana; may reoccur as explanation given by Charaka2 i.e.
The term Panchakarma is frequently used as synonyms of Shodhana. It consists of
Vamana, Virechana, Anuvasana Basti, Niruha Basti and Nasya Karma. Due to its
multiple effects Basti is the most important constituent among the Panchkarma.
According to Ayurvedic physiology Kapha and Pitta are depends on Vata, as it governs
their functions. Basti alleviates morbid Vata dosha from the root level along with other
associated Doshas, in addition it nourishes the body tissue.3 Therefore, Basti therapy
covers more than half of the treatment of all the disease, 4 while some authors consider it
as the complete remedy for all the ailments. Therefore, Basti is considered the best
remedy for morbid Vata, but it can also be used in Kapha and Pittaja disorders by using
different ingredients.5 Though the rout of drug administration in Basti karma and enema
of modern science is same but actions are entirely different, Basti posesses both
Samshodhana and Samshamana effects along with this it does the functions of
shukradharana, Brimhana in emaciated person; Karshana in obese person, Chakshushya,
prevents the aging, improves the luster, strength and helps longevity by acting locally as
well as systematically at cellular level. Thus, it has a wide application in treatment aspect.
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
10
In contemporary science mainly enema is given to remove the mala from the large
intestine.
Karma
History and medicine starts from the very moment when the human being came into
existence that’s why the ancient treatises are stands with description of disease and their
treatment.The evaluation of Basti can be traced from Vedic era viz Rigveda and
Atharvaveda which is considered as the oldest authentic manuscripts of the world.
Veda: - The Kaushika Sutra of Atharvaveda, Basti is indicated as a substitute for minor
operation.6
Purana: - In Agnipurana, Basti is indicated as a principle treatment in complaints
marked by predominance of Vata.7 It is also stated that according to season different
Sneha should be used for Basti.8 in Ashwa Chikitsa Kathana, Taila Basti is recommended
in horses to relieve their fatigue immediately.9
Yogic Literature: - In Gheranda Samhita, Basti is included in Satkarma. Two kind of
Basti’s has been described on the bases of their application.
Jala Basti – To be done in water.
Sushka Basti – To be done on land.
In samhita
All the classical treatises of Ayurveda have emphasized the importance and wide
application of Bastikarma as the most effective therapeutic measures than the other.
Acharya Charaka has nicely described the uses, advantages and complications of
Bastikarma, “shareera shreshta” Shusruta elaborately described about Bastiyantra,
Netra, Types of bastis, complications and its management in kalpasthana. Avasthanusara
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
11
basti vyapath has been beautifully explained by Acharya Vagbhata. Sharangadhara also
has given much importance to bastikarma and he explained Uttaravasti. Yogaratnakar,
Bhavaprakasha and Vangasena also dealt the bastikarma by adding newer combinations
like vaitharana vasti, ksheera basti, etc.
Kashyapa equated the word “Amrutam” to the Basti, 10 and he indicated basti in
children’s. The present renowned author of Ayurveda have also elaborately explained the
possible modification of equipments this is definitely encouraged us and helps in easy
practice less tedious work with minimized complication.
MADHUMEHA
The knowledge of madhumeha is very familiar to Indians since prevedic period
there is ample of descriptions are found in this period.
Prevedic period: -
The lord Ganesha was a stoola pramehi. He suffered from prameha due to excess
intake of “Moodaka” and lack of strenuous work. His father Lord Shiva advised him to
take ‘Kapitta, jambu, and Shiva Gutika’ as a treatment of stoola pramehi.
Vedic period: -
A study of ancient literature indicates that diabetes was fairly well known and
well conceived as an entity in ancient India. The knowledge of the system of diabetes
mellitus, as the history reveals, existed with the Indians since prehistoric age. Its earliest
reference (1000 BC in the Ayurvedic literature) is found in mythological form where it is
said to have originated by eating Havisha, a special food that used to be offered at the
times of yagna organized by Dakshaprajapati. The disease was known as ‘Asrava’ during
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
12
vedic era (6000 BC)
Vedas are the oldest literature of the universe. In Kousika su.26/6-10 of
Atharvaveda, we find a reference of Asravana and Prameha.
In Atharvaveda Asrava vyadhis are mentioned, in which some symptoms like
rasasrava, atimootra, atisara etc are included. The Vedic Commentators Sayana and
Keshava described Asrava as mootratisara i.e. excessive urination. Later in 1962 whintey
interpreted Aasrava as flux, while Griffith named it as morbid flow.
The word Pramehe is used so many times in Kautilya’s Arthashastra (321-296
BC) in the context of inducing Prameha to the enemies as a part the criminal customs of
the kings, to dominate over the opposite. Mentioned a method of producing prameha, i.e.
the spot is obtaining from burning Chan lion (Krukalaka) and house lizard (Gruha
Goulika) together with the intestines of mottled frog (Chitra bheka) and honey, if
administered it causes prameha.
In Atharvaveda 6/44/3 Vishanaka drug is indicated in Vatavyadhis, one of the
commentators Keshava commenting on this, he explained “Vaikruta nashani as vaikruta
asravya nashani.”
In the mantra 23-1-3 of Atharvanaveda the drug emerged from valmika are
indicated in atisara, atimootra and nadivranam.
SAMHITA PERIOD: -
The golden age of Ayurvedic history is Samhita Kala. The main classical texts of this era
are Brihatrayis.
Charaka samhita: -
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
13
Maharshi Atreya - the father of Indian Medicine conducted earliest scientific study on
madhumeha It is a point of historical importance that in Charaka samhita nidana sthana
4/37, he mentioned the loss of sweet substance from urine. In Sutrasthana 17/78, he has
described prameha as Anusangi, and the stoola madhumeha occurs due to avritatwa of
vayu and Samprapthi of madhumeha in the same chapter.
Sushruta samhita: -
Sushruta, the father of surgery has narrated the aetiopathogenesis of prameha on
the basis of an endogenous entity being caused due to “Dhatvagnimandya”. The course
and complications of the disease along with different line of treatment are discussed at
various places in Sushrutaa Samhita
The most notable contribution from Sushruta is seen; he dedicated a separate
chapter for the management of madhumeha. He has described nivritti lakshanas of
madhumeha, on the basis of pathogenesis. Madhumeha of two types dhatukshayajanya
anssd Avaranajanya madhumeha.
Astanga hridaya: -
Vagbhata has described some specific drugs like Dhatri, nisha for the treatment of
Prameha.
Astanga sangraha: -
He expressed the similar opinion of the Charaka and Sushruta; later he quoted the
symptom Tanu madhuryata.
Kashyapa samhita: -
In vedana adhyaya of Sutrasthana Acharya Kashyapa mentioned the signs and symptoms
related to Bala pramehi.11
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
14
Bhela samhita: -
Two types of prameha are given in Nidanasthana swakritija prameha and prakritija
prameha.12
Harita samhita: -
Acharya Harita enumerated 13 types of prameha with different nomenclature like puya
prameha, Takra prameha, Rasa prameha, Ghrita prameha etc.13
MEDIEVAL PERIOD: -
In this period no more classics have been written but this period of history of
Indian medicine is known as period of commentators.
Madhavakara: -
Madhavakara (9th century A.D) in his work madhava nidana compiled the thoughts of his
earlier acharyas without adding any thing new to the knowledge on madhumeha
Gayadas: -
Gayadas (11th century A.D) commentators of sushruta samhita elucidated that the
symptoms of Avilatwa of urine in prameha is due to the presence of dooshya like meda,
mamsa etc (Su.Ni. 6/6)
Chakrapanidatta: -
Chakrapanidatta in 35th chapter he documented the treatment of prameha.
Dallhana
Another 12th centurion commentator of Sushruta samhita; while commenting on Sushruta
Review of Literature
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
15
samhita nidanasthana 6/3; he contributed a myth that females do not suffer from
madhumeha.
Sharangadhara
13th century A.D he belongs to 12th century, he described 20 types of prameha with some
new recipes for the management.
Bhavamishra
Acharya Bhavamishra added some new herbo-mineral preparations for the management.
Yogaratnakara: - Specific yogas are vividly explained.
Agnipurana
The Kshoudra and Kshoudraprameha are quoted; also some specific treatment is
mentioned for prameha.
Valmiki ramayana: -
There is a reference that the monkeys who were serving Rama, suffered from
madhumeha due to madhura Ahara sevana.
Ayurveda is well aware about the extent in which all the body tissues are involved in the
pathogenesis of Prameha. The outstanding pioneers of Ayurved Charaka, Sushruta and
Vagbhata better known as the holy triad made the earliest reference to diabetes as a
“diseased flow of urine” and “honey urine.” It seems, during this period no Greco-Roman
physicians were acquainted with symptoms of abnormal urine.
Vyutpatti
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
16
Etymology of Basti
The word ‘Basti’ has its origin from the root ‘Vas’ with the suffix of Pratyaya
‘Tich’ gives rise to the word ‘Basti’ and it belongs to masculine gender.
According to Siddhanta Kaumdi, the root ‘Vas’ gives following meaning:
1) “Vasu Nivase”13 - this means to stay, to reside and to dwell.
2) “Vas-aachadane” – which gives covering.
3) “Vas vasane surabhikarane”– Fragrance.
4) “Vasti vaste aavrunothi mootram” – which covers the urine.
5) “Nabheradhobhage mootradhare” – urinary bladder.
Paribhasha: -
The term basti can be used in different sense, in the context of Panchakaram; it
gives the following meaning.
1) “Vastinam deeyate vasti.”14
“Vastirabhideeyate yasmat tasmat vastiritismrita.”15
Basti means bladder and it is used as the measure devise for the bastikarma. The
medicines like decoction, Milk, oil, Ghee etc are taken in the basti and administered
through gudamarga by a basti netra. Hence the term basti is used to designate the process
in panchakarma.
Hence, Basti conveys the following meanings.
Medicine stays in large intestine for sometime after its introduction through the
rectum, which causes movements in large intestine and waste materials there in which
are begged for their elimination.
An organ where urine is collected i.e. urinary bladder, which is situated below the
umbilicus.
An instrument, which is used to introduce Basti drugs in the rectum.
Vyutpatti
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
17
Definition of Basti:
1) The apparatus used for introducing the medicated materials is made up of Basti
or animal urinary bladder16
2) The procedure in which the medicaments are introduced inside the body
through the rectum with the help of animal urinary bladder is termed as Basti17.
3) The bag made by animal bladder is termed as Basti.
4) Acharya Charaka has defined the Basti as the procedure in which the drug
prepared according to classical reference and administered through rectal canal
reaches upto the Nabhi Pradesha, Kati, Parshva, Kukshi churns the accumulated
Dosha and Purisha and spreads the potency of the drugs to all over the body and
easily comes out along with the Purisha and Doshas is called Basti.18
According to modern science, enema is the procedure in which any liquid
preparation is introduced through rectum by means of adequate instruments
(Ghosh) or injection as liquid or gas into the rectum.
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
18
Shareera
Focus of this study is on Madhutailika Basti. Therefore, a discussion on the anatomy and
physiology of guda and pakwashaya where the Basti is administered is necessary prior to
the discussion on the anatomy and physiology of Pancreas, pituitary gland, adrenalin
gland and liver, these are the sites of this disease.
The word shareera composes both structural and functional aspects of the body. As basti
in considered importantly in the subject certain anatomical features of rectum and large
intestine is also described.
Guda / Rectum
Synonyms:
Amarkosha - Aapanam, Payu
Jatadharam – Guhyam, Gudavartma
Vijayarakshita – Apanah, Mahatsrotas
Gangadhara – Bradhanam
Vachaspati – Vitmarga
Other words that are mentioned in contact to Guda various Acharyas are
Charaka – Uttaraguda, Adharaguda, Sthulaguda (C. V5/4, Si 9/3), Gudamukha
Sushruta – Gudamandhala, Gudavalaya, Payuvalaya, Gudaustha.
Vagbhatta – Gudamarga
Dalhana – Gudantram
Sushrutha has explained elaborately on the anatomical structure of guda
while describing Arsoroga. Guda is a part, which is the extension of sthoolantra with 41/2
angula in length. It has got 3 valis (parts) named as Gudavalitrayam.19
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
19
1.Pravahini – that which does pravahana.
2.Visarjini – that which does viasrajana
3.Samvarani – that which does samvarana
There is another structure called as Gudostha, which is about a distance of 1½
yavapramana from the end of hairs. The first vali samvarani starts at a distance of 1
angula from gudostha. The width of each vali will be 1 angula and of the colour of
elephant’s palate. 20
Charaka when described about the koshatagni has considered uttaraguda and adharaguda.
The modern commentators consider them as rectum and anus respectively.21 all Acharyas
have considered guda as one among the bahyasrotas and one among the dashajeevitha
dhamani. 22, 23, 24
The rectum forms the last 15cm of digestive tract and is an expandable organ for the
temporary storage of fecal material. Movement of fecal material into the rectum triggers
the urge to defecate.
The last portion of the rectum, the Ano-rectal canal, contains small longitudinal folds, the
rectal columns. The distal margins of rectal columns are joined by transverse folds that
mark the boundary between columnar epithelium of the proximal rectum and a stratified
squamous epithelium like that in the oral cavity. Very close to the anus or anal orifice, the
epidermis becomes keratinized and identical to the surface of the skin.
There is a network of veins in the lamina propria and submucosa of the ano-rectal canal.
The circular muscle layers of the muscularis externa in the region forms the internal
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
20
sphincter and is not under voluntary control. The external anal sphincter guards the anus
and is under voluntary control. Pudental nerves carry the motor commands. 25
Pakwashaya / Large intestine
Pakwashaya is considered as one among the ashaya by Sushrutha,
Vagbhata.26,27 Arunadatta comments as pakwashaya is the seat of pakwa anna i.e. that
which attains pureeshatha.28 Charaka and Vagbhata considered this as one among the
koshtangas. 29, 30 Sharangadhara has specified the location of pakwashaya (pavanasaya)
as below the Tila i.e. the liver.31
The horseshoe shaped large intestine or large bowel begins at the end of
ileum and ends at anus. Average length is about 1.5 meters and width of 7.5cms. It is
divided into 3 parts: -
1.Cecum – T portion (pouch like)
2.Colon – large portion.
3.Rectum – the last – 15 cm portion.
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
21
Absorption in the Large Intestine
The re-absorption of water is an important function of the large intestine. Although
roughly 1500 ml of material enters your colon each day, only about 200 ml of feces is
ejected. The remarkable efficiency of digestion can best be appreciated by considering
the average composition of fecal wastes: 75 percent water, 5 percent bacteria, and the rest
a mixture of indigestible materials, small quantities of inorganic matter, and the remains
of epithelial cells.32
In addition to reabsorbing water, the large intestine absorbs a number of other substances
that remain in the fecal material or that were secreted into the digestive tract along its
length:
Diabetes mellitus is a chronic disease due to the disordered carbohydrate metabolism and
results due to deficiency of insulin secreted by the beta cells of Islets of Langer Hans of
pancreas. But the hormones of pituitary and adrenal glands are also intimately related to
the development of this state. Apart form this liver had its own role in the manifestation
of this disease, because it stores the glucose in the form of glycogen under the influence
of insulin. Any alteration in this leads to diabetes. So following glands are involved in the
pathology of the diabetes mellitus –
Pancreas
Pituitary
Adrenal
Liver
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
22
Pancreas33
The pancreas lines within the abdomino-pelvic cavity in the ‘J’ shaped loop between the
stomach and the small intestine. It is a slender, plane organ with a nodular consistency.
The adult pancreas is 20 –25 cm long and weights about 80 gm. The broad head of the
pancreas lines within the loop formed by the duodenum as it leaves the pylorus. The
slender body extends transversely towards the spleen and the tail is short and bluntly
rounded. The pancreas is retroperitoneal and is firmly bound to the posterior wall of
abdominal cavity.
The surface of the pancreas has a lumby, lobular texture. A thin, transparent connective
tissue capsule wraps the entire organ. You can see the pancreatic lobules, associated
blood vessels and excretory ducts through the anterior capsule and the overlying layer of
peritoneum.
Arterial blood reaches the pancreas by way of branches of the splenic, superior
mesenteric and common hepatic arteries. The pancreatic arteries and Pancreaticoduodenal
arteries are the major branches from these vessels. Splenic vein and its branches drain the
pancreas.
The pancreas is primarily an exocrine organ producing digestive enzymes and buffers.
The large pancreatic duct delivers these secretes to the duodenum. A small accessory
duct, or duct of Sanforini, may branch from the pancreatic duct. The Pancreatic duct
extends within the attached mesentery to reach the duodenum, where it meats the
common bile duct from the liver and gall bladder.
The pancreas has two distinct functions, one endocrine and other exocrine. The exocrine
pancreas roughly 99 percent of the pancreatic volume consists of clusters gland cells,
Shareera
pancreatic acini, and their attached ducts. Together the gland and duct cells secrete large
quantities of an alkaline, enzyme rich fluid. This secretion reaches the lumen of the
digestive tract by traveling along a network of secretary ducts.
The endocrine pancreas consists of small groups of cells scattered among the exocrine
cells. The endocrine clusters are known as pancreatic Islets, or the Islets of Langer Hans.
Pancreatic islets account for only about 1 percent of the pancreatic cell population.
Nevertheless, a typical pancreas contains roughly 2 million pancreatic Islets.
Each Islet contains four different cell types.
Alpha cells –
Produces the hormone Glucagon, it raises blood glucose levels by increasing the rates of
glycogen break down and glucose release by the liver.
Beta cells – Produce the hormone insulin. Insulin lowers blood glucose by increasing the
rate of glucose uptake and utilization by most body cells and increasing glycogen
synthesis in skeletal muscles and the liver. Beta cells also secrete amylin, a recently
discovered peptide hormone whose role is uncertain.
Delta cells – Produce a peptide hormone identical to somatostatin, a hypothalamic
regulatory hormone. Somatostatin produced in the pancreas suppresses glucagon and
insulin release by other islet cells and slows the rates of food absorption and enzyme
secretion along the digestive tract.
“Evaluation of efficacy of Madhutailika 23Bastikarma In the management of Madhumeha
”
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
24
F cells –
Produce the hormone pancreatic polypeptide. It inhibits gallbladder contractions and
regulates the production of some pancreatic enzymes. It may help to control the rate of
nutrient absorption by the digestive tract.
Here focus is made on insulin and glucagon, the hormones responsible for the regulation
of blood glucose concentrations, which are given below. These hormones interact to
control blood glucose levels. When blood glucose levels rise, beta cells secrete insulin,
which then stimulates the transport of glucose across cell membranes. When blood
glucose levels decline, alpha cells secrete glucagon, which stimulates glucose release by
the liver.
Insulin
Insulin is a peptide hormone released by beta cells when glucose levels rise above normal
levels (70 to 110 m/c). Elevated levels of some amine acids, including arginine and
leucine, also stimulate insulin secretion. Insulin exerts its effects on cellular metabolism
in a series of steps that begins when insulin binds to receptor proteins on the cell
membrane. Binding heads to the activation of the receptor which functions as a kinease
and attaches phosphate groups to intracellular enzymes. Phosphorylation of enzymes then
produces Primary and secondary effects within the cell, the biochemical details remain
unresolved.
One of the most important effects is the enhancement of glucose absorption and
utilization. Insulin receptors are present in most cell membranes. Such cells are called
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
25
insulin-dependent. However, cells in the brain and kidneys, cells in the lining of the
digestive tract, and red blood cells lack insulin receptors. These cells are called insulin
independent, because they can absorb and utilize glucose without insulin stimulation.
Effects of insulin on its target cells –
01. Acceleration of glucose up takes
This effect results from an increase in the number of glucose transport proteins in the cell
membrane. These proteins transport glucose into the cell by facilitated diffusion.
02. Acceleration of glucose utilization and enhanced ATP production
This effect occurs for two reasons –
(a) The rate of glucose use is proportional to its availability. when more glucose enters
the cells, more is used.
(b) Second messengers activate a key enzyme involved in the initial steps of glycolysis.
03. Stimulation of glycogen formation (skeletal muscles and Liver cells)
When excess glucose enters these cells, it is stored in the form of glycogen.
04. Stimulation of amino acid absorption and protein synthesis
05. Stimulation of triglyceride formation in adipose tissues
Insulin stimulates the absorption of fatty acids and glycerol by adipocytes. The adipose
cells then store these components as triglycerides. Adipocytes also increase their
absorption of glucose; excess glucose is used in the synthesis of additional triglycerides.
As whole (summary) insulin secreted when glucose is abundant and this hormone
stimulates glucose utilization to support growth and the establishment of carbohydrate
(glycogen) and lipid (tryglyceride) reserves. The accelerated use of glucose soon brings
circulating glucose levels with in normal limits.
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
26
Glucagon
When glucose concentrations fall below normal, alpha cells release glucagons, and
energy reserves are mobilized. When glucagons binds to a receptor in the cell membrane;
it activates adenylate cyclase, and cAMP acts as a second messenger that activates
cytoplasmic enzymes. The primary effects of glucagons are –
Stimulation of glycogen breakdown in skeletal muscle and liver cells.
Stimulation of triglyceride breakdown in adipose tissues.
Stimulation of glucose production at the liver.
Gluconeogenesis
It is a process of glucose synthesis in the liver; the liver cells absorb amino acids from
blood stream, convert into glucose, and release the glucose into the circulation. The
results are a reduction in glucose use and the release of more glucose into the blood
stream consequently; blood glucose concentrations soon rise towards normal glycemic
level.
Pancreatic alpha cells and beta cells monitor blood glucose concentrations, and the
secretion of glucagon and insulin occur without endocrine or nervous instructions. Yet,
because the alpha cells and beta cells are very sensitive to changes in blood glucose
levels, any hormone that affects blood glucose concentration will indirectly affects the
production of insulin and glucagon. Insulin production is also influenced by autonomic
activity. Parasympathetic stimulation inhabits it.
Pituitary Gland 34
It is an important ductless gland with lot of functions, including the control of the other
ductless glands and of body growth. This gland measures 1.5 cm in the coronal plane, 1
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
27
cm in the sagittal plane and 0.75 cm in vertical form. It lies within the cella tarsica of the
sphenoid bone and the posterio-superior to the sphenoid air sinuses, below the optic
chiasma. It is flattened ovoid laying the hypophysial fossa and connected to the inferior
surface of the hypothalamic part of the brain by the infundibulum.
Structurally it can be divided
into 2 parts –
1) Anterior lobe
2) Posterior lobe
Posterior lobe of the hypophysis is the expanded end of the infundibulum and is
developed from the brain. The anterior lobe is much larger than the posterior lobe and
consists of three parts, which partly surrounds that lobe and the infundibulum. The distal
part forms most of the anterior lobe. It is separated from the posterior lobe by the thin
seat of glandular tissue applied to the posterior lobe. The infundibular part is a narrow
upward projection of the distal part. The anterior lobe develops from the ectoderm and
has only vascular connection with brain.
Anterior lobe is the master gland of the endocrine system, because it produces protein
tropic hormones, which affects the other ductless glands. In these secretions two
hormones are having direct action on carbohydrate metabolism, which leads to
hyperglycemia or hypoglycemia. The two hormones are –
Growth Hormone or Somatotrophic hormone – (GH or STH)
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
28
Adrenocorticotrophic hormone (ACTH)
The pituitary effect of STH on carbohydrate metabolism is to stimulate its storage.
Administration of growth hormone will produces hyperglycemia and glycosuria. The
high blood glucose level leads to its exhaustion and atrophy. So the growth hormone has
diabetogenic effect especially in man. The hormone is however increasing the glycogen
content of cardiac muscles.
Administration of ACTH possesses similar effects as induced by growth hormone. Both
STH and ACTH increase gluconeogenesis and diminish the rate of oxidation of glucose.
Thus the anterior pituitary has a diabetogenic role. GH is also known as Somatotrophin
and somatotrophic hormone causes cells to grow and multiply and it increases the rate of
protein synthesis. GH accelerates the rate at which glycogen stored in the liver is
converted to the glucose and released in the blood. GH raises blood glucose level and the
raise in the glucose, triggers insulin secretion. ACTH by stimulating secretion of gluco-
corticoids brings about hyperglycemia and also directly stimulates the release of GHIF
and inhibits the secretion of insulin. One stimulus that inhibits GH secretion is
hyperglycemia. An abnormally high blood sugar level stimulates the hypothalamus to
secret the regulating factor GHIF and it inhibits the release of GHAF and thus the
secretion of GH. As a result blood sugar level decreases.
Adrenal Gland 35
Adrenal glands are situated on the upper poles of the kidneys. Each gland weights about 4
gms. A distinct connective tissue capsule surrounds the parenchyma of the gland.
Beneath the capsule the cortex is arranged in three layers –
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
29
Zona glomerulosa – Secretes mainly aldeosterone and it secretes less amount of gluco-
corticoids and sex hormones.
Zone fasciculata –
It secretes mainly gluco-corticoides.
Zona reticularis – Secretes the sex hormone
and glucocorticoids,
All the three zones of the adrenal gland can
synthesis the gluco-corticoids. The chief action
of the gluco-corticoids is to increase
glyconeogenesis in the liver and stimulates formation of glycogen in the liver and
muscles. The adrenal cortex also asserts diabetogenic affects. Proteins are converted into
carbohydrates i.e. glyconeogenesis occur through the action of gluco-corticoids.
Therefore, constant production of carbohydrates and the insulin is required to metabolize
the excess of carbohydrates. The excessive glyconeogenesis exerts continued strain upon
the cells of Islets leads to hyperglycemia. When it is severe, it damages the beta cells and
permanent insulin deficiency results. The adrenal action however depends upon the
action of anterior pituitary.
Liver 36
The liver is the largest gland in the body. The greater part of the liver lies under the
covering of the ribs and costal cartilage. The liver is a dark brown highly vascular soft
organ. It is approximately 1/50th of the body weight in the adults, but larger in the
newborn. The liver lies normally in the right hypochondrial and epigastric regions. The
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
30
surrounding organs determine the shape of the liver; it retains the shape of a blunt wedge.
It has two surfaces – diaphragmatic surface and visceral surface.
Lobes of liver –
The main lobes of liver right
and left are demarcated form one another
above and in front by the falciform ligament
and below and behind by the fissures for the
ligamentum teres and ligamentum venosum.
The right lobe includes two subsidiary lobes.
The liver plays a central and crucial role in the regulation of carbohydrate
metabolism. Its normal functioning is essential for the maintenance of blood glucose
levels and of a continued supply to organs that require a glucose energy source. This
central role for the liver in glucose homeostasis offers a clue to the pathogenesis of
glucose intolerance in liver diseases but little insight into the mechanisms of liver disease
in diabetes mellitus.
The Role of the Liver in Glucose Homeostasis
An appreciation of the role of the liver in the regulation of carbohydrate homeostasis is
essential to understanding the many physical and biochemical alterations that occur in the
liver in the presence of diabetes The liver uses glucose as a fuel and also has the ability to
store it as glycogen and synthesize it from no carbohydrate precursors (gluconeogenesis).
Underscoring the important role the liver plays in maintaining normoglycemia.
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
31
Glucose absorbed from the intestinal tract is transported via the portal vein to the liver.
Although the absolute fate of this glucose is still controversial, some authors suggest that
most of the absorbed glucose is retained by the liver so that the rise in peripheral glucose
concentration reflects only a minor component of postprandial absorbed glucose.
Therefore, it is possible that the liver plays a more significant role than does peripheral
tissue in the regulation of systemic blood glucose levels following a meal.37 Katz and
associates, 38 however, suggest that most absorbed glucose is not taken up by the liver but
is rather metabolized via glycolysis in the peripheral tissues.
Many cells in the body, including fat, liver, and muscle cells, have specific cell
membrane insulin receptors, and insulin facilitates the uptake and utilization of glucose
by these cells. Glucose rapidly equilibrates between the liver cytosol and the extra
cellular fluid. Transport into certain cells, such as resting muscle, is tightly regulated by
insulin, whereas uptake into the nervous system is not insulin-dependent.
Glucose can be used as a fuel or stored in a macromolecular form as polymers: starch in
plants and glycogen in animals. Glycogen storage is promoted by insulin, but the capacity
within tissues is physically limited because it is a bulky molecule.
Insulin is formed from a precursor molecule, preproinsulin, which is then cleaved to
proinsulin. Further maturation results in the conversion of proinsulin into insulin and a
smaller peptide called C-peptide.
A small amount of proinsulin enters the circulation. It has a half-life 3–4 times longer
than that of insulin because it is not metabolized by the liver. However, proinsulin has
<10% of the biological activity of insulin.
Shareera
“Evaluation of efficacy of Madhutailika Bastikarma In the management of Madhumeha”
32
Insulin is metabolized by insulinase in the liver, kidney, and placenta. About 50% of
insulin secreted by the pancreas is removed by first-pass extraction in the liver. Insulin
promotes glycogen synthesis (glycogenesis) in the liver and inhibits its breakdown
(glycogenolysis). It promotes protein, cholesterol, and triglyceride synthesis and
stimulates formation of very-low-density lipoprotein cholesterol. It also inhibits hepatic
gluconeogenesis, stimulates glycolysis, and inhibits ketogenesis. The liver is the primary
target organ for glucagon action, where it promotes glycogenolysis, gluconeogenesis, and
ketogenesis.39, 40
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
33
BASTIKARMA: -
Among the shodhana Chikitsa basti has its unique importance in treating the major
disease like madhumeha, Vatavyadhis etc. due to the power and advantages it confers
on patients. It differs in many aspects like in principle, mode of application and in
wide advantages it renders. The term basti means bladder; it is used as a major device
for bastikarma. It is also said that the medicine in suspension, administered through
the bastiyantra, first reaches the lower abdominal part of the patient. The lower
abdominal area or the pelvis also contains the organ basti i.e.urinary bladder, due to
these reasons the term basti is used in Panchakarma.
Importance of Bastikarma: -
All the acharyas were appreciated basti has a unique form of treatment
modality considering the efficacy it generates in remodeling the hampered doshas. It is
uncomparable elimination therapy than the other because it expels the vitiated doshas
rapidly as well as it nourishes the body.41 It can be easily perform in all the age group
persons; where other shodhana procedures are difficult to perform.42 Bastikarma is the
best choice of treatment for vatadosha and vata associated with kapha and pitta. As vata
being chief among the three doshas and it is functional requirement for both kapha and
pitta, if once co-ordination gets disturbed then the disease is going to manifest.43 in
madhumeha kapha is arambhaka and vata is the preraka. Vata is responsible for gati
gamana, which is much requiring for shreera vyapara.44
Charaka very specifically given importance to treat the sthanika dosha first and
sthanantara dosha, Pakwasaya is said to the main seat of vata dosha. By adopting
treatment modality like bastikarma will helps in bringing vata into its normalsy, vata
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
34
mainly involved in the pathogenesis of mandhumeha and ohter diseases.45 Hence, it is to
be considered as one of the suitable treatment for vata dosha predominant diseases,
supporting to this Vagbhata named it as “Ardhachikitsa.”46 Apart form this it is
considered as superior then the other therapeutic measures; on account of its varied
actions like samshodhana, samshamana and samgrahana, etc.47
Charaka explained nirooha Basti is contraindication in udara vyadhi,48 again
while explaining yogya for nirooha basti; he indicated in Bala, Varna, Mamsa and
Shukrakshaya condition nirooha basti can be given,49 it is clear that nirooha is
contraindicated in specific conditions like were excessive rookshatha is present in such
condition it versions the condition. Madhumeha is a condition; were the detoriation of
bala, varna and ojas are roetinly noticed. For maintaining Bala and Varna of a patient;
basti can be given in madhumeha patient.
Classification of Basti: -
Knowledge of the classification is very essential for the better understanding point
of view. In classics different types of Basti are explained based on the amount of the
drug, the quality of the substance and the expected action of the Basti, etc. there is
difference of opinion in classification. The term basti has been used for all types of
bastikarma, which includes nirooha, anuvasana, uttarabasti etc. Charaka used the term
basti exclusively for nirooha eventhough he is considred both nirooha and anuvasana as
shodhana procedures.50 finely bastikarma has been brought into the following
classifications.51
1) Adhishtana bheda : - The site of application viz abhyantara and bahya
2) Dravya bheda: - on the bases of medicine used viz madhutailika basti, kashaya basti,
taila basti, ksheera basti, pichha basti
3) Karma bheda: - on the bases the action it does viz shoadhana basti, shamana basti,
lekhanabasti, brihmana basti, etc
4) Sankhya bheda: - The number of bastis given as a course yaga basti i.e. 8 in number,
kala basti i.e. 16 in number
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
35
5) Anushangika bheda: - miscellanios verities.
6) Matra bheda: - Based on quantity of vasti dravya used.
1. Adhishtana bheda: -
According to the site of application of basti it is of two types –
a. Internal
b. External
a. Internal
i) Pakwasayagata basti: - The administration of medicine via
ano-rectal route to pakwasaya.
ii) Garbhasayagata basti – The administration of medicine through
the vaginal route to garbhasaya.
iii) Mutrasayagata basti – The administration of medicine via
urethral route to mootrasaya.
iv) Vranagata basti – The medicine administered through the
vranamukha by the process of bastikarma.
b. External
In certain diseases the medicated oil is kept over the part of the body using
a cap or with flour paste for prescribed period of time and named after the site of
application of oil such as – Shirobasti, katibasti, urobasti, etc.
2. Dravya bheda: -
It is of two types
a) Nirooha basti (Evacuative or Un-unctuous Enema): -
The propornity of kwath is more, and it is the main ingredient among other
four common ingredients I.e.makshika, lavana, sneha and kalka. Nirooha basti
posseses varied therapeutic effects like shodhana; it makes the apakarshana of vit,
sleshma, pitta and anila. It restores the dridata, bala Varna, shukra and it prevents the
aging process; 52, it is named as asthapana basti, as it acts like a vaya and ayusthapaka.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
36
Madhutailika basti is the vikalpa of Nirooha; the synonyms of madhutailika vasti are
sidda basti, yapana basti and yuktarata basti.53
The effect of nirooha will spread all over the body; the potency of drug
reaches at the cellular cellular level thus it helps in eliminating the vitiated doshas
from all the srotases54,55.
ii) Anuvasana basti (Unctuous Enema): -
It is Sneha pradhana vasti hence auvasana is named as sneha basti. “Anuvasan api na
dushyatyanudivasam va deeyata ityanuvasana:” the peculiarity of this basti is no
adverse effects, it is safe, can be practice daily.56
Types
Based on the sneha matra it is of three types57
1) Sneha Basti: - 6 Pala (298ml)i.e.1/4th of the quantity of Nirooha.
2) Anuvasana Basti: - 3 Pala (144ml) i.e. half of the Sneha Basti.
3) Matra Basti: - 1½ Pala (72ml) and this is the minimum quantity of Sneha Basti
MATRA BASTI
Definition:
“Hrisvaya: sneha matraya: matrabasti: samo bhaveth” It is a type of Sneha Basti.
The Sneha matra is very less as compared to the Sneha Basti so it is named as matra basti,
56, 57, and .58
Indication:
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
37
Ashtanga Samgrahakara emphasized on regular administration of the Matra Basti
and it can be administered at all times and in all seasons just as Madhutailika Basti,
vaitarana basti.
Table.No-1
Sr. Indications Ch. A.H. A.S.
1) Karma karshita + - -
2) Bhara karshita + + +
3) Adhva karshita + + +
4) Vyayama karshita + + +
5) Yana karshita + - +
6) Stri karshita + + +
7) Durbala + + +
8) Vata Rogi + + +
9) Bala - + +
10) Vriddha - + +
11) Chintatur - + +
12) Stri - - +
13) Nripa - + +
Sr. Indications Ch. A.H. A.S.
14) Sukumar - - +
15) Alpagni - + +
16) Sukhatma - + -
Contraindication:
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
38
In classics, there are no major contraindications mentioned for matra Basti, but
Ashtanga Sangrahakara has stated that Matra Basti should not be administered in Ajirna
condition.
Qualities: The Matra Basti is promotive of strength, helps in easy elimination of Mala
and Mutra. Brimhana nature this basti helps in pacifying the Vata dosha.
Dose:
According to Vagbhata the dose of Hrsva Snehapana is recommended for matra
Basti. The matra which gets digeste in two Yama (i.e. 6 hours) is called as Hrsva matra.
Sushruta has explained the dose as ½ of the dose of Anuvasana Basti and according to
him the dose of Anuvasana Basti is ½ of the dose of Sneha Basti Hence, the does of
Matra Basti is 1½ Pala = 6 Tola = 72ml61.
According to Chakrapani the dose of Sneha Basti is 6 Pala, dose of Anuvasana
Basti is 3 Pala and of Matra basti is 1½ Pala47 (Ch. Si. 4/54).
On the basis of above references, it is clear that the dose of Matra Basti is 1½ Pala i.e.
6 Tola = 72ml.
3. Karma bheda: -
This classification is made baased on their action62, 63
a) Shodhana basti – Contains shodhana dravyas and removes dosha
and malas from the body.
b) Lekhana basti – Reduces medodhatu and produces lekhana in the body.
c) Sneha basti – Contains more of sneha and produces snehana
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
39
in the body.
d) Brumhana basti – Increases the rasadi dhathus and indirectly it
helps in nurishing the body.
e) Utkleshana basti – Causes utklesha of malas and doshas by
increasing its Pramana.
f) Doshahara basti – Purificatory or eliminating type.
g) Shamana basti – Produces shamana of doshas.
Sharangadhara added, shodhana basti, lekhana, brimhana, deepana and
pachana types of bastis.64 Vataghna basti, balavarnakrita basti, snehaneeya basti,
sukrakrit basti, krimighna basti, vrushatvakrit basti has been explained by Charaka.65
4. Sankhya bheda: -
Charaka has made this classification based on the number of snehabastis
and niroohabastis in a treatment. That is totle 8 basti in yaga basti, 16 in kala basti and 30
in karma basti.66
5. Matra bheda: -
The quantity may vary from person to person and it depends on
rogi bala, roga bala and vaya of the patient.
a) Dvadashaprasruta basti – In nirooha, the maximum dose or quantity of
bastidravya prescribed is dvadashaprasruta i.e. 24
palas.67
b) Prasritayogika basti – Charaka has prescribed various types of
nirooha in different doses considering the strength
of the patient and condition of the disease.68
c) Padaheena basti – matra of this basti is 9 prasruthi.69
6. Anushangika bheda: -
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
40
a) Yapana basti – Enhances bala, shukra and mamsa. In treating
the vyapats produced by excessive coitus. It can
be practice daily.70
b) Siddha basti – It increases the bala, varna, and prasanata.71
c) Yuktaratha basti – Mainly indicated for travelers on vehicles etc.72
d) Vaitharana basti –It is mainly concentrating on the elimination of
doshas.73
e) Ksheera basti – Explained for shoolam, vitsangam, anaha, and
mootrakrichra.74
f) Ardhamatrika nirooha basti –snehana and swedana karmas are not
required. Mainly it is indicated in
rajayakhsma, shoola, krimi and in vatarakta.
It improves sukrha and ojus.75
g) Picha basti – It is given with pichhila dravyas like
Shalmaliniryasa and lajjalu. It is indicated in
pichhalasrava and jeevashonita. It is acts as
Sangrahi.76
h) Mutra basti – It is Gomutra pradhana basti it is mridu in
nature, safe and pacifies the doshas.77
i) Rakta basti – it is indicated in adhika rakta srava.78
Drugs used in Basti Karma: -
Number of drugs belonging to animal and plant origin has been
described in the classics, which are used in bastikarma. For example, herbs, milk,
mutton juice, eggs, urine, alkalis, salts etc. The above lists suggest that almost all
available drugs can be used for bastikarma.80
1. Phalini drugs - Drugs useful for emesis can be used in
asthapanabasti. e.g: -phala, jeemutaka,
ikshwaku, dhamargava, kutaja, and
kritavedhana.
2. Sneha dravyas - Ghrita, taila, vasa, majja.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
41
3. Mutravarga dravyas - Aja, avi, go, mahisha, hasti, ushtra, haya, etc.
4. Asthapana & anuvasana gana - Dasamoola, bala, eranda, punarnava, yava,
kola, kulatha, guduchi, madanaphala, palasa
etc.
5. Adjuants for asthapanabasti - Trivrit, bilwa, pippali, kushta, sarshapa, vacha,
kutaja, satahwa, yashtimadhu, madanaphala.
6. Adjuants for anuvasanabasti - Rasna, devadaru, bilwa, madanaphala, satahwa,
swetapunarnava,raktapunarnava,gokshura,
agnimandha, syonaka.
Contents of niroohabasti82, 83, 84
The usual contents of nirooha basti are: -
1.Makshika (honey)
2.Lavana (rock salt)
3.Sneha (oil/ghee/taila)
4.Kalka (medicines made as paste)
5.Kwatha (decoction)
According to the condition of patient and disease other ingredients like
milk, mamsarasa, amla dravya, mutra and guda are also used.85 Taila is selected
considering the disease and condition of patient. Drugs for kalka, if no drug is
specifically mentioned shatapushpi choorna can be used.86 Kwatha is the decoction made
as per the ingredients selected rationally to suit the condition of the patient.
Contents and quantity of nirooha basti
The quantity of nirooha is 12 prasrita, out of this 5 prasrita kwatha i.e. 10
palas. The sneha should be 1/6th, 1/4th and 1/8th i.e. 4 pala, 6 pala, 8 pala in pitta, vata and
Bastikarma
kapha dosha respectively.87 in nirooha. 24 palas of nirooha dose may be adjusted as
follows:
1.Makshika – 4 palas.
2.Lavana – 1 karsha
3.Sneha – 4 palas.
4.Kalka – 2 palas.
5.Kwatha – 10 palas.
20 palas.
The remaining portion should be made up by avapa dravyas (or
prakshepaka dravyas) like gomutra, mamsarasa etc. i.e. 4 palas totals it to 24 palas.
According to Sushrutha88
1.Makshika – 4 palas.
2.Lavana – 1 karsha.
3.Sneha – 6 palas.
4.kalka – 2 palas.
5.Kwatha – 8 palas.
6.Avapadravya – 4 palas
Total quantity is 24 palas.
MADHUTALIKA BASTI
Nirukti: -
This unique basti contains madha and taila in equal proportionate hence this basti is
named as madhutailika basti89.
Paryaya: -90
Yapana basti
Yuktarata basti
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
42
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
43
Doshahara basti
Siddha basti
Types of madhutailika basti
All the Acharyas have been explained, different types of madhutailika basti’s with
different ingredients, those are as follows: -
According to sushruta: -91
Table No-2
S.no Ingredients Dose
1 Madhu 1-karsha
2 Saindhava 1-tola
3 Taila 1-karsha
4 Shatapushpi choorna 1-tola
5 Erandamoola kwatha 1-karsha
Importance of madhutalika vasti.92
This basti can be practice even in female, sukumaras, etc
Dosha niraharanartha, bala, varnartha, it can be continuously given with ought any
marked complications, easy administration,
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
44
Dashamoola madhutailika basti: -93
Vagbhata explains it in Astanga samgraha and in Astanga hridaya. The key ingredients are as follows: - Each 1 pala of Panchamoola and Gokshura,
Ksheera 1 adaka
Yastimadhu 1 prastha
Madhu, Taila, Seedhu, Sareeva, Bala, Sahachara, Darbha, etc
It is very mild and it is indicated in bala, sukumara, vrudda, and in female without
complication.
Vangasena also explained madhutailika basti and he mentioned its properties they are as
follows: -
Ingredients: - Madhu 1 Prakuncha
Taila 1 Prakincha
Eranda kashaya 6 Prakuncha
Saidhava 1 karsha
Shatapushpi ½ Phala
Madhutailika ksheera basti 94
It is explained by sangrahakara, considered as ksheerabasti. It is mainly indicated
in sukumara, sthree and mrudu persons.
Content of this basti are: - ksheera, guduchi, brihateedvaya and magadi (pippali)
Yastimadhu is used as kalka.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
45
Basti Yantra
The device used for basti karma is called as bastiyantra. It comprises by two parts –
1.Bastinetra
2.Bastiputaka
Bastinetra
The netra should be made of gold, silver, and copper or with other higher metals,
alloys, long bones, bamboo, wood etc. Generally netra must resemble like tail of cow
with a tapering end and a wider base, or like pyramid shape with round ends and smooth
surfaces.95 the dimensions are different for different age group.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
46
Table No: - 3
Measurements of Bastiyantra.96, 97,98.
Lumen of netra No. Age
in
years
Length
in
Angula
Diameter of narrow
end
Diameter of broad end
1. < 1 5 1 angula
2. 1 - 6 6 Size of green gram 1 angula
3. 7- 11 7 Size of black gram 1½ angula
4. 12-15 8 Size of kalayam 2 angula
5. 16- 20 9 Size of wet kalaya 2½ angula
6. > 20 12 Karkandhu 3 angula
Uttarabastiyantra
7. - 12 – 14 Sarshapa size -
Susrutha’s opinion
8. 1 6 Green gram Feather of kanku bird must pass
through.
9. 8 8 Black gram Feather of eagle must pass through.
10. 16 10 Kalayam Feather of peacock must through.
11 >25 21 Kolasthi Feather of vulture must pass
through.
Pramana of vranabasti netra
The hole should be of a mudga pramana, with 8 angulas of length.99
Karnika
In order to prevent undue penetration of the bastinetra deep in to the
rectum, a karnika or rim has to be made. It is to be placed at a required point above the
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
47
distal end. Two karnikas are provided on the netra at distance of 2 angulas between one,
another at proximal end to tie the bastiputaka properly.100
Bastiputaka
The container of the bastidravya is known as bastiputaka. And it
should be made suitable for well fitting with the bastinetra and should not have any
bad smell. If good bladder is not available oter materials like skin of lower limb or
neck of monkeys or other animals; thick cloth with sufficient strength and size are
recommended for the purpose101
As the technology advances the development various types of
materials are available to make up of bastiputaka and even disposable bastinetra are
available. The rubber bladder and polythene bags are best choice these materials are
disposable, safe and easy to perform.
Table No: -4
Netradosha and putakadosha102,103
No. Netradosha Features Effect
1. Hraswata Too short Dravya will not reach pakwasaya
2. Deerghata Too long Dravya go beyond the pakwasaya
3. Tanuta Too thin Produces kshobha
4. Sthoolata Too big Produces lakshana
5. Jeernata Old dhatu used Injury to guda
6 Shithilabandhana Not fixed properly to the
putaka
Dravya comes out
7. Parshwachhidra Hole on side Leakage of dravya happens
8. Vakrata Curved / irregular Dravyagati becomes irregular
9. Assannakarnika Karnika too near Karma becomes of no use
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
48
10. Prakrustakarnika Karnika too far Causes raktasrava by gudamarma
peedana
11. Anusrotata Small hole Cannot perform properly
12. Mahasrotrata Broad hole Cannot perform properly
No. Putakadosha Features Effect
1. Vishama Shape not in uniform Gati vishamata happens during
pressing
2. Mamsala Muscular tissue present Produces offensive small
3. Chinnachidrayukta Presence of hole Dravya comes out
4. Sthoola Thick one Does not push dravya
5. Jalayukta Anastamosis present Produces leakage
6. Vatala Excess air space Frothy type of dravya
7. Snigdha Unctuous Slip form the hand
8. Klinnata Wet Difficult to pass through
Indications and contra-indications of Bastikarma
As basti is one of the prime treatment modality of Ayurveda,
the knowledge of the indication and contraindication will make the sucsess in the
treatment.
A brief description has been made here.
Table No: -5
Ayogya / anasthapya104,105,106
Bastikarma
f “Evaluation oeffica hutailika sti cy of Mad ba In the mana adhum a”gement of M eh
49
No. Type of patient Cha. Su. Vag. Complication
1. Ajeerna + + -
2. Atisnigdha + - +
3. Peetasneha + - -
Dooshyodara, Moorchha, Shotha.
4. Utklishtadosha + - -
5. Alpagni + + +
Teevra aruchi
6. Yanaklanta + - -
7. Atidurbala + + -
8. Kshudhaarta + - -
9. Trishnaarta + + -
10. Sharmaarta + - -
Shaeerashosha, pranaparodha,
Kruchraswasa
11. Atikrisha + + +
12. Bhuktabhakta + - +
13. Pitodaka + - -
More karshya, utklesha of dosha
happens
14. Vamita + - +
15. Virikta + - +
More rookshata happens
16. Krita nasyakarma + - + Manovibhrama, Srotonirodha
17. Krudha + - -
18. Bheeta + - -
Bastidravya moves up
19. Matha + + -
20. Moorchita + + -
Samnjanasha and Hrudayopaghata
21. Prasaktachhardi + + +
22. Prasaktanishteeva + - +
23. Swasaprasakta + + +
24. Kasaprasakta + + +
25. Hikkaprasakta + - +
Bastidravya moves up because of the
existing urdhwagati of vata
26. Baddhagudodara + - +
27. Chhidrodara + - +
28. Dakodara + - +
29. Adhmana + - +
Leads to death by causing severe
distension of abdomen
30. Alasaka + - -
31. Visoochika + - -
32. Asmadosha + - -
33. Amatisara + - +
Causes teevra amavastha of the body
34. Madhumeha,
Prameha
+ + + Vyadhi vardhakam
35. Kushta + + +
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
50
Table No: -6
yogya /asthapya107,108,109
No. Indication Ch. Su. Vag. No. Indication Ch. Su. Vag.
1. Sarvangaroga + + - 37. Rajakshaya + + +
2. Ekangaroga + + - 38. Vishamagni + - -
3. Kukshiroga + - - 39. Spikshoola + - -
4. Vatasanga + + + 40. Janushoola + - -
5. Mutrasanga + + + 41. Janghashoola + - -
6. Malasanga + + + 42. Urushoola + - -
7. Shukrasanga + - + 43. Gulphashoola + - -
8. Balakshaya + - - 44. Parshnishoola + - -
9. Mamsakshaya + - - 45. Prapadashoola + - -
10. Doshakshaya + - - 46. Yonishoola + + -
11. Shukrakshaya + + - 47. Bahushoola + - -
12. Aadhmana + + + 48. Angulishoola + - -
13. Angasupti + - - 49. Sthanashoola + - -
14. Krimikoshta + - - 50. Dantashoola + - -
15. Udavarta + + - 51. Nakhashoola + - -
16. Sudhatisara + + + 52. Parvasthishoola + - -
17. Parvabheda + - - 53. Shopha + - -
18. Abhitapa + - - 54. Sthmaba + - -
19. Pleehadosha + - + 55. Aantrakoojana + - -
20. Gulma + + + 56. Parikartika + - -
21. Shoola + + + 57. Maharogoktavatavyadhi + - +
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
51
22. Hridroga + - - 58. Jwara - + +
23. Bhagandara + - - 59. Timira + + -
24. Unmad + - - 60. Pratishaya - + -
25. Jwara + - + 61. Adhimantha - + -
26. Bradhna + + + 62. Ardita + + -
27. Shirashoola + + + 63. Pakshaghata + + -
28. Karnaroga + - - 64. Ashmari - + -
29. Hritshoola + - - 65. Upadamsha - + -
30. Parshwashoola + - - 66. Vatarakta - + -
31. Prushtashoola + - - 67. Arshas - + -
32. Katishoola + - - 68. Stanyakshaya - + -
33. Vepana + - - 69. Manyagraha + + -
34. Aakshepa + + - 70. Hanugraha + + -
35. Angagaurava + - - 71. Ashmari - + +
36. Atilaghava + - - 72. Moodhagarbha - + +
Indications for anuvasana basti 110,111,112
Anuvasana is indicated in patients who are already indicated
for asthapana, but special mention has been given to certain conditions like rooksha,
kevala vataroga and atyagni where anuvasana is more beneficial.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
52
Table No: -7
Persons unfit for the anuvasana basti 113,114
No. Contraindications Ch. Su. Vag. Complications
1. Anasthapya + + +
2. Abhuktabhakta + - + Sneha moves upwards
3. Navajwara + - -
4. Kamala + - +
5. Prameha + - +
Leads to udara
6. Arshas + - - Leads to aadhmana
7. Pratishyaya + - -
8. Pandu + + +
9. Arochaka + - - Leads to more annabhilasha
10. Mandagni + - -
11. Durbala + - -
Increases the condition
12. Pleehodara + + +
13. Kaphodara + + +
Leads to more dosha vardhana
14. Oorustambha + - +
15. Garapeeta + - +
16. Kaphabhishyanda + - +
17. Gurukoshta + - +
18. Shleepada + - +
19. Galaganda + - +
20. Apachi + - +
21. Krimikoshta + - +
22. Prameha - + +
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
53
23. Kushta - + +
24. Sthaulya - + +
25. Peenasa - - +
26. Krushna - - +
27. Varchobheda + - +
28. Vishapeeta + - +
Preparation and procedures of bastikarma
The preparation and procedures made before, during and after
administration of nirooha, anuvasana, uttarabasti with little differences. Generally, these
procedures are classified into three parts: -
1.Poorvakarma (pre-operative)
2.Pradhanakarma (operative)
3.Paschatkarma (post-operative)
in classics many complications are mentined that are produced due to
improper and in efficient administration. Better practical experience is necessary to
prevent the possible complications.
Selected patients for basti therapy have to undergo through clinical
examinations to ascertain the physical as well as the mental conditions. Usually the
following ten factors are to be considered for clinical examination.115
1.Dosha 2.Oushada 3.Desa 4.Kala 5.Satmya
6.Agni 7.Satwa 8.Vaya 9.Bala
This will enable the physician to decide, the type of basti, number of
bastis, basti dravya, etc to be administered in the particular patient.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
54
Dose schedule116,117,118
Table No: - 8
The adult dose of nirooha basti is dvadashaprasrita i.e. 24 palas.
Dose No. Age in
Years Ch. Vag. Su.
1. 1 ½ prasrita
i.e. 1 pala
1 pala 2 anjalis of patients hand
2. 2 2 pala 2 pala
3. 3 3 pala 3 pala
4. 4 4 pala 4 pala
5. 5 5 pala 5 pala
6. 6 6 pala 6 pala
7. 7 7 pala 7 pala
8. 8 8 pala 8 pala 4 anjalis of patients hand
9. 9 9 pala 9 pala
10. 10 10 pala 10 pala 8 anjalis of patients hand
11. 11 11 pala 11 pala
12. 12 12 pala 12 pala
13. 13 14 pala 14 pala
14. 14 16 pala 16 pala
15. 15 18 pala 18 pala
16. 16 20 pala 20 pala
17. 17 22 pala 22 pala
18. 18 – 70 24 pala 24 pala
19. Above 70 20 pala 20 pala
To be fixed based on netra,
dravya pramana, age, bala
and saralaswabhava
20. Above 25 12 prastha
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
55
PROCEDURE OF BASTIKARMA: -
Anuvasanabasti
Pre-operative procedure
The patient should pass is natural urges then body of the patient should be
anointed with suitable sneha and mrudu sweda with hot water. He is advised to have his
prescribed meal it is madyama matra and made to take a short walk. Patient is asked to lie
over basti droni which is not very high, and the head must be at lower level. The patient
should be on his left side drawing up the right leg and straightening the left leg.
Operative procedure
The prescribed amount of taila should be taken in the bastiputaka and tied
well placing the bastinetra in position. Air is trapped from bastiyantra by gently pressing
the bastiputaka. Then the anal region and the netra should be smeared with oil to
minimize the pain and irritation. Gently probe the anal orifice with the index finger of the
left hand and introduce the bastinetra through it into the rectum up to the mark of first
karnika. Keeping in the same position press the bastiputaka by putting the adequate force
then withdraw from the sight.
Post-treatment procedures
The patient is kept in same position as long as it would take to count up to
hundred. The patient should be gently struck three times on each of the soles and over the
buttocks. The distal part of the cot should be raised thrice. Allow him to lie for sometime
in the same position, if given sneha passed immediately; another anuvasanabasti should
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
56
be adopted. After passing the motion with sneha in proper time the patient is allowed to
take light food if he feels hungry. 9 hours is the maximum time for basti pratyagamana.
Niroohabasti
Pre-treatment procedure Sutable time to administer Niroohabasti is Madhyahne
kinchidavrute i.e is in noon, with an empty stomach. Abhyanga and swedana
should be done prior to the procedure and the patient is advised to be lie upon the
cot as in anuvasanabasti. Bastidravya prepared as per the direction should be taken
in bastiyantra and introduced; other procedures are as same in anuvasana basti.
Post-treatment procedures
After the pradhana karma patient is lie in supine position pillow should be
plced below the vankshana pradesha. The other procedures followed in anuvasana should
not be done in this codition. After passing motion he may be advised to take bath with hot
water and have normal food along with yusha, mamsarasa or milk in kapha, vata and pitta
predominant diseases respectively. The maximum time for bsati pratyagamana is one
muhurtha (48 minutes). If it did not pass out, giving basti, which consists of sneha,
kshara, mutra, amla dravyas and Phalavarti, can bring it out. It should have the properties
like snigdha, Ushna, and teekshna. If the nirooha is passed out instantly again 2 or 3
bastis can be given. But if the patient shows excited symptoms of vata, snehabasti should
be given immediately. As jataragni is not much hampered; so specific regimen is not
necessary during the pariharakala.119
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
57
Complications of basti Generally basti vyapatas are classified under two catogaries:-
1) vaidya kruta 2) bastikruta
complications of Snehabasti 120
Six types of complications may occure due to the following factors
1. Vata, 2.Pitta, 3.Kapha, 4.Atibhukta, 5.Pureesha, 6.Abhukta Specific signs and symptoms with treatments are not mentioned
Basti vyapats:-121
Twelve bastikruta vyapats are explained in classics those are as follows:-
1. Ayoga: -
If administred less quantity of basti dravya, saidhava, add oil leads to
heaviness in abdomen, obstruction of flatus stool and urine, local burninsensation,
inflammation, itching, anorexia and dyspepsia.
2. Atiyog: -
Administration of teekshna basti in mridu koshta person leads to atiyoga and
symptoms are similar as in vamana-virechana atiyoga.
3. Klama: -
Conduction of mridu basti in ama avastha, pitta and kapha gets vitiated and
srotorodha; leads to dyspepsia. There after vata also become vitiated and causes
fatigue, syncope, burning sensation, colic, chest pain, heaviness.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
58
4) Adhmana: -
Due to administration of alpa veerya drugs to strong person, rooksha
person and costive bowel, the drugs not able to expel vitiated doshas and vata gets
vitiated leads to adhmana causing pain in basti and hridaya, severe burning sensation,
pain in testicles and groin.
5. Hikka:-
Hiccup results in administering teekshna basti to weak person and mrid
koshta with excessive expulsion of doshas.
6. Hritprapti:-
Bastidravya reaches the heart by entering into deeper levels due to
complete squeezing or improper handling of bastiputaka and causes
pain in chest andthe surroundings.
7. Urdhwagamana:-
Suppression of urges before or after bastikarma and squeezing bastiputaka with
high pressure leads to the upward movement and may come out through mouth.
8. Pravahika:-
Administration of less potent and insufficient quantity of bastidravya to the
person
suffering form intensive vitiated doshas leads to pravahika.
9. Shiroarti:-
Includes symptoms of headache, earache, deafness, tinnitus and coryza,
eye
disordersdue to administration of less potent sheetaveerya dravyas with
insufficient quantity toweak persons.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
59
10. Angarti:-
Administration of teekshna basti without conducting pre-operative procedures like
abhyanga and sweda leads to angarti with upward movement of vata and twisting and
pricking pain in the body.
11. Parikartika:-
Administration of ruksha and teekshna basti in excessive quantity to the person
having mridukoshta and in conduction of less vitiated doshas leads to the excessive
expulsion of doshas causing parikartika.
12. Parisrava:-
Administration of teekshna and ushna bastis to the person suffering from pitta
roga / raktapitta leads to parisrava and causes burning sensation, erosion and
Cutting pain in anal region, severe bleeding and fainting.
Defects of physician 122
1.Sa vata bastidana – Entry of an air into rectum leads to pain in
abdomen and colic.
2.Druta praneeta – Quick administration of basti dravya leads to pain
in hip, anus, thigh, calves and retention of urine.
3.Tiryak praneeta – Horizontal introduction leads to blockage at the
tip of bastinetra. Introduction of bastidravya by
pressing basti putaka more than once leads to chat
pains, headache, and pain in thighs.
4.Ullipta – Introduction of bastidravya by pressing
bastiputaka more than once leads to chat pains,
headache, and pain in thighs.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
60
5.Sakampa bastidana – Shivering while administration leads to erosion,
burning and swelling at anal region. Not deeply
introduced leads to burning pain in intestines.
6.Apraneeta – Not deeply introduced leads to burning pain in
intestines.
7.Atimanda data – If done too slowly drug does not reach till
intestines.
8.Ativega data – Forceful introduction leads to the dravya reaching
up to koshta and sometimes may come out through
upper orifices.
Basti Karmukata.
Bastikarma having mulitidimentional therapeutic effects as early mentioned
for better understanding it can be studied under the following headings.
The procedural effect
The rationality behind the left lateral position is the gud
valees becomes relaxed there by it helps in the administration of basti. Pakwashaya
resides in the given left side so the given basti dravya reaches the pakwasaya, as it
is the main seat of vata; hence the given drugs will counter act the vatadosha. He
also mentions that the grahani is situated in the left side. Chakrapani states that
Agni will be in the natural state in the posture while Gangadhara says; Agni,
grahani and nabhi are present in the left side. Jejjata comments Agni is present left
side over the nabhi, guda has got a left sided relation with sthoolantra. So
bastidravya can reach to the large intestine and grahani, as they are present in the
sequence.
Action based on drug effect
Action of bastidravya is due to its Anupravanabhava, which
contains sneha along with other dravyas like makshika, saidhavaSneha easily moves
up to grahani by anupravanabhava guna similar to that of dravya, which freely
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
61
moves in the utensil. Charaka says bastidravya reach nabhi, katipradesha and
kukshi.
The Shodhana effect
The action of basti is mainly depends on its veerya. The drug
used in the basti karma will however spread in the body from pakwasaya due to
their veerya; through the appropriate channels and draws the vitiated doshas to
pakwashaya. It is like sun in the sky draws the water from earth. The veerya is
drawn into the body by vata dosha i.e. first by apana, then udana and throughout the
body by vyana. In charaka siddi he gives a simily like water sprinkled at the root of
tree circulates all over the tree and nourishes the body by its own specific property.
In the same way bastikarma eliminates the morbid doshas and dooshyas from all the
parts of the body.
Probable Mode of Action
Practically we can see that after appropriate administration of
bastikarma the signs and symptoms of vatavyadhi will be reduced.
Bastidravya enters into the pakwasaya, where the water and
minerals are absorbed in proximal colon. Sodium and potassium which are essential
fundamental factors of the body, it is prove that bioavilability of a drug is more in
rectal rout. The basti dravyas gets absorbed by intestinal microflora; their by it
maintains the electrolyte ballence in the body. It enhances the biodegradablity of the
drugs and it increases the absorption of colon. The pakwashaya contains the
maximum number of nerve plexuses originating from the hypo gastric plexus and
lumbosacral plexus etc. and spreads all over the body. The given drug gets star
absorbing in intestinal flora, through heammoroidle vein potency of drug enters in
to the systemic circulation. Bastidravya prepared by madhu, lavana, sneha etc helps
in formation of healthy bacteria in large intestine, it is essential for the absorption
and nourishment at cellular level.
Bastikarma
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
62
Another probable method is based on veerya. It is possible
the veerya of the bastidravya pass through the autonomic nervous system and
expels out vitiated dosha from the body, as we see in the pressure receptors. When
bastinetra is introduced in the rectum the same phenomenon may take place, which
results in initiation of defecation reflex due to visceral distention and pressure
response.
Saindhava contains NaCl and it is integral part of the body. It
is having properties like srotosravaka, srotoshodhaka, etc these are necessary in
generating the action potential, it maintaince the osmotic pressure. The release of
catecholamines during visceral distention initiates the pressure response and
ultimately helping in defecation. When hypertonic solution is given in the form of
bastidravya, it circulates from blood vessels to the outer fluid.
Absorption of bastidravya 60%-80% of water absorbed from the
gut, Absorption in the proximal colon is better than the distal part as a result this
rout substitute’s oral rout.
Madhumeha
Madhumeha
Charaka explained Madhumeha under “Prameha” in Sutrasthana 17th, Nidanasthana 4th
and Chikitsa 6th chapter. Sushruta Acharya also explained madhumeha in Nidana 6th
chikitsa 11-12th and 13th chapter. In Chikitsasthana Sushruta has dedicated an exclusive
chapter for madhumeha itself. Even Vagbhata also explained madhumeha in Nidana
stana and chikitsa stana.
Majority of the descriptions are available in the context of Prameha, such as
Nitukti samanya Nidana. Samanya samprati suits madhumeha and has it is one among 20
types of Pramehas and all the Pramehas in due course, if neglected or not treated attain
the stage of Madhumeha. Considering all the above points, the description of Prameha
will also be made along with Madhumeha. Diabetes mellitus has a nearest clinical entity
of a Madhumeha so a very brief description of diabetes mellitus will be made in this
particular study.
Nirukti (Etymology): -
Madhumeha is composed by two words madhu and meha. It is a masculine gender
formed by “Mihtghy”
The word Madhu is derived from the root ‘Mana’ and the meaning as
“manaava bhodane” i.e., which gives the psychic contentment (vachaspathyam); it
refers to the meaning Honey, Kshoudra, Madya, Pushparasa, Jala, and Madhurasa etc.
MEHA: - The word ‘Meha’ is derived from the “Miha” Dhatu124, which is employed in
the sence of Sinchana, Ksharana and Prasrava (excessive excretion), making
water and as a prameha RogaBheda (Vachaspathyam).
“Mehati ksharathi shukratiranena iti.”
“Evaluatio In the management of Madhumeha”
64
Madhumeha Prameha: - It is also a masculine gender formed by “Pra + miha”.
In Shbadha kalpadruma, Meha or Prameha is defined as follows.
“Prakarshena mehati ksharthi. Iti veerydiranaenaiti prameha.”
The literary meaning of Prameha is to micthurate, the verbal noun Mehanam
Signifies urination as well as acts of passes any morbid urethral secretion. Hence the
disease is named, as madhumeha ‘Meha’ is Synonym of Mutra dosha by Raja Nighantu
and bahumutrata by Hemachandra.
Paribhasha (Definition)
Madhumeha is a disease in which mutra of the patient attains similar property like
madhura (honey). The patient passes the urine like madhu, which is having Kashaya,
Rooksha Guna along with the Prabhoota Avila mutrata.125
Acharya Charaka has given a definition of madhmeha as the disease in which one
passes urine as astringent, sweet and rough (Cha.Ni). Sushruta used the word Kshoudra
meha as synonym for madhumeha and he defined it as the urine of patient resemble like
honey and acquires a sweet taste.
According to Vagbhata in any types of Prameha not only urine the whole body also
becomes sweet; it is to be named as madhumeha.126
Definition of diabetes mellitus
The term diabetes mellitus described as a metabolic disorder of multiple
etiology characterized by chronic hyperglycemia with disturbances of carbohydrate,
fat and protein metabolism resulting from defects in insulin secretion insulin action
or both. Although hyperglycemia is most outstanding of its biochemical measures,
diabetes means to be a pan metabolic disorder. It is generally accepted that all the
derangements result from either absolute or relative deficiency of insulin in
association with almost reciprocal changes in the activity of glucagons.127
“Evaluatio In the management of Madhumeha”
65
Madhumeha Natural history of type 2 diabetes
Diabetes mellitus refers to a range of conditions that are all characterized by elevation of
the blood glucose level. It may be roughly divided into two principal varieties, type I and
type II, with different etiologies. Type I diabetes presents in childhood as an autoimmune
attack on the pancreatic ß-cells that result in their complete destruction: consequently, the
patient must take insulin for the rest of their life.128 It accounts for <10% of all diabetes
and will not be considered further here. Impaired glucose tolerance, which precedes
diabetes and is a risk factor for the disease, currently, affects a further 200 million
worldwide. Until recent years, type II diabetes was rarely observed in individuals under
the age of 50, but increasing numbers of children are now being diagnosed with the
disease.129 this probably reflects the growing prevalence of childhood obesity, as type 2
diabetes is exacerbated by obesity and a sedentary lifestyle.
Diabetes leads to a reduced life expectancy and quality of life, and a greater risk
of heart disease, stroke, peripheral neuropathy, renal disease, blindness and amputation.130
The direct health care costs of the disease are also considerable, and have been estimated
at around 5% of the total annual expenditure on health in Western societies. Both insulin
secretion and insulin action are impaired in type-2 diabetes (reviewed in. Their relative
importance has been hotly debated, but it is now recognized that ß-cell dysfunction is a
key element in the development of the disease.131 Abnormalities in insulin secretion
precede the onset of type-2 diabetes and may be present even when subjects show normal
glucose tolerance. By the time of diagnosis, insulin secretion is significantly reduced and
it continues to diminish inexorably throughout the course of the disease.132 Type 2
“Evaluatio In the management of Madhumeha”
66
Madhumeha diabetes can also occur in the absence of insulin resistance and, conversely, some severe
forms of insulin resistance (such as those caused by mutations in the insulin receptor) may
not be accompanied by diabetes. It now appears that insulin resistance only leads to
diabetes if combined with a genetically determined propensity to ß-cell dysfunction.133 in
these individuals, however, insulin resistance plays an important role in the development
of diabetes by placing an increased demand upon the ß-cell that it is unable to match.
Theoretically, the insulin secretary defect could result from either a failure of ß-
cell function or a reduction in ß-cell mass (due to increased apoptosis or reduced ß-cell
replication). Most quantitative estimates of ß-cell density in post-mortem tissue indicate
that type-2 diabetics have either no change or <30% reduction in ß-cell mass, 134 that is
independent of the duration of the disease. A substantial reduction in ß-cell mass is only
found in association with amyloidosis, which occurs at later stages of the disease. In
baboons, a decrease in ß-cell mass of >50% is require to cause diabetes and
hyperglycemia does not occur in type-1 diabetics as long as ß-cell mass remains above
30–50%.135 It therefore seems that the insulin secretary defect in type 2 diabetes does not
result primarily from insufficient ß-cell mass but rather from impaired insulin secretion.
“Evaluatio In the management of Madhumeha”
67
Madhumeha Paryaya (Synonym): -
Acharya Charaka and Sushruta used the term madhumeha, kshoudrameha in place of
madhumeha.
Some other synonyms are found in classics.
Ojomeha: -
It is enumerated as a subtype ofvataja prameha amongst the four. Acharya
Charaka has mentioned that the vitiated vata changes sweet taste of oja into kashaya
resulting in ojomeha (cha.si.6/17)
Pushpameha: -
In Anjana, Nidana the word paushpameha has been narrated paushpa rasa denotes
madhu. Above all synonyms postulated unanimously that all our Acharya’s have
mentioned the urine concordant with madhu.
NIDANA
Nidana (etiological factors) means the causative factors for producing a disease.
According to this any factor, which has a tendency or capacity to produce
disease, can be considered as nidana.
The knowledge of the causative factors is very essential to assess the
sadhyasadyata and chikitsa. It has been classified under various headings with different
views. Among them one classification reads as Bahya and abhyantara hetu. Bahya hetu is
an extrinsic factor to the shareera to cause a vyadhi and it includes ahara achare, kala etc.
Abhyantara hetu is an intrinsic factor and it comprises the doshas and
doshyas.
Charaka acharya classified specifically bahya nidana in to two types’ samanya
and vishesha. Specific nidana are explained for madhumeha. Samanya nidanas of
“Evaluatio In the management of Madhumeha”
68
Madhumeha pramehas and vataja prameha nidana are attributed to madhumeha, as madhumeha is one
of the vataja prameha.
For all types of pramehas Kapha dosha is the key factor and it can be established
by gangadhara’s version. According to him Gulma is caused by vayu, raktapitta by pitta
and madhumeha caused invariably due to the vitition of kapha dosha. Especially in
madhumeha kaph is the arambhaka dosha and vata is the preraka dosha to kapha.
In sthoola the madhumeha is mainly due to doshavarana which is caused by the
vitition of kapha it avarana and leads to vataprakopa. Though the kapha is arambhaka or
main dosha in the samprapti of madhumeha pitta and vata also play an important role in
complicating the disease.
Samanya Nidanas are those, which are explained in general irrespective of the
concerned. This nidanas of various pramehas are discussed below can be grouped under
two main varieties.136
Sahaja (Hereditary)
Apathyaja (Acquired)
Sahaja (Hereditary Causes): - Charaka and Sushruta have explained that bheeja dosha
is also a cause for madhumeha. Sushruta included this disease under adhibala pravritaja
category. Here the term beeja considered as shukra and shonita. If beejas are vitiated with
dosha, it is responsible for causation of prameha they will produce a jatha prameha,
further prameha has also been considered as kulaja vikara.
Apathyaja (Acquired causes): -
Again it is classified into two groups,
Samanya (General).
Vishesha (According to dosha).
This samanya nidana can again be classified into types: -
Ahara Sambandha.
Vihara Samabandha.
“Evaluatio In the management of Madhumeha”
69
Madhumeha Table No: -9
1) AHARA SAMANDI NIDANAS137: -
SL
NO. NIDANA Caraka Sushruta Vagbhata Ma.ni Bhe.Sam Bha.Pra Y.R
1 Dadhi + - + - + + 2 Gramya, Oudaka,
Mamasa + - - + - + +
3 Anupa Mamsa + - + + + + + 4 Payaha + - + 5 Navanna pana + - - + - + + 6 Guda vikara + - + + - + + 7 Sheeta,
Snigdha,
Madhura
Madya sevena
- + + - - - -
8 Dravannapana
sevena - + - - - - -
9 Swadu, Amla, Lavana,
Snigdha, Pichhila,
Shutala ahara
- + + - - - -
10 Sura sevana - - + 11 Ikshu rasam + + + - - - - 12 Adhyasana 13 Medovardhaka
AharaAtiSeven
a
Table No: -10
2) VIHARA SAMBANDI NIDANA’S137: -
S.no. Nidana Charaka Sushruta Vagbhata
1 Asya sukham + - -
2 Swapna Sukham + - -
“Evaluatio In the management of Madhumeha”
70
Madhumeha 3 Diva Swapnam - + -
4 Avyayamam - + -
5 Alasyam - + -
6 Chinta Tyaga
7 Swapnaprasanga + - -
8 Shayanaprasanga + - -
9 Asanaprasanga + - -
Along with these nidanas the other factors, which affect the kapha dosha, are to be
considered as madumeha nidhana. In general the above factors, which are explained in
the table, are for prameha. Still the same factors are held responsible for the causation of
madhumeha.
The above said nidhanas can be classified under apathyanimittaja and it is termed
as swakruta.
Apathya is that which is unconducive to individual constitution.
Vishesha nidana: -
Except charaka other acharyas have explained the common causative factors and
they have particularly stressed on the factors, which affects the kapha, medas and mutra.
Charaka explained nidanas specific to the doshas concerned but he too has equally voiced
on those factors, which vitiate kapha and medas.
KAPHAJA PRAMEHA NIDANA138: -
Aharaja Nidanas: -
A) Rasa – Madhura padartha atisevana
B) Guna – Drava taruna dravya atisevana
C) Dravyas –
“Evaluatio In the management of Madhumeha”
71
Madhumeha
Dhanya’s – Hanyaka, Chanak, Uddalaka, Naishada, Mukundaka,
Mahavrihi, Pramodaka, Sugandhaka, Sarpishmati, Masha etc
Mamsa: - gramya, Oudaka, Anupa, Mamsa, Rasa
Others – Shakas, Tila, Pistanaa, Payasa, Ksheera, Vilepi kshoudra,
Mandaka, Dadhi etc.
Vihara sambandhi nidanas: -
Swapna prasanga, Shaya prasanga, Asana prasanga Vyayama vruja varjana, Anya
kapha meda mutra Vridhikara Viharas.
PITTAJA PRAMEHA NIDANA139: -
Ahara sambandhi nidana: -
a) Rasa – Amla, Lavana, Katuadhika sevena
b) Guna – Ushna kshara adhika sevena
c) Anya – Ajeerna dravyas and Vishamaharam
Vihara Sambandi Nidana’s
• Ati teekshna atapa sevena
• Agni Santapa
• Shrama
• Krodha
VATAJA PRAMEHA NIDANA140: -
Ahara Sambandi Nidana’s
• Rasa – Kashaya, Katu rasa Ati sevena
“Evaluatio In the management of Madhumeha”
72
Madhumeha
• Guna – Rooksha laghu sheeta Ati sevena
• Anya – Anashana
Vihara Sambandhi Nidana’s
Vyavaya, ativyayama Udvega
Shodhana atiyoga Atishoka
Vega sandharana Shonita ati seka
Abhighata Ratri Jagarana
Atapa Sevana Vishama Shareera Nasyam
All the pramehas at their initial stage are due to kapha dosha and kapha is an
inevitable factor to cause prameha perhaps on these lines, at first Nidanas related to
kapha dosha is seen.
The vitiated kapha then vitiates the dhatus of similar properties like medas,
mamsa etc. If the pramehas are neglected in this stage, the improper formation of dhatus
in due course leads to dhatu kshaya.
The affected person if consumes the pitta prakopak ahara and gets indulged in the
acts, which provokes pitta, resultes in pittaja prameha’s.
The Nidanas of vata prakopaka reveal that the severe deterioration of the dhatus is
the resultant, if one indulges in the aharas or viharas, which are told in it and in due
course, madhumeha, occurs because of dhatus kshaya.
MADHUMEHA NIDANA141: -
Charak very specifically explained Nidana responsible for the manifestation of
madhumeha, which can be narrated as follows: -
• Guru Snigdha Lavana rasatmaka dravya Atisevana
“Evaluatio In the management of Madhumeha”
73
Madhumeha
• Navanna and Pana
• Atinidra
• Asya Sukhama
• Achentya
• Avyayama
• Asamshodhana
These factors contribute to the vikriti of the Kapha, Pitta, Meda and Mamsa.
These vitited factors cause avarodha to normal vayu gati. it in carries the ojus to vasti and
resulting in madhumeha.
STHOULYA AS A NIDANARTHAKARA ROGA
According to Acharya Sushruta Apathyanimittaja prameha’s are sthoola. Sthoulya is
the nidanarthakara roga for prameha142.
In sthoulya the vayu gati gets obstructed by the baddha medas, As a result there will
be the vitiation of vayu. Which in term stimulates the samana vayu resulting; in the
aggravation of jataragni and causes increased absorption of food and the Individual
becomes Adhika bhojya vyakti (excessive eater).
ETIOLOGY OF DIABETES MELLITUS143: -
A defective or deficient insulin secretary response, which translates in to
impaired carbohydrate use, is a characteristic feature of diabetes mellitus and resulting
into hyperglycemia.
The chronic hyperglycemia of diabetes in associated with long-term damage,
dysfunction and failure of various organs like Eyes, Kidney’s, Nerves, Heart and Blood
vessels.
“Evaluatio In the management of Madhumeha”
74
Madhumeha Genetic factors: -
Genetic factors are even more important than Types I diabetes. Among
identical twins the concordance rate is 60% to 80% in first-degree relatives with type II
diabetes the risk of developing disease is 20% to 40%.
The two main defects that characterized in type II diabetes are –
01) A derangements in the beta cell secretion of Insulin
02) A decreased response of peripheral tissues to respond to Insulin.
Obesity: - Among the initiating events, which are proposed for type II diabetes. Obesity
is an extremely important environmental factor. Approximately 80% of type II diabetes
is obese.
Age: - As the age advances the number of beta cells in pancreas, which produce insulin
gets reduced. So the risk of diabetes increases with age especially after 40 years.
Sedentary life: - People with sedentary life style are more likely to have diabetes are
compared to those who lead an active life. It is believed that exercise and physical
activity increase the effect of insulin on the cells.
Heridatory: - According the famous diabetalogist Warren and Le Compet. When both
the parents have diabetes, all the children may expect to develop the disease, if they live
long enough. When one parent has diabetes and the other is diabetic carrier, 40% of their
children may develop the disease. If a diabetic or a carrier marries an individual who
neither has diabetes nor a diabetic carrier none of the children with have diabetes.
Obesity is one of the major causative factors for diabetes mellitus as it causes
insulin resistance. In Ayurveda, sthoulya is mentioned as a Nidanarthaka roga for
prameha, and this prameha falls under the santarpanajanya vyadhis.
Madhura, Snigdhadi, Bhojana are the main Nidana’s for madhumeha, in
contemporary science it is explained that the excess eating and sedentary life style are the
predisposing factors for diabetes mellitus.
“Evaluatio In the management of Madhumeha”
75
Madhumeha CLASSIFICATION
Knowledge of classification will helps in proper understanding of the disease and
to formulate an effective treatment protocol.
In classics various types of prameha had been described based on many factors.
Though prameha is stated to be a condition due to the vitiation of all the three doshas, the
disease is mainly divided in to 3 groups. (Ref.Cha.Chi.6/7)
Kaphaja Pramehas - 10
Pittaja Prameha - 06
Vataja Prameha - 04
Though there is a similarity in the opinion of Brihatrayes regarding the numbers
of pramehas in each group. But they seem to be different in the nomenclature used by
them.
Table No: -11
TYPES KAPHAJA PRAMEHA: -
Sl.no Names Charaka Sushruta Vagbhata Ma.Ni
1 Udaka meha + + + +
2 Ikshu meha + + + +
3 Sandra meha + + + +
4 Sandraprasada
Meha
+ Sura meha Sura meha Surameha
5 Sukla meha + Pista meha Pista meha Pistameha
6 Sikata meha + + + +
7 Sita meha + Luvana meha + +
“Evaluatio In the management of Madhumeha”
76
Madhumeha 8 Shanair meha + + + +
9 Lala meha + Phena meha Lala meha Lala meha
10 Shukra meha + + + +
Table No: -12
TYPES OF PITTAJA PRAMEHA: -
Sl.no. Names Charaka Sushruta Vagbhata Madhava
1 Kshara meha + + + +
2 Kala meha + Amla meha + +
3 Nila meha + + + +
4 Lohit meha + Ahinitameha Rakta meha Rakta meha
5 Manjishtha meha + + + +
6 Haridra meha + + + +
Table No: -13
TYPES OF VATAJA PRAMEHA: -
Sl.no. Names Charaka Sushruta Vagbhata Madhava
1 Vasa meha + - + +
2 Majja meha + Sarpi meha + +
3 Hasti meha + + +
4 Madhu meha + Kshaudra
meha
+ +
“Evaluatio In the management of Madhumeha”
77
Madhumeha PROGNOSTIC CLASSIFICATION: -
Prognosis is an inevitable part of Chikitsa so far as a wise physician is concerned
and unbiased prognosis is the key factor for the success of treatment.
Sadhya Yapya Asadhya
Kaphaja Pittaja Vataja
Sthoola Not much obese Krisha
Apathya nimittaja Acquired Sahaja
Early stage Acute stage Advanced stage
Without complication With complication With complication
NOTE: - According to Vagbhat Avritajanya madhumeha is Kastha Sadhya and
dhatukshayajanya as Asadhya.
Based on etiological factors: -152
a) Sahaja b) Apatya nimittaja
c) Prakritija d) Swakritaja
Based on Samprapti of madhumeha153
a) Kashayaja b) Avaranajanya
a) Dhatukshayajanya b) Doshavritajanya
Based on Chikitsa, physical status and strength.154
• Sthoola
• Krisha
• Balawan
• Durbala.
“Evaluatio In the management of Madhumeha”
78
Madhumeha In nut shell, sahaja and Apathyanimittaja are types of madhumeha. The Krisha,
Dhatukshayajanya and Apatarpanajanya can be correlated with sahaja madhumeha.
The sthool Avaranajanya and Santarpanajanya can be correlated with
Apathyanimittaja madhumeha.
CLASSIFICATION OF DIABETES MELLITUS
The current expert committee of American diabetes association has proposed
changes to the NDOG/WHO classification scheme. The revised Etiologic classification
of diabetes mellitus is as follows155: -
I) Primary Diabetes
Type I: - Beta-cell destruction, usually leading to absolute insulin Primary deficiency.
a) Immune mediated
b) Idiopathic
II) Type II diabetes (may range from predominantly insulin resistance with relative
deficiency to a predominantly secretary defect with insulin resistance.
Under this type II again 2 types can be seen
1) None obese NIDDM
2) Obese NIDDM
Genetic defects of beta cell function including maturity on set diabetes of young
known as MODY
III) Other specific types
“Evaluatio In the management of Madhumeha”
79
Madhumeha
A) Genetic defect of beta cell function
a) Chromosome 12, HNF – 1 Alpha (MODY S)
b) Chromosome 07 Glucokinse (MODY 2)
c) Chromosome 20 HNF 4 Alpha (MODY 1)
d) Mitochondral DNA
e) Others
B) Genetic defects in insulin action: -
Type 4 insulin resistances, Lepsechaunism, Rabson Mendenhall
Syndrome. Lipoatrophic diabetes and others.
B) Disease of exocrine pancreas: - Pancreatic pathology
a) Pancreatitis
b) Hemochromatosis
c) Fibrocalculous
d) Neoplastic Disease
e) Pancreactetomy
f) Cystic fibrosis and others.
D) Iaotrogenic: - Drug induced or chemical induced.
a) Glucocorticoids
b) Thiazides
c) Alpha – Intrferon
d) Thyroid Hormone.
F) Endocrinopathies: - Endocrine disease induced.
a) Cushing’s Syndrome
b) Acromegaly
c) Thyrotoxicosis
d) Phaeoc hromocytoma
e) Glucogonoma.
“Evaluatio In the management of Madhumeha”
80
Madhumeha
G) Infections: -
• Congenital rubella
• Cytomegalo virus and others
H) Other genetic syndromes sometimes associated with diabetes.
a) Dawn’s syndrome,
b) Klenefelter’s syndromes etc.
I) Gestational Diabetes Mellitus (GDM)
In classics the classification of a disease made it clear that for the sahaja
prameha beeja dosha have been mentioned as causative factors. Such patients are said to
be weak emaciated. Suffering from thirst, loss of appetite and are required to be treated
with a nourishing diet.
In contemporary science the genetic and hereditary factors are mentioned
as causative factor. Such patients are weak emaciated and they are asthenia. The above-
mentioned patient is juvenile diabetes and requires a nourishing diet, so sahaja prameha
can be consider as juvenile diabetes.
Poorvaroop
The Symptoms, which are produced during the process of sthanasamshraya avastha, are
called as poorva roopa, and the symptoms which appears prior to the manifestation of the
disease, are called poorvaroopa i.e. is “4th Kriyakala”.
There is no direct explanation of the poorva roopa of madhumeha as such. But
poorva roopa of prameha can be considered as poorva roopa of madhumeha.
“Evaluatio In the management of Madhumeha”
81
Madhumeha Table No: -14
Showing the poorva roopas144
S.no Poorva roopa C.S S.S A.H A.S M.N B.P Y.R
1 Kesha Jatilibhava + + - + - - -
2 Asyamadhuryata + - + + + + +
3 Karapada daha + - - - - - -
4 Karapada suptata + - - - - - -
5 Mukha talu kantha
gala shosha
+ - - - - - -
6 Pipasa + + - + + + +
7 Alasya + - + - - - -
8 Kaye malam + - - + - - -
9 Angeshu paridaha + - - - - - -
10 Anga suptata + - - + - - -
11 Shatapada
Mutrashaya
abhisarana
+
+
-
-
-
-
-
12 Vishra shareera
gandha
+ + - + - - -
13 Atinidra + - - - - - -
14 Tandra + + - + - - -
15 Snigdha,Pichhila
guru gatratam
- + + + - - -
16 Madhura shukla
mutrala
- + - + - - -
17 Durgandha swara - + - + - - -
18 Talu, gala,
danteshu
malotpathi
-
+
-
-
-
-
-
19 Nakhati vriddhi + + - + - - -
“Evaluatio In the management of Madhumeha”
82
Madhumeha 20 Swedam + - + - - - -
21 Keshathi vruddhi + - - - - - -
22 Sheetpriyatwan + - + + - - -
23 Mootra
abhidhavanti
pipeelakasha
+
-
-
-
-
-
-
24 Ghanangata + - + - - - -
25 Angashaithilatwa + - + - - - -
ROOPA
The vyakta or pradurbhoota lakshanas of the vyadhi is seen in the 5th kriyakala.
The vyadhi bodhaka linga of all 20 types of prameha is prabhoota and Avila mootrata.
The prabhoota mootrata can be considered in terms of increased volume of urine and
frequency of micturation.’Avita mootrata refers to increased turbidity of urine.
Roopa means symptoms of the actual manifestation of disease. At this stage dosha
dushya samoorchana would have been completed and the onset of the disese would have
been commenced. Madhavakara explains it as when symptoms in the stage of
poorvaroopa become fully or clearly manifested they are called roops. Roopa is the
prominent diagnostic key of a disease and hence thorough knowledge of the various
roopas of each disease essential for a physician.
Hence the lakshanas of madhumeha are mainly grouped under two categories that
is
1) Mootra Sambandi.
2) Sarvadaihika lakshanas.
“Evaluatio In the management of Madhumeha”
83
Madhumeha MOOTRA SAMBANDHI LAKSHANAS: -
Clinical features of the prameha may be divided into two groups they are: -
• Samanya Lakshanas
• Vishesha Lakshanas
1) SAMANYA LAKSHANAS145: -
Samanya Lakshanans of madhumeha are those which are ascribed to prameha, they
are as follows
i) Prabhoota mootrata ii) Avila mootrata
Prabhoota mootrata: -
The increase in quantity and frequency is known as prabhoota mootrata.
It is manifested due to increase of sharreera kleda, the reasons for which are
explained in the context of Samprapti. The frequency is increased due to vitiation of
apana vayu. Due to hyperglycenia in madhumeha, glycosuria manifests which in terms
hampers the tubular absorption of water leading to polyuria.
Avila mootrata: - Moorta avilata is nothing but the turbidity of mootra, which is
manifested due to drava and guru guna vriddhi of kapha and medhas. This can be noticed
by the increase in the specific gravity of the urine.
VISHESHA MOOTR SAMBANDI LAKSHANAS
In madhumeha mootra is manifested with Kashaya, Madhura, Rooksha, Pandu
and madhu Sama lakshanas. Bhavaprakasha clarify the controversy of the word kashaya
as kashaya varna. The implication of this term is still debatable. The presence of madhura
“Evaluatio In the management of Madhumeha”
84
Madhumeha rasa in mootra is mainly because of ojo visramsa into mootra, which can be easily
understood by pipeelika abhisarana and by qualitative analysis of urine test. Rooksha
guna is due to vitiation of vata. Pandu varnata of mootra is because of kleda dusti which
influences kapha to attain more liquid state. Madhusama mootra implies the colour, smell
and taste of mootra similar to that of madhu. It has to be understood that along with the
samanya lakshanas madhusama mootra is the pratyatmaka lakshanas of madhumeha.
Table No: -15
Showing the roopa of prameha:-
S.no Roopa C.S S.S A.H A.S M.Ni Y.R B.Ra G.Ni
1 Kashaya + - - + + + + +
2 Madhura + - - + + + + +
3 Pandu + - - - - - - -
4 Rooksha + - - + + + + +
5 Snigdha - - - + - - - -
6 Ojadhatu - - - + - - - -
7 Kshoudravat
Madhviva
- - + - - - + -
8 Kshoudra rasa - + - - - - - -
9 Kshoudra varna - + - - - - - -
SARVADAIHIKA LAKSHANAS: - On the basis of their occurrence, these lakshanas
can be grouped into two divisions.
• Apathya nimittaja
• Sahaja, as there is a difference in the pathogeneses of both the varieties, so
lakshanas vary from each other
LAKSHANAS OF APATHYA NIMITTAJA MADHUMEHA
“Evaluatio In the management of Madhumeha”
85
Madhumeha
a) Sthoola
b) Bahu Ashee
c) Snigdha
d) Shaya
Asana, Swapnasheela the Samprapthi of Apathya Nimittaja madhumeha has been
explained earlier. The vitiation of Kapha, Kleda, Medas is due to the indiscreet food
habits. Thus leads to the medovaha Srotodusti due to medodhatwagni mandya. Thus
the person develops sthoulya. The samana voyu avarodha in koshta is the reason for
prabhoolagni from which the person desires and consumes more food. It has been
said earlier that the meda sthana is the pitta sthana and hence the vayu in kosta is
obstructed which later lead to the excessive secretions of pitta in amashaya which
results in the above said lakshanas. The affected person is termed as snigdha due to
the karmataha vriddi of shleshma. Madhumeha is one among the 20 types of
pramehas. So these may be present in madhumehi.
Kaphaja Pramehas146
1) Udaka meha: - The person passes clear urine, excessive in quantity, whitish, cool,
odourless and watery.
2) Ikshumeha: - The urine of person becomes sweat, cool slightly viscid, turbid and
resembling the juice of sugar cane.
3) Sandra meha: - The urine gets thickened if kept over night in a vessel.
4) Sandraprasada meha: - The character of urine manifests here partly dense and
partly clear after keeping in a vessel.
5) Shukla meha: - White urines are excreted here and appear as if mixed with flour,
and frequency of maturation takes place.
6) Shukra meha: - The person frequently passes urine, white, appears like shukra.
“Evaluatio In the management of Madhumeha”
86
Madhumeha
7) Sheeta meha: - The person excretes here large quantities of urine, which is
exceedingly sweet and cold.
8) Sikata meha: - The passing of urine is mixed with hard and small particles.
9) Shanair meha: - There is no force of urine during the time of passing, more over
person feels difficulty at the time of excretion.
10) Alalameha: - The urine is full of mucus threads is slim and viscid.
Pittaja Pramehas147
1) Kshara meha: - The urine is alkali like in character.
2) Kala meha: - The provocation of pitta transforms the urine as warm and black in
colour.
3) Neela meha: - Passes urine of the colour of the wings of jaybird and is acidic in
reaction.
4) Lohita meha: - Urine smells like raw flesh and saltish warm and red.
5) Manjishta meha: - Person passes urine, which is profuse in quantity smells like
fresh meat.
6) Haridra meha: - Urine is of the colour of the colour of turneric water and is
pungent.
Vataja Pramehas148
1) Vasa meha: - Provoked vata passes urine mixed with or having the appearance of
fat.
2) Majja meha: - Discharges urine with majja frequently due to provoked vata.
3) Hasti meha: - Discharges frequently excusive amounts of urine like elephant.
4) Madhumeha: - Passes urine which is astringent and sweet in taste, yellowish and
whitish in colour Urine contains similar proportion of Honey.
Madhumeha Roopa149
Acharya Sushruta gives explanation regarding the lakshanas of Madhumeha, as
follows –
1) Gamanat sthananichati
2) Sthanat asananichati
3) Aasanat sayyamichati
“Evaluatio In the management of Madhumeha”
87
Madhumeha
4) Shayanat swapnamichati.
Apart from the above lakshanas urine similar to honey in colour and taste are also
attributed to Madhumeha.
Clinical Features150
It is very difficult to sketch with brevity the diverse clinical presentation of
diabetes mellitus. Only a few characteristic patterns will be presented.
The type II (NIDDM) diabetes present with polyuria, polydipsia but unlike type I
diabetes patients are often older and frequently obese. Some times weakness or weight
loss also noted. Apart from these features others like, polyphagia, pruritis vulvae,
glycosuria, infections, delayed healing of wounds, impotency, are also noted.
Polyuria is due to the osmotic diuretic effect of glucose in kidney tubules. The
glycosuria induces an osmotic diuresis and thus polyuria, causing a profound loss of
water and electrolytes.
The obligatory renal water loss combined with the hyper osmolarity resulting
from the increased levels of glucose in the blood tends to deplete intracellular water,
triggering the osmoreceptors of the thirst centers of the brain. In this manner intense
thirst (polydipsia) appears.
The catabolism of proteins and fat tends to induce a negative energy balance,
which in turn leads to increasing appetite, i.e. polyphagia. Despite the increased appetite,
catabolic effects prevail, resulting in weight loss and muscle weakness. Frequently,
however the diagnosis made after routine blood or urine testing mainly in asymptomatic
persons.
Whenever the quantity of glucose entering the kidney tubules in the glomerular,
filtrate rises above approximately 225 mg/min, a significant proportion of the glucose
begins to spill in to the urine and when the quantity increases above about 325 mg/min,
which is tubular maximum for glucose. All the excess, above this is lost in to urine
(Glycosuria).
A comparative study of madhumeha lakshanas with the Diabetes mellitus
explained in the modern science reveals a lot of similarities between them.
“Evaluatio In the management of Madhumeha”
88
Madhumeha
Prabhootaavilamootrata is considered as a prathyatma lakshana of Prameha. In
this the bahudrava kapha along with other dooshyas mainly kleda pradhana dooshyas in
the basti is the cause for prabhoota mootrata. The same reason has been given in modern
science for polyuria that the osmotic diuretic affects of glucose in the kidney tubules.
Glycosuria explained in the modern science can be taken as madhusama mootra.
The reason for this madhusama mootra is bahudrava kapha or ojus (Glucose), which is
excreted through moootra.
Pipasa or polydipsia mentioned in both sciences. Depletion of intracellular water
triggering the osmoreceptors of thirst center of brain and thirst is noted which is similar to
pipasa of Ayuredic science, here due to excessive loss of the urine; pipasa is noted.
Bahukankshata has been mentioned as a lakshana in apathya nimittaja
madhumeha, the same in modern science in terms of polyphagia.
In modern science the condition weakness is due to lack of glucose utilization,
loss of electrolyte and protein loss. In Ayurveda this same condition is due to aparipakwa
dhatus i.e., lack of proper nourishment of dhatus.
By considering the above similarities, we can come to a conclusion that
Madhumeha explained in Ayurvedic science and the diabetes mellitus mentioned in the
modern science are almost similar condition.
SAMPRAPTI: -
Only Charaka explains the sirect Samprapti of madhumeha. Charaka explained
the relevance of avarana in the samprapti or formation of madhumeha. He explained this
in the “Keeyantaha Shiraseeya Adhyaya” of Sutrasthana. On this contex he explained the
Nidasnas, which are almost Kapha and Pitta Vardaka.
After exposer to aetiological factors of prameha /madhumeha followed by vividha
dosha vyapara in the body, i.e.the morbid process-taking place in the production of
disease is called Samprapti.
“Evaluatio In the management of Madhumeha”
89
Madhumeha There are three factors, which are responsible for the manifestation of the disease
in general. Charaka explains the Hetu vishasha, Dosha vishesha, Dushya vishesha are
held responsible for the vikar utpatti or Anutpathi.151
The main principle of Chikitsa, as said by Indu, is Samprapthi Vighatana.
“Yatha dustena doshena” conveys the meaning of the degree of morbidity of
bodily elements or vikalpa Samprapti. In which condition the organism suffers from
discomfort. The vitiation of dosha and dhatus in the disease varies from person to person
and the morbidity of these elements also differs for example-Samhata roopa Vriddhi,
Vilayana roopa vriddhi, gunatha vriddhi and karmatha vriddhi etc.
All these morbid changes will not essentionally occur in all the disesase.
“Kalenopadetaha Srvae”(A.Hr.Ni), justifying the necessity of mentioning prameha
samprapti. All the above refereces regarding the samanya prameha samprapti and
madhumeha samprapti will be made.
SAMPRAPTI GHATAKA: -
Dosha - Kapha is in Bahu abhaddha
Piita is in Vriddhavastha
Vata – Avrita.
Dushya – Rasa, Rakta, Mamsa, Meda, Asthi, Majja, Sukra
Oja, Lasika, Kleda, Sweda.
Srotas - Anna, Udaka, Meda, Mutra.
Dusti Prakara – Atipravritti, sanga, vimargagmana.
Agni – Vaishamya and Dhatwagni mandhya.
Ama - Sama Kapha and Sama Dhatus.
Udbhava Sthana – Medovaha srotomoola – vapavahana
Sanchara Sthana – Sarva Shareera, Sarva doshaja,
Meda, kleda sahita; mootra vaha sroto Anupravesha.
Vyakta Sthana – Sarva Shareera (mootravaha srotas).
Vyadhi Swabhava – Chirakari.
“Evaluatio In the management of Madhumeha”
90
Madhumeha
Depending upon Hetu vishesha, Dosha vishesha, Dushya vishesha and their
degree of vitiation 4 types of disorders may occure based on vikara vighata bhava. Vikara
Vighata bhava is explained as that factor which participats in the formation and hence
does not allow the disease to manifest. So based on Vikara Vighta bhava the four types of
occuring disease are as follows.
a. When the hetu vishesha, dosha vishesha, dooshya vishasha are not
congenial they, then the formation of disease will not occure.
b. If these three become congenial to each other lately among them, then the
delay in formation of disease will takes place.
2) If these three are mild in vitiation, then they give rise to mild disorder or a
disorder with the presence of only few lakshanas or vice versa. So in all the
disorders the utpatti is based on vikara vighata bhava and abhva.
SAPEKSHA NIDANA
Proper diagnosis is the foundation to the success of a treatment because many
diseases affecting a srotas have similar manifestations, enough to confuse a physician but
picking up threadbare with a little difference to clinch a diagnosis is an art aspired by all.
Deep knowledge and untiring practice are the means to perfection as Vagbhata has
rightly mentioned “abhyasat prapyate dristihi karma siddhi prakashini”.
Madhumeha is a mootra. atipravruttaja vikara1 with prabhoota and avila mootrata
as pratyatma lakshanas, characterized by madhusama. Although there are many diseases
presenting with Atipravrutti of mootra, the diagnosis of madhumeha is usually a
straightforward proposition, because of its characteristic poorvaroopas.
“Evaluatio In the management of Madhumeha”
91
Madhumeha Moreover within the perview of the disease madhumeha, the kapha, pitta and vata
have characteristic presentations, which have been described in such a way as not to
leave any scope for doubt. In other words, if a patient presents with mootra atipravrutti,
lakshanas of kapha, pitta or vata like shukla mootrata haridramootrata or vasa mootrata
and if they are associated with prameha poorvaroopas then the disease is per se prameha
or madhumeha. Charaka explains this concept giving the example of a situation where
one comes across a patient who is presenting with haridra or rakta mootrata. Here the
absence of prameha poorvaroopas will prove the existence of rakta pitta and exclude
prameha
In the presence of madhura and picchala lakshanas of prameha, one should
consider two possibilities for differentiation whether the condition is anilatmaka due to
dosha ksheenata or kaphasambhava as a result of santarpana
As discussed earlier, here one should essentially consider madhumeha as a
consequence of vata vruddhi as a result of dhatukshaya where vata is the anubandhya
dosha and madhumeha as a result of margavarana janya vata vruddhi where vata is a
anubandha dosha and is directly dependent upon kapha, which has undergone vruddhi
because of santarpana. The factors for differentiation are as follows
Madhumeha (anilatmaka) Madhumeha (Kaphasambhava)
Rogi : Krusha
Nidana a) Vatakara ahara vihara along
with vata vruddhi as a result of
chirakalina madhumeha
b) Beeja uapatapa
Sthoola
Kaphakara ahara vihara
“Evaluatio In the management of Madhumeha”
92
Madhumeha Rogi avastha : Bala to madhyama vaya
Roopa : Vata pradhana
Samprapti : Madhumeharambhaka dosha
dusti leading to vapavahana
dusti especially in sahaja
madhumehi
Vyadhiswaroopa : Ashukari
Sadhyasadhyata : Asadhya
Upadrava : Vata pradhana upadravas
Chikitsa : Santarpana
Madhyama to vruddha
Kapha pradhana
Kaphamedodusti leads to
madhumeharambhaka dosha, dusti in
vapavahana
Chirakari
Sadhya in the beginning
Kapha pradhana upadravas
Apatarpana
Madhumeha is basically medovaha srotodustijanya vikara but its pratyatma
lakshanas become vyakta in the mootravaha srotas with abnormal changes in the rasa,
varna, gandha, sparsha of the mootra and it is characterized by prabhoota1 and avila
mootrata.
Prabhoota mootrata means atipravrutti of mootra. It goes without mentioning that
there is also an increased frequency of micturition and avila mootrata means Atyartha
Kalusha4 Samalam5 or Malinam akulam6 which means that there is a considerable change
in the quality of urine as per the above mentioned factors. Considering these factors, it
becomes contextual to enumerate the conditions where there is increased frequency of
urine and abnormality in its quality. Most of the times these symptoms are associated
with mootravaha srotodusti and other diseases where differentiating madhumeha is not a
problem for evident reasons.
“Evaluatio In the management of Madhumeha”
93
Madhumeha
Mootralakshana (Pravartana Nimitta) Symptoms
1) Abhikshnam (Muhurh muhurh, Punah punah : a) Ashmari (C. Ci. 26/38)
Subahushah, vikiranam b) Mutratita (S. U. 58/12)
c) Vatika mootrakrichra (C. Ci
26/32)
d) Ushna vata (Ah. N. 9/36)
2) Atipravrutti a) Amavata (M. N. 25/9)
b) Arsha poorvaroopa (As. N. 7/7)
c) Sahaja arsha (C. Ci. 14/8)
d) Kaphaja arsha (C. Ci. 14/17)
e) Mutra praseka (S. Ci 7/36)
f) Upasthita prasava (S. Sa. 10/7)
g) Chidrodara (C. Ci. 13/44)
h) Asadhya masurika (M. N.
54/27)
i) Ama jwara (C. Ci. 3/135)
It becomes relevant to consider the following conditions where hyperglycemia is
common manifestation under the heading of differential diagnosis
I Diabetes mellitus & Endocrine disorders:
a) Pituitary gland
1) Pituitary diabetes due to growth hormone
2) Acromegaly
“Evaluatio In the management of Madhumeha”
94
Madhumeha
3) Diabetes insipidus
b) Adrenal Cortex
1) Cushing’s Syndrome
2) Steroid diabetes due to administration of steroids
3) Primary Hyperaldosteronism
c) Adrenal Medulla
1) Phaeochromocytoma
2) Addison’s disease
3) Adrenalectomy
d) Thyroid
1) Hyperthyrodism
2) Myxoedema
II Pancreatic Diabetes
1) Acute pancreatitis
2) Mumps (rarely)
3) Chronic pancreatitis
4) Haemochromatosis
5) Total pancreatectomy
6) Carcinoma of pancreas
III Diabetes liver
1) Cirrhosis of liver
2) Gall Stones
IV Drugs & diabetes
“Evaluatio In the management of Madhumeha”
95
Madhumeha 1) Thiazide, Chlorthalidone, frusemide, oestrogen containing oral contraceptives, β
blockers & catacholaminergic drugs
V Miscellaneous
1) Type I glycogen storage disease
2) Down’s syndrome
3) Turner’s Syndrome
4) Huntington’s chorea
5) Burns
Conditions where there is polyuria
Polyuria should not be confused with prostratic hypertrophy or cystitis because
here it is only increased frequency of micturition & not increased quantity.
I Polyurea due to water diuresis
Cranial or neurogenic diabetes insipidus: This is due to an identifiable lesion in the
hypothallamus pituitary or both leading to failure of A.D.H.
Nephrogenic diabetes insipidus:
Familial form seen in males only also as an accompaniment of Fanconi syndrome
Psychogenic polydipsia or compulsive water drinking this is a hysterical condition. There
is clinically marked fluctuation here.
II Polyurea due to increased solute load
Diuretic therapy
Chronic renal failure
SADHYA SADHYATA
“Evaluatio In the management of Madhumeha”
96
Madhumeha The prognosis of the disease is to be established only after the consideration of
Sadhya or Asadhya. The Vyadhis are classified on the basis of prabhava as sadhya and
Asadhya further Sadhya vyadhis are classified as Sukha Sadhya and Krichra Saadhya.
Asadhya vyadhis are bifurcated in to yapya and anapakramya Prathyukheya.
The assessment of Sadhya and Asadhyata of the disease arte depending upon the
following factors: -
1) Hetu
2) Poorvaroopa
3) Roopa
4) Dosha, Dushya, Kala, Prakruthi
5) Marga – Gati
6) Adhisthana
7) Upadrava
8) Aristha
9) Mental state
10) Bala
11) Chikitsa karma bhedha,
Vagbhatacharya adds the some new points
12) Vaya
13) Linga
14) Indriya Sthiti
15) Grahasthiti
16) Jitatmana
And also mamsa, upachaya are also be taken in to consideration.
The clear knowledge of the above factors will help one to assess the Saadhyata or
the Asadhyata of a vyadhi.
PROGNOSIS DEPENDING UPON DOSHA
“Evaluatio In the management of Madhumeha”
97
Madhumeha The ten Kaphaj prameha are said to Sadhya six types of Pittaja meha are yapya
and four types of Vataja meha are Asadhya.
As madhumeha is Vataja pramehas, Vataja pramehas are told as Asaadhya. Hence
madhumeha is also to be considered as Asaadhya. The factors that are considered as
pathya for vayu is an Apathya for meda. So due to Virudhopakrama or contradiction in
treatment eq. snigdha for vaya Kshaya it increases the medas.
Again this can be classified as yapya and anupakramya pratyakyeya.
ASADHYA MADHUMEHA
In the following condition the disease madhumeha will become asaadhya.
1) Kapha pittal prameha, which is long standing and
associated with poorva roopa if exhibited in Vataja
prameha then it should be demand as asaadhya.
2) If the madhumeha patient is durable, emaciated then it
should be Rx. As asaadhya.
3) Beeja doshaja madhumehas are asaadhya.
4) The manifestation of all poorva roopa in meha if the
Kaphaja, Pittaja, Prameha converted in to Vataja
prameha then it is said to be Asaadhya.
5) If pidikas are manifested in madhumeha should be
treated as Asaadhya.
KRICHRA SAADHYA MADHUMEHA
It seems that krichra Saadhyata of madhumeha is possible in Apathyanimittaja
madhumeha that too were there is an avarana of Vayu is present due to medas or Kapha
or Pitta. That is why in such conditions acharyas have advised to consume Lague Ahara
“Evaluatio In the management of Madhumeha”
98
Madhumeha and tikta rasa aharas along with exercises. If neglected in the earlier period of
Madhumeha then in later course it will become Asadhya due to dhatu Kshaya.
Basavarajeeyam a 16th centurion practical sound physician of Telengana invented
New test for urine for the prognosis of each dosha group the urine of prameha patients is
to be collected in a wide mouthed vessels and boiled on a mild flame till evaporation. The
incurability of the disease depends up on the amount of residue a Vataja prameha is
considered as incurable if the residue is 1/5th of the volume of urine taken for test. Pittaja
prameha is incurable if the residue is 1/4th and Kaphaja prameha is residue is 1/9th.
MADHUMEHA CHIKITSA VIVECHANA
The principles of chikitsa can hence be studied as, a) Nidana parivarjana,
b) Apakarshana, c) Prakruti Vighata. These principles of treatment are to be studied
separately with respect to dhatukshayajanya madhumeha & Margavarana janya
madhumeha.
Nidanaparivarjana in Margavarana janya Madhumehi:
An apathyanimittaja medhumehi usually sthoola, who likes Abhyavaharana & hates
chantramana a situation just like of the helpless eggs on a tree, they cannot move to avoid
their predators & hence fall victim to them. Here the patient should be made to avoid all
& Kaphakara ahara vihara either to prevent the occurrence or to cure the disease.
Nidana parivarjana in dhatu kshaya janya Madhumehi: - Nidana parivarjana in such
madhumehis is studied with special reference to sahaja madhumeha. It lies entirely on the
mata or pita as to how best they act to prevent the occurrence of the disease in them.
Apakarshana & Prakruti Vighata: - The apakarshana of doshas are mainly done
through samshodhana but only when roga & rogi bala are in pravaravastha and when
“Evaluatio In the management of Madhumeha”
99
Madhumeha either one or both are avara then it is done through langhana and langhana panchana,
which constitutes samshamana chikitsa, in other words prakruti vighata.
Apakarshana in Margavarana janya madhumeha: - Shodhana, when in such
madhumehi if the dhatukshaya is minimum & there are kapha & medodusti laxana then
vamana should be performed. & if there are pittaja laxanas & dhatu kshaya does not
render the patient durvirechya then virechana can be performed. Similarly if the
anubandha vata laxanas are more and the patient is samshodana arha then basti can be
performed.
Madhumeha is a swedana ayogya vyadhi but swedana can be administered. The
selection of yogas for samshodana & snehana should be selected as per the recipes
prescribed in kalpa shtana. After shodana shamana chikitsa can be done by,
Kaphamedohara dravya.
Prakruti vighata in dhatu Kshaya Janya madhumeha: - Dhatu kshaya avastha is the
result of beeja dusti in sahaja madhumeha & due to a state of atikarshita dhatus as a result
of continued dhatu kshaya, which is nothing but the progressed stage of margavarana
janya madhumeha both the situations are considered samshodana anarha. In such cases
samshamana chikitsa is advised, whereas madhumeha in both these cases are asadhya and
hence need not be treated. Notwithstanding this, the principles of chikitsa for vataja
pramehas are for vata anubandhadoshatva, which is still dependent on the kapha &
pittadoshas and not for vata anubandhya dosha janya madhumeha characterized by
atishaya karshana of dhatus. Hence samshamana chikitsa should be appropriately adopted
in such patients.
Avastha Anusara Chikitsa of Madhumeha: -
“Evaluatio In the management of Madhumeha”
100
Madhumeha Sushruta in the chapter of prameha pidaka chikitsa has indentified the stages of
madhumeha & accordingly advised the treatment, which can be discussed as, stage
I: Chikitsa in poorvaroopavastha; stage II: Chikitsa in Vyaktavastha; stage III:
Chikitsa in upadrava avastha; stage IV: Chikitsa in pravrudha upadrava avastha; stage
V: Chikitsa in asadhya avastha.
Stage I: Is the poorvaroopa avastha where the dosha dushya sammurchana has just begun
the disease should be treated with apatarpana, vanaspathi kashaya and chagamootra. If
left untreated the madhumeha it proceeds to the II stage.
Stage II: This is the vyakta avastha of madhumeha where due to continued madhura ahara
sevana. The sweda mootra and sleshma attain madhura bhava & hence should be treated
with ubhaya samshodana i.e vamana, virechana & basti. If left untreated the disease
progresses to stage III
Stage III: In this stage the mamsa & shonitha undergo pravrudha dusti causing shopha &
other upadravas and these should be appropriately treated as mentioned accordingly, like
siramokshana in shopha. If left untreated the disease progresses to stage IV.
Stage IV: In this stage the upadravas like shopha would have attained ativrudha avastha,
manifesting symptoms like Ruja & vidaha, where shastra chikitsa and vranakriya should
be performed. If neglected the disease proceeds into Asadhya avastha which is the V &
the final stage.
Stage V: In the asadhya avastha, the upadravas become mahantha and & makes the
disease asadhya, like here when the pooya of pidakas attain abhyantaraprapti and become
utsanga.
“Evaluatio In the management of Madhumeha”
101
Madhumeha Analysis: Though explained as prameha pidaka avastha chikitsa,description of stage wise
progression of the disease and the treatment has been done by sushruta on the pretext of
explaining the prameha pidaka chikitsa. This description seems to be chikitsa in case of
apathyanimittaja madhumeha, the course of this illness has been discussed already under
samprapti & accordingly in the poorvaroopavastha sushruta advises apatarpana & other
shamana dravyas as there is Alpadosha &alpa dhatu dusti, hence unless the need arise,
samshodana is not the treatement of choice and as the laxanas are predominantly due to
kapha, kaphahara chikithsa should be done & this seems to be the logic behind
prescribing apatarpana & tikshna dravyas like chaga mootra. Whereas in vyakta avastha
there is bahu dosha & a relatively alpa dhatu dusti like medas & rakta which warrants
shodhana, accordingly vamana, virechana&basti has been adviced as the rogi is still
balavan & sthoola & so shodanarha.
In the next stages there is a progressive dhatu kshaya & production of upadravas.
The patient is shodana anarha & there is vata pradhanyata. Hence only shamana chikitsa
& respective upadrava chikitsa should be done. Sushruta has stressed the importance of
timely intervention in madhumeha because in case of negligence the disease progresses
involving gambhira dhatus & the upadravas pervade the entire body making it asadhya.
Santarpana Apatarpana Chikitsa in Madhumeha: -
Madhumeha has been described as santarpanotha vyadhi as well as apatarpanotha
vyadhi. The former is apathya nimittaja madhumeha & later is sahaja madhumeha or
madhumeha due to dhatu karshana due to long standing prameha. Accordingly two forms
of madhmehis are ancountered one who is sthoola & balavan for whom Apatarpana is the
best & the other who is krusha & paridurbala for whom santarpana is the best.
“Evaluatio In the management of Madhumeha”
102
Madhumeha I. Apatarpana chikiatsa: is done in the form of langana langanapachana &
doshavaseehana. a) Langana this is done in alpadashavastha where only upavasa pipasa,
maruta atapa sevana1rooksha udvartana, pragada vyayama, Nishi Jagarana & so on,
which are kaphamedo hara are helpful. b) Langana pachana: This is done in
madhyamadoshavastha where along with langana, Ama pachana is done with tikshna
ushna dravyas. c) Doshavasechana: This is done in Bahudoshavastha where the shodana
of doshas are done from ubhaya margasII. Santarpana Chikitsa: Laghusantarpana chikitsa
is prashastha for krusha and durbala rogis the following can be administered in
madhumehi. a) Manthas,
b) Kashaya, c) Yava, d) Churna, e) Lehya, f) Laghu Bhakshya. These formulations
should be prepared such that they cause santarpana without causing vridhi of kapha &
medas. Among all these yava is considered as best for madhumehi which will be
discussed in the chapter of pathya apathya.
Shresta Aushadha prayoga in madhumeha: -
Shilajathu, guggulu & loharaja: These three dravyas are medicines par excellence in
madhumeha, either in krusha or sthoola, as they are virukshana & chedaneeya, which is
good for kapha, as well as Rasayana, which is good for dhatukshaya & vatavrudhi.
MANAGEMENT OF DIABETES MELLITUS
Management, rather than treatment, is the appropriate term in Diabetes mellitus,
and involves diet, exercise, insulin, oral hypoglycaemics, patient education and
counselling. Insulin and oral drugs are discussed here and the other aspects of
management in subsequent chapters.
“Evaluatio In the management of Madhumeha”
103
Madhumeha INSULIN: Insulin is required for treatment of all patients with IDDM & many patients
with NIDDM. No single standard exists for patterns of administration of insulin and
treatment plans vary from physician to physician. With a given physician for different
patients three treatment regimes will be described. Viz. Conventional, Multiple
subcutaneous injections (MSI) and Continuous subcutaneous insulin infusion (CSII).
Conventional Insulin Therapy: involves administration of one or two injections a day
of intermediate acting insulin such as zinc insulin (NPH insulin) with or without the
addition of small amounts of regular insulin. This practice is based on the concept that
regular insulin lowers the plasma glucose level rapidly after which more slowly absorbed
insulin maintains the lowered level. Here patients should be taught to decrease insulin
when extra exercise is anticipated.
Multiple subcutaneous insulin injection technique (MSI): Most commonly involves
administration of intermediate or long acting insulin in the evening as a single dose
together with regular insulin prior to each meal.
Continuous subcutaneous insulin infusion (CSII): This involves the use of a small battery
driven pump that delivers insulin subcutaneously into the abdominal wall. Adjustments in
dosage are made in response to measured capillary glucose values, as in MSI. Though
CSII provides better Diabetic control, there is a higher risk of Hypoglycaemia and
Diabetic Ketoacidosis.
ORAL AGENTS:
Sulphonyl ureas: NIDDM that cannot be controlled by diet & exercise often responds to
sulphonyl ureas. Sulphonylureas, like Chlorpropamide & Tolbutamide, act primarily by
“Evaluatio In the management of Madhumeha”
104
Madhumeha stimulating release of insulin from β cell, but are useful only in patients with relatively
mild disease.
Second generation drugs such as Glipizide & Glyburide are effective in smaller
doses and differ little from Sulphonylureas. Hypoglycemia occurs less often with oral
agents than with insulin. But when it occurs it tends to be severe & prolonged.
Biguanides: Metformin is useful in NIDDM patients who are not responsive to diet &
exercise. The primary action is thought to be inhibition of hepatic gluconeogenesis & it
also may enhance glucose disposal in muscle & adipose tissue. Melformin does not cause
hypoglycemia unlike sulphonylureas, metformin can cause lactic acidosis hence should
not be given in patients with renal disease.
Thiazolidinedione derivatives: Such as troglitazone, lower blood levels of glucose, free
fatty acids & triglycerides and appears to reduce insulin resistance. Troglitazone is
approved for use in obese patients with NIDDM who are poorly controlled on insulin.
SUMMARY:
Madhumeha Diabetes Mellitus
Margavarana Janya madhumehi
is sthoola & balavan so apatarpana
chikitsa in the form of langhana &
Nidana parivarjana
Dhatu Kshaya Janya madhumehi is
Krusha & durbala hence santarpana
Chikitsa.
NIDDM patient is obese, so diet exercise
and oral hypoglycemics (sometimes insulin
also)
IDDM – patient is thin so insulin therapy
“Evaluatio In the management of Madhumeha”
105
Madhumeha
Prameha Pidaka
Charka in his Suthrasthana explained special Samprapti for madhumeha and he
explains that the lakshanas manifest and vanish at times. He also states that if neglected,
this disease causes serious types of pidakas in subcutaneous, muscular area, vital parts
and joints of the body. Hence pidaka can be termed as upadrava of madhumeha.
There are different opinions among the acharyas regarding the number of pidakas
as follows.156
Table No: -16
Showing the list of prameha pidakas157,158
No. Charaka Sushruta Vagbhata
1. Sharavika Sharavika Sharavika
2. Kachapika Kachaptka Kachapika
3. Jalini Jalini Jalini
4. Sarshapika Sarshapika Sarshapika
5. Alaji Alaji Alaji
6. Vinata Vinata Vinata
7. Vidradi Vidhradi Vidhradi
8. - Masurika Kuluttika
9. - Putrini Putrini
10. - Vidarika Vidarika
COMPLICATION OF DIABETES MELLITUS159
It can be classified into two groups
1) Acute complications: -
“Evaluatio In the management of Madhumeha”
106
Madhumeha
a) Metabolic – Ketoacidosis, Hyper Osmolar non Ketotic coma, lactic
acidosis
b) Infective apisodes of RIT, UTI, Skin etc.,
c) Surgical complications – Gangrene, Carbuncles
2) Chroni Complications: -
a) CVS – Premature altheroma, Ischaemic or
CHD – Thromibosis, HT, Claudication etc
b) Nervous System – CVD, Peripheral neuropathey, Sensory and motor
neuropathises.
c) Excretory System – Recurrent UTI, RF, Chronic polynephritis
d) Eyes – Cataracts, Retinopathy
e) Respiratory System – Pulmonary kocks
f) Digestive System – Stomatitis, Dental sepsis, fatty filtration of lives
g) Bones and Joints – Osteoporosis, Frozen shoulder on, Neuropathic joints
h) Skin – Monitial infections, trophic ulcers, carbuncles
i) Gonad possible hormon changes.
Some upadravas can be correlated to some of the complications of modern sciences
for e.g.- thrishna, bhrama, shoola, tamapravesha, swasa etc with that of the
ketoacidosis in which all these symptom are seen and even in hypoglycemic condition
also.
ARISHTA LAKSHANAS
Only a few references regarding arishta lakshanas of madhumeha and prpamehas
can be found in the classics.
They are as follows: -
“Evaluatio In the management of Madhumeha”
107
Madhumeha If the bala and mamsa of a madhumeha rogi is severely deteriorated then he
should be considered as achikitsya.
Swapna vishayaka – If person dreams of drinking various types of snehas in
association with chandalas (that is out cast men) then he dies of prameha. If a
madhumeha rogi dreams of consuming water then he dies of prameha.
Doota vishayaka – The meeting of the messenger and the physician near the pond
or along with water then the prognosis will be bad. If the patient is suffering from
prameha.
Anya – In spite of regular bath and the application of perfumes if the flies attach
concurrently on a madhumeha rogi. Then he will die soon. If madhumeha is present with
the upadravas it is to be considered as arista. If he is lethargic obese, atisnigdha and is a
varacious eater. Then death impends in the form of prameha.
The knowledge of Arishta is very much essential to understand the prognosis of a
disease, which denotes death definitely.
PATHYA AND APATHYA
Very often, traditional medicinal systems are criticized for the strict
dietary restrictions. Many patients may not be inclined to embrace this
therapy, thinking that they will have to observe strict ‘Pathyam’.
It means ‘pathya‘ is one, which is beneficial to the path/channels.
‘Pathyam‘ includes those factors, which do not adversely affect the body
as well as mind, and which are favourable to maintain good health.
“Evaluatio In the management of Madhumeha”
108
Madhumeha ‘Pathyam’ includes specific foods and drugs (from natural sources), which
are beneficial and are in accordance with the functioning of body channels
or pathways through which they pass. The chronic disease, ‘diabetes’, can
be controlled by giving comprehensive attention to three aspects i.e.
Ausadha (medicine), Aahar (diet and Vihar (exercise).
The term Pathya means that which compatible to health. Pathya plays a
significant role in controlling Madhumeha. If person who is a Madhumehi indulges in
the habit of taking Apathyas then certainly the effect of the medicine will prove futile and
the disease aggravates. If person follows the Apathya than are advised for him, then it
will help him certainly to bring down increased state of disease.
Some points are to be considered before framing Pathyas for Madhumehi patients.
1) Nidana parivarjana
2) Considerations towards Sthoola and Krisha Madhumeha
patients
3) Vata and Kapha Nashaka Ahara and Vihara.
1) Nidana parivarjana: - The aharas, which have been explained for Samanya
Pramehas. Or Vishista Prameha is to be termed as Apathuyas. So Nidhana
parivarjana will become pathya for the patients.
2) General considerations on sthoola and krisha madhumeha patients: -
Pathyas differ from patients to patient as difference in the treatment. It
depends on the Nidana Samprapthi of the disease. For example in Sthoola
Madhumeha there is a Margavarodha of vayu by Vridda Kapha and medas.
Patients should be advised to follow the following diet.
“Evaluatio In the management of Madhumeha”
109
Madhumeha 1) The diet (Pathya) which aims towards the alleviation of Kapha Dosha and
Medodhatu
2) The diet, which inhabits the vitiation of Vayu.
3) The diet, which gives bala to the patient even with a low calorie value.
LIST OF PATHYAS
The following dravyas are having the qualities as mentioned in earlier description.
a) Jangal Mamsa
b) Shyamak
c) Uddalaka
d) Kodrava
e) Goodhooma
f) Chanaka
g) Tikta rasa Pradhana shakas that are grown in Jangal desha.
h) Yavanna
i) Kulattu
j) Purana shali dhanya-madhy.
“Evaluatio In the management of Madhumeha”
110
Nidana sevana
Vikrita bahudrava kapha (Shleshma)
Travels all over the body because of shareera shithilata
Medodhatwagni mandya
Vitiation of medovaha srotas
Bahu abaddha medas
Dosha dushya sammurchhana
Bahudrava shleshma with bahu abadhha meda
Vitiation of other dooshyas
Adhika kledata of dhatus
Basthi
MADHUMEHA
Beeja dosha
Sthoulya
Shleshma, pitta, meda, mamsa,
ativriddhi
Obstruction to vata due to
aavarana by vitiated kapha,
pitta and meda.
Squeezing of ojus
MADHUMEHA SAMPRAPTI
Genetic predispostion Envirnoment
Multi genetic defecets Obesity
Primary beta-cell defect Peripheral tissue insulin resistance
Deranged insulin Secretion Inadequate glucose utilization
Hyperglycemia
Beta cells exhaustion
Type II diabetes
PATHOLOGY OF TYPES II DIABETES
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
111
Drug review
Madhu / Honey:
Honey obtained from the sealed comb cells is a naturally converted form of
sugary food from the nectar of flowers & other plant exudations systematically collected
and stored by honeybees. Honey is a thick, syrupy, translucent, pale, yellow or yellowish
brown to dark brown liquid. It chiefly contains dextrose and fructose, moisture & small
amounts of sucrose & mineral constituents. The presence of enzymes, vitamins
suspended matter proteins, acid and colouring matter. Dextrin maltose, melezitose,
pentosans & gums are also reported.
Property:-
It is guru, Ruksha, Kashaya and sheeta veerya & it is pitta, Rakta & Kaphahara,
Moreover it is yogavahi which means it has samananukari dravyaprabhodhita shakti. In
other words madhu due to its prabhava assumes & magnifies gunas of whatever dravya is
used along with it. Hence madhu is used along with most of the aharas & aushadhas
which are Kaphamedo and mehahara but madhu should be used in small quantities
otherwise it causes vatavrudhi.
Contents: Alkaloids:
Moisture – 20.6% Pyrolizidine alkaloids
Proteins – 0.3% Jacohne, Jacozine
Carbohydrates – 79.5% Jacobine, seneciphylline
Minerals – 0.2% & senecionine
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
112
Calcium – 5%
Phosphorus – 16.0%
Iron - 0.9%
Riboflavin – 0.04%
Niacin – 0.2%
Vit C. - 4.0%
Energy – 319 K cal / 100g
Properties: Honey serves as mild laxative, bactericidal, sedative, antiseptic & alkaline
characteristics. It has ingredients which very similar to antibodies. Diet rich in honey is
recommended for infants, Convalescents & diabetic patients. It is generally
recommended as a remedy for cold, cough, fever, sore eyes & throat, tongue and
duodenal ulcers, liver disorders, constipation, diarrhea, kidney and other urinary
disorders, pulmonary T.B. rickets, marasmus, scurvy and insomnia. It is used as a remedy
on open wounds after surgery. It is reported to prevent infection & promote heating.
Pharmacotherapeutics of honey:-
It has been proposed that honey contains a sucralfate like substance that may be
responsible for its antioxidant property and gastric protection, deterioration in the
processes of lipids peroxidation and rise in the activity of antioxidant system of an
organism.
Saindhava Lavana. (Rock salt)
This is the best among lavana varga draya. Rock salt is the common
name for the mineral Halite.
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
113
Components - NaCl can have impurities of gypsum or transparent cubes. It has a
pure saline taste.
Rasa - lavana
Guna - laghu, snigdha, sukshma.
Veerya - ushna.
Vipaka - madhura.
Properties - chakshushya, hridya, ruchikara, promotes appetite and assists the
Digestion, assimilation and purgative action.
Tilataila: Tilataila is best Snehadravya among sthavara sneha as explained by
Charaka. Taila is used widely for internal and external conditions. Taila is most easily
available fixed oil of herbal origin used extensively in the form of food and medicines.
Acharya charaka mentioned that Tilataila is best among the taila vargas. It
alleviates vata but, at the same time does not aggravate kapha. From therapeutic point of
view the quality of taila is “Na Anyaha Snehastatha Kwachitsamskaram nuvartate” ie.
When taila is subjected (samskara) with other dugs it takes the property of that drug.
Vagbhata explains the importance of Tilataila as “Krishanam Bhrimhanayalam
Sthoolanam Karshanaya Cha”. It does Bhrimahana Karya for Krisha persons and does
Karshana for sthoola persons.
In Krusha persons, Srotosankochana is present (i.e. constriction of channels).
Taila when administered, by its Tikshna Vyavayadi gunas enters the Sukshmatisukshma
Srotases and accomplishes Shodhana karya. By Shrotoshuddhi, shareera pusthi will
occur. Hence in this manner it does “Tasmath Krishanam Bhrimhanayalam mittupanam”.
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
114
In Sthoola persons, by its sukshma, teekshnoshna gunas it enters Sukshmasrotases
does kshapana karya for meda. Due to kshapana of meda, the person becomes krisha.
Importance of murchana of tila taila: Crude oil contains Amadosha i.e, some enzyme
lipase and racine (toxic proteins), by morchana process Amadosha are removed and also
durgandhata & ugrata are removed. After doing Moorchana Samskara Sneha gets good
smell and colour. Apart from theses Sneha will gets the qualities of the drugs used for
Murchana. While by Sneha paka and Murchana the veerya of the Sneha is enhanced.
Before going to prepare any Aushadha siddha yogas, Taila Murchana is required.
Murchana means to enhance, to spread over. By this process amadosha is removed.
Usually Tailas are ushna veerya in nature. When treated with drugs like Amalaki,
Haritaki, etc., in the qualities of tailas changes takes place. i.e., Taila attains Sheeta
veerya. If Gritha & Tailas are treated with Rooksha, Ushna, Sheeta Dravyas, snehatwa
property will not be lost.
The drugs used for Murchana of Tilataila are Haritaki, Vibitaki, Amalaki,
Haridra, Mustha, Vatankura, Hrivera (Rasna), Ketaki pushpa, Manjistha, Lodra. With
their lekhaneeya property and also removes the Amadosh of Taila.
Beneficial effect of Moorchana sanskara reduces the degree of Saturation but enhances
the degree of Unsaturation. It indicates the role of unsaturated fatty acids in reducing
Serum Cholesterol, Serum Triglycerides and LDL levels which are other wise risk factor
for the development of Atherosclerosis, Hyper tension, Coronary heart diseases etc.
List drugs for murchana process:-
Manjistha - 1/16th part
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
115
Haritaki - 1/64th part
Vibhitaki - 1/64th part
Amalaki - 1/64th part
Mustha - 1/64th part
Haridra - 1/64th part
Lodra - 1/64th part
Vatankura - 1/64th part
Hrivera - 1/64th part
Nalika - 1/64th part
Ketakipushpa - 1/64th part
Tila taila - 1 part
Jala - 4 part
Eranda
Ricinus communis Linn. (Euphorbiaceae)
Synonyms: - :erandah, tarunah, sukla, citra, gandharvahastaka, pancangula, vardhamana,
amanda, dirghadandakah,etc.
Rasa (taste):-tikta, svadu [dhn] madhuram [mpn] madhuram [bpn] katu, tikta [rjn]
guna (quality):-guru [dhn] guru [mpn] guru [bpn]
veerya (potency):-usna [dhn] usna [mpn] usna [bpn] usna [rjn]
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
116
Karma (action):-sula hara [mpn] sula hara [bpn]. It is Vatashamaka, Rasayana, and
Medhya
Dosha-karma (action on doshas):-vata hara [dhn] kapha hara [mpn] kaphavata hara
[bpn] kaphavata hara [rjn]
roga-haratwa :
udavarta, pliha, gulma, bastisula, antravrddhi [dhn] sula, sopha, kati, vasti, sira pida,
udara, jwara, bradhma, svasa, anaha, kasa, kustha, amavata [mpn] sula, sopha, kati, vasti,
sirapida, udara, jwara, bradhma, svasa, anaha, kasa, kustha, amamarutha [bpn] jwara,
kasa [rjn]
Chemical Constituents of Root
Alkaloid -- Ricinine 1% ; Leaf --Ricinine, N-dimethylricinine, Kaempferol, Quercetin ;,
B- amyrin , Hyperoside , Quinic acid; gallic, skimmic, ellagic, ferulic and coumarinic
acids Seeds --- Ricinoleic acid ( 89% of fatty acids of castor oil ), Ricin; Seed cake --
Ricinine (Alkaloid ) ;. Seed- Toxic principles -2.8 - 3 %
Shatapushpi
(Anethum sowa)
Paryaya: - Shatapushpi, Chatra, Bahupushpa,etc
Properties:-
Guna: - laghu, ruksha, teekshna.
Rasa: - katu, tikta.
Veerya: - ushna
Drug review
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
117
Vipaka: - katu
Doshagnata: - due to its ushna and teekshna property it acts as a kapha vata shamaka.
Chemical composition: - a seed contains sainted oil.
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
118
RESEARCH APPROACH: -
It is believed that success of the research work mainly depends on
its Methodology, so utmost care is in study design is very essential. Hence, in this
section, the researchers put forward the systemic procedures, which are followed by the
researcher’s right from the identification of the problem to the final conclusion.
In this work I aimed to evaluate the efficacy of Madhutailika bastikarma in Madhumeha.
The efficacy was determined by finding out the difference between the baseline
data of the parameters to the after treatment data.
Source of data: -
Patients suffering form madhumeha were selected from P.G. S. & R., Department
of Panchakarma O.P.D. of D.G.M. Ayurvedic Medical College and hospital, Gadag by
preset inclusion and exclusion criteria.
Study design: -
The study design selected for the present study was prospective
clinical trial. Demographic data and disease-specific data are collected according to the
case-record form given in the appendix.
The treatment modality used in this clinical study was Vasti karma, which
included sthanika abhyanga sweda, anuvasana vasti, and nirooha vasti i.e.
madhutailika vasti, and which was followed by parihara kala and follow up 15
days. During the follow-up period patients were given placebo capsules.
1) Abhyanga with murchita tila taila.
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
119
2) Anuvasana vasti with murchita tila.
3) nirooha vasti i.e. madhutailika vasti.
A minimum of 30 patients was taken for study. All the patients received
classical vasti karma.
Inclusion criteria: -
Patients satisfying the following criteria were taken for study. They are –
The patients between the age group of 35 to 60 years.
Non-complicated NIDDM.
Patients having the clinical features of madhumeha.
Irrespective of sex.
Madhumeha patients having well body strength, sthoola and also fit for Vasti
karma.
Exclusion criteria: -
If any of the following conditions were noted, such patients were excluded form
the present study. They are –
Insulin dependant diabetes mellitus.
Patients complicated with other systemic disorders.
Patients less than 35 and above 60 years of age.
Patients with diabetic complications.
Duration of the Study
The treatment modality used in this clinical study was Vasti karma, which
included sthanika abhyanga sweda, anuvasana vasti, and nirooha vasti i.e.
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
120
madhutailika vasti, and which was followed by parihara kala and follow up 15
days. During the follow-up period patients were given placebo capsules.
Abhyanga with murchita tila taila.
Anuvasana vasti with murchita tila.
nirooha vasti i.e. madhutailika vasti.
A minimum of 30 patients was taken for study. All the patients received
classical vasti karma.
.
Plan of study: -
The treatment modality used in this clinical study was Vasti karma, which
included sthanika abhyanga sweda, anuvasana vasti, and nirooha vasti i.e.
madhutailika vasti, and which was followed by parihara kala and follow up 15
days. During the follow-up period patients were given placebo capsules.
Selected patients were given basti karma.
A. Deepana-pachana – Deepana pachana till nirama laskhanas appears. For this the
drug administered was trikatu choorna, 3 gms 3 times a day before food.
B. Abhynaga– Sthanika abhynaga and ushna jala snana. For abhynaga moorchita tila
taila was used.
C. Basthi karma – five Anuvasana and three Madhutailika Basti
D. Parihara Kala – sixteen days parihara kala.
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
121
E. Follow up – Follow up for one month. During this period of follow up the patient
was advised to follow the diet, which he had followed prior to our study.
Data Collection
Patients were thoroughly examined both subjectively and objectively. Detailed history
pertaining to the mode of onset, previous ailment, previous treatment history, family
history, habits, ashtavidhapareeksha and dashavidhapareeksha and physical examination
findings were noted. Routine investigations were done to exclude other pathologies
Investigations and Selection of Patients: -
Objective parameters:-
The following investigations were done prior to the study.
1. Blood – FBS, PPBS.
2. Urine – Urine sugar.
After interpretation of the laboratory investigations, mild and moderate types of
patients were taken for study. Mild and moderate criteria’s are given here.
Table No. 15. Showing the grades of the blood sugar level.
Sl. Level FBS RBS PPBS Urine
sugar
01. Normal 70-120 mg/dl. 100-140 120-180 Nil
02. Mild 121-170 mg/dl. 181-230 181-230 0.5%
03. Moderate 171-220 mg/dl. 231-280 231-280 1.0-1.5 %
04. Severe 221-mg/dl and 281 mg/dl and 281 mg/ dl and 2% and
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
122
above above above above
Subjective parameters: -
Apart form the above parameters; the following parameters were also taken for
assessing the patient. They are –
Prabhuta mutrata
Kshudadhikya
Pipasadhikya
Karapada daha
Ati sweda
Method of Assessment and grading: -
The assessment of results is made by observing the severity of symptoms and
laboratory investigations.
The severity of the symptoms, urine sugar, fasting blood sugar and post prandial
blood sugar were assessed before the treatment, after Vasti karma, after parihara kala, and
follow up, i.e.15th day of period.
Grading of parameters: -
The results were evaluated by observing subjective and objective parameters by
grading method. The grading was done in the following manner.
1. Prabhuta mutrata: -
Grade 0 – 2-3 times / day, 0-1 times / night.
Grade 1 – 4-5 times / day, 2-3 times / night.
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
123
Grade 2 – 6-7 times / day, 4-5 times / night.
Grade 3 – > 7 times / day, > 5 times / night.
2. Pipasadhikya: -
Grade 0 – Normal.
Grade 1 – Slightly increased.
Grade 2 – Severely increased.
3. Kshudhadhikya: -
Grade 0 – Normal.
Grade 1 – Increased, but can tolerate.
Grade 2 – Increased, but can’t tolerate without consuming food.
4. Kara pada daha: -
Grade 0 – Absent.
Grade 1 – Slightly present.
Grade 2 – Present.
4. Ati sweda: -
Grade 0 – Absent.
Grade 1 – Present.
5. F.B.S.: -
FBS levels,
Grade 0 - 120 and below
Grade 1 - 121-140
Grade 2 - 141-160
Grade 3 - 161-180
Methodology
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
124
Grade 4 - 181-200
Grade 5 - 201-220
6. PPBS (Post prandial Sugar): -
PPBS levels –
Grade 0 - 180 and below
Grade 1 - 181-200
Grade 2 - 201-220
Grade 3 - 221-240
Grade 4 - 241-260
Grade 5 - 261-280
7. Urine sugar: -
Urine sugar -
Grade 0 - Nil
Grade 1 - 0.5
Grade 2 - 1.0 - 1.5
Master Chart No 1 Sex Religion Occupation Socioeconomic status Diet Duration Sl.
No. OPD No.
Age (yrs) M F H M S A L P M UM HC Veg Mix ND > 1 > 2 > 3
01. 5204 40 - + + - + - - - + - - + - - + - - 02. 5235 50 + - + - + - - - - + - + - - - + - 03. 5311 35 - + + - + - - - - - + + - - + - - 04. 5324 58 + - + - + - - - + - - - + - + - - 05. 5337 43 + - + - + - - - + - - - + - + - - 06. 5383 62 + - + - + - - - - + - + - + - - - 07. 5385 59 + - + - + - - - - - + + - + - - - 08. 5451 46 + - + - + - - - - + - + - - - - - 09. 929 57 + - + - - - - + + - - - - + - + - 10. 945 50 + - + - + - - - - + - - + - + - - 11. 1140 55 - + + - + - - - + - - + - - - + - 12. 1141 62 + - + - + - - - - + - + - - - - + 13. 1184 40 + - + - + - - - - - + - + - - + - 14. 1613 38 - + + - - - + + - - - + - - + - - 15. 1718 49 + - + - + - - - + - - - + - - - + 16. 1413 58 + - - + - - + + - - - - + - - + - 17. 1221 46 + - + - - - + + - - - - + - - - + 18. 1519 52 + - + - + - - - - + - + - + - - - 19. 2906 54 + - + - - - + + - - - - + - - + - 20. 2933 43 + - - + + - - - - + - - + - - + - 21. 3062 51 + - + - + - - - - + - - + - - + - 22. 3094 63 - + + - + - - - + - - - + + - - - 23. 3603 52 + - - + + - - - - + - - + - + - - 24. 3227 57 + - + - + - - - + - - - + - - - + 25. 3375 49 + - + - + - - - + - - + - - + - - 26. 3438 44 + - + - + - - - - + - + - - + - - 27. 3495 57 + - - + + - - - - + - - + - + - - 28. 3630 56 + - + - + - - - - + - - + - - + - 29. 3750 53 + - + - + - - - - + - - + + - - - 30. 3751 48 + - + - + - - - - + - - + + - - -
M – Male; F- Female; H- Hindu; M- Muslim; S – Sedentary; A – Active; L – Labor;P- Poor; M – Middle class; Um – Upper middle class; HC – High class; ND – Newly diagnosed;.
Master Chart No 2 Family history Family
history Koshta Agni Bowel Habits Prakriti Sl.
No. OPD No.
Al Ay No Du P A Mr Ma Kr M T S F C S A T No KP KV VP 01. 5204 + - - 8
Mnts + - - + - - + - - + - - - - - - +
02. 5235 + - - 1 ½ yrs
+ - - + - - + - - + - + - - - + -
03. 5311 + - - 2 yrs + - - + - + - - - + - - - + + - - 04. 5324 + - - 2
mnts - + - + - - + - + - - + - - + - -
05. 5337 + - - 1 yr + - + - - - + - - + - + - - + - - 06. 5383 + - - 1 yr - + - + - - + - + - - + - - + - - 07. 5385 + - - 6
mnts + - - - - + - + - + - - - + + - -
08. 5451 + - - 6 mnts
+ - + - - - + - + - + - - - - + -
09. 929 - - + - - + - + - - + - - + + - - - - - + 10. 945 + - - 14 mnts - + - + - - + - - + + - - - - + - 11. 1140 + - - 1 mnt - + - + - + - - - + - + - - - + - 12. 1141 + - - 5
mnts + - - + - - + - - + - + - - - - +
13. 1184 + - - 1 yrs + - - - + + - - - + - + - - - - + 14. 1613 - + - 6
mnts + - - - + - + - - + - - - + - + -
15. 1718 + - - 3yrs + - + - - - + - - + - + - - - + - 16. 1413 - + - 4mnts + - + - - + - - + - - + - - + - - 17. 1221 + - - 6mnts - + - + - - + - - + - + - - + - - 18. 1519 + - - 1 yr + - - + - - + - - + - - - + + - - 19. 2906 + - - 2yrs - + - + - - + - + - - + - - + - - 20. 2933 + - - 2yrs + - - + - - + - + - - + - - + - - 21. 3062 + - - 1yr + - - + - + - - - + - + - - + - - 22. 3094 - - + - + - - + - + - - + - - - + - + - - 23. 3603 + - - 9
mnts + - + - - + - - - + + - - - + - -
24. 3227 + - - 1yr - + - + - - + - - + - - - + + - - 25. 3375 + - - 2yrs + - - + - - + - + - - - - + + - - 26. 3438 - + - 3 yrs + - - + - - - + - + - - - + - - + 27. 3495 + - - 1 ½
yrs + - - + - - + - - + + - - - - - +
28. 3630 + - - 3mnts - + - + - - + - - + + - - - - + - 29. 3750 + - - 8
mnts - + - + - - - + + - - + - - - + -
30. 3751 - + - 6 mnts
- + - + - - - + + - - - - + - + -
Al – Allopathy; Ay – Ayurveda; No. – No history; Du. – Duration; P – Present; A – Absent; Mr. – Mridu; Ma. – Madhyama; Kr. – Krura; M. – Manda; T. Teekshna; S. – Sama; F – Free; C. – Constipation; S. – Smoking; A. – Alcohol; T. – Tobacco; N. – No habits; KP. – Kapha-pitta; KV – Kapha-vata; VP – Vata-pitta.
Master Chart No 3 Prabhoota
mutrata Pipasadhikya Kshudadhikya Karapadadaha Ati Sweda FBS PPBS Urine sugar Body weight Sl. OPD
NO. BT AT AF BT AT AF BT AT AF BT AT AF BT AT AF BT AT AF BT AT AF BT AT AF BT AT AF
01. 5204 2 1 0 2 1 1 1 0 0 1 1 0 0 0 0 126 125 98 197 170 149 1 1 0.5 63 62 62 02. 5235 1 1 0 1 0 0 2 0 1 0 0 0 0 0 0 120 112 110 158 132 126 1 0.5 0 80 77 78 03. 5311 1 0 0 2 1 1 1 1 0 2 1 0 1 1 1 106 110 104 145 150 138 0.5 0.5 0 70 68 65.5 04. 5324 2 1 0 2 1 0 1 0 0 1 1 0 0 0 0 132 125 127 225 198 175 1 1 0.5 74 73 73.5 05. 5337 2 1 0 2 1 1 2 1 0 2 1 0 1 0 0 138 136 117 180 170 153 1 0.5 0.5 95 92.5 93 06. 5387 1 0 1 1 0 0 2 1 0 2 1 1 0 0 0 110 110 98 193 170 142 0.5 0.5 0 65 63.5 62.5 07. 5385 2 1 1 2 1 0 2 0 1 1 1 0 0 0 0 105 100 98 150 164 130 0.5 0 0 72 71 70.5 08. 5451 1 0 0 1 0 1 1 0 0 1 0 0 1 0 1 130 120 111 230 198 160 1 0.5 0.5 68 67 67.5 09. 929 2 1 0 1 0 1 0 0 0 1 0 0 1 0 0 120 120 105 193 190 164 1 0.5 0.5 75 73.5 74 10. 945 1 0 0 2 1 0 1 0 1 1 0 1 0 0 0 135 130 115 246 255 190 0.5 0.5 0.5 68 66.5 67 11. 1140 1 0 0 2 1 1 2 1 0 1 0 0 1 1 0 118 118 100 173 160 128 0.5 0 0 76 77.58 73.5 12. 1141 2 1 0 1 0 0 1 0 0 0 0 0 1 0 0 105 105 100 154 185 130 0 0 0 68 68 68.5 13. 1184 1 0 0 1 0 0 2 1 0 1 0 0 1 1 1 138 125 107 197 230 160 0.5 0.5 0 78 78 77 14. 1613 1 0 0 2 1 0 1 0 0 1 1 0 0 0 0 156 150 138 363 400 330 1.5 1.5 1 64 64 63 15. 1718 1 0 0 1 0 0 1 0 0 1 0 1 0 0 0 160 134 126 257 260 211 1.5 0.5 1 62 61 60.5 16. 1413 2 1 0 1 0 0 0 0 0 1 1 0 0 0 0 141 116 102 222 230 191 1 0.5 1 59.5 59 59 17. 1221 1 0 0 2 1 0 1 1 0 0 0 0 0 0 0 170 139 159 265 238 204 1 0.5 1 63.5 64 62 18. 1519 2 1 0 2 1 0 2 1 0 1 0 0 0 0 0 118 138 115 193 205 183 0.5 0.5 0.5 73 72.5 72.5 19. 2906 2 1 1 1 0 1 2 1 1 1 1 0 1 1 1 170 139 158 298 310 271 1 1.5 1 89 88.5 88 20. 2933 2 2 1 1 0 0 2 1 1 1 0 0 0 0 0 130 140 123 273 248 203 0.5 0 0 61.5 62 61.5 21. 3062 1 0 0 1 0 0 0 0 0 0 01 0 1 0 0 107 85 94 215 225 183 0.5 0 0.5 58 58.5 58 22. 3094 3 2 1 2 1 1 2 1 0 0 0 0 1 1 0 188 152 141 305 330 268 1.5 1 1 76 75.5 74.5 23. 3603 1 0 0 1 0 0 1 1 0 1 1 0 1 0 0 116 113 94 275 164 141 1 0.5 0.5 67 66 63.5 24. 3227 1 1 0 1 0 1 2 1 0 1 0 0 0 0 0 118 115 108 183 170 145 0.5 0 0 55 53.5 53 25. 3375 2 1 1 2 1 1 2 1 1 1 1 0 1 0 0 138 135 120 140 213 174 1 0.5 0 58 57 56.5 26. 3438 3 2 1 2 1 0 1 0 0 0 0 0 1 1 1 102 104 90 147 179 143 0.5 0 0 85 82.5 83 27. 3495 3 2 1 1 1 0 2 1 0 1 0 1 1 0 0 220 216 178 444 372 370 1.5 1 1 63 61 61 28. 3630 3 2 1 2 1 0 1 0 1 0 0 0 0 0 0 141 125 103 198 189 163 0.5 0 0 62 61 60.5 29. 3750 3 1 1 2 1 1 2 1 1 1 1 0 1 1 0 195 180 138 236 240 181 0.5 0.5 0.5 64 64 63.5 30. 3751 2 2 1 1 0 0 2 1 1 1 0 0 1 1 0 133 119 116 276 220 174 0.5 0.5 0 65 63.5 63.5
BT – Before treatment; AT – After treatment; AF – After follow-up.
Results
Table. No- 17 Showing the Data of Age Group Incidence and Response
Sl.no.
Age.group.
No.of.pts.
%
GR
%
MR
%
PR
%
1
35-39
02
6.66
-
-
2
100
-
-
2
40-44
05
16.66
3
60
2
40
-
-
3
45-49
06
20
3
50
3
50
- -
4
50-54
07
23.33
2
28.57
3
42.85
2
28.57
5
55-59
07
23.33
2
28.57
4
57.14
1
14.28
6
60-64
03
10
1
33.33
1
33.33
1
33.33
Among age group 35-39 it contains 2 patients i.e. (6.66%) and 2 patients responded moderately (100%). 40-44 age groups include 5 patients i.e. 16.66% and in that all 3 patients i.e.60% responded well, 2 patients i.e. 40% responded moderately.
Age group 45-49 includes 6 patients i.e. 20% and in that 3 patients (50%) responded well, 3 patients (50%) responded moderately. Age group 50-54 includes 7 patients i.e. 23.33%. In those 2 patients i.e. 28.57% responded well, 4 patents i.e. 57.14% responded moderately and one patient showed poor response. 55-59 age group contains 7 patients i.e. 23.23% is in that 2 (28.57%) patients responded well, 4 patients responded moderately i.e. (57.14%) and 1 i.e. (33.33) patient showed poor response. Last 60-64 age group includes 3 patients i.e. 10% and in that 1 (33.33%) patient responded well, 1 patients responded moderately i.e. (33.33%) and 1 patient showed poor response.
Graph no-1
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
125
Results
0
1
2
3
4
5
age
no o
f pts
GR 0 3 3 2 2 1MR 2 2 3 3 4 1PR 0 0 0 2 1 1
35-39 40-44 45-49 50-54 55-59 60-64
Table. No- 18 Showing the Sex Group Incidence and Response Sl.no.
Sex
No.of.pts.
%
GR
%
MR
%
PR
%
1
Male
25
83.33
10
40
12
48
3
12
2
Female
05
16.66
2
40
2
40
1
20
Out of 30 patients, 25 were males (83.33%) and 5 were females (16.66%). Among
males 10 patients (40%) responded well, 12 patients (48%) responded moderately and 1
patient showed poor response.
Among females 2 patients responded well i.e. (40%), 2 patients responded
moderately (40%) and 1 patient showed poor response.
Graph no-2
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
126
Results
0
5
10
15
GR MR PR
Sex group incidence and response
Male Female
Table. No- 19 Showing the Chronicity and Response
Sl.no. Duration No.of.pts % GR % MR % PR % 1 <1 06 20 2 33.33 2 33.33 2 33.33 2 >1 11 36.66 6 54.54 4 36.36 1 9.09 3 >2 09 30 2 22.22 6 66.66 1 11.11 4 >3 04 13.33 2 50 2 50 - -
Among 30 patients, 6 patients’ (20%) were newly diagnosed. In that category 2
patient’s (33.33%) responded well and 2 patients (33.33%) responded moderately and 2
patient’s showed poor response.
In the above 1 year group, 11 patients’ (36.66%) and in that 6 patients (54.54%)
responded well, 4 patient’s response was moderate (36.36%) and one patient i.e. (9.09%)
showed poor response.
In the >-2 year group contains 9 patients (30%). Among them 2 patient’s
(22.22%) responded well, 6 patients (66.66%) responded moderately and 1 patient
(11.11%) showed poor response.
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
127
Results
More than 3 year group contains 4 patients (13.33%) and in that 2 patients
responded well and 2 patient’s showed moderate response.
Graph no-3
chronicity and response
0
5
10
15
<1 yr >1yr >2 >3
No.of.pts GR MR PR
Table. No- 20
Showing the Incidence of Religion and Response
Sl.no.
Religion
No.of.pts.
%
GR
%
MR
%
PR
%
1
Hindu
26
86.66
12
46.15
11
42.30
3
11.53
2
Muslim
04
13.33
1
25
2
50
1
25
3
Others
-
-
-
-
-
-
-
-
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
128
Results
In religion 26 patients were Hindu (86.66%) and4 patients were Muslim
i.e.(13.33%). Among the Hindus, 12 patients (46.15%) responded well, 11 patients
(42.30%) responded moderately and 3 patients (11.53%) showed poor response.
Graph no-4
0
5
10
15
Hindu Muslim Others
religion and response
GR MR PR
Table. No- 21 Showing the Socioeconomic Status and Response Sl.no. Economic
Status. No.of. pts.
% GR % MR % PR %
1
Poor
05
16.66
-
-
4
80
1
20
2
Middle
08
26.66
5
62.5
2
25
1
12.5
3
Upper Middle
14
46.66
5
35.71
7
50
2
14.28
4
High Class
03
10
2
66.66
1
33.33
-
-
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
129
Results
Among 30 patients 5 patients was poor i.e. (16.66%), in that 4 (80%) patient’s
responded moderately and 1 patient (20%) showed poor response.
8 patients (26.66%) were middle class, among them 5 patient’s (62.5%) response
was good, 2 patient’s (25%) responded moderately and one patient (12.5%) showed poor
response.
14 patients were upper middle class and in that 5 patients (35.71%) responded
well, 7 patients (50%) responded moderately and 1 patient (14.28%) showed poor
response.
Among 3 high-class patient (10%). 2 Patients (66.66%) responded well and one
patient (33.33%) responded moderately.
Graph no-5
02468
Poor Middle UpperMiddle
HighClass
Economic status and response
GR
MR
PR
Table. No- 22
Showing the Incidence of Religion and Response
Sl.no.
Religion
No.of.pts.
%
GR
%
MR
%
PR
%
1
Hindu
26
86.66
12
46.15
11
42.30
3
11.53
2
Muslim
04
13.33
1
25
2
50
1
25
3
Others
-
-
-
-
-
-
-
-
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
130
Results
In religion 26 patients were Hindu (86.66%) and4 patients were Muslim
i.e.(13.33%). Among the Hindus, 12 patients (46.15%) responded well, 11 patients
(42.30%) responded moderately and 3 patients (11.53%) showed poor response.
Graph no-6
0
5
10
15
Hindu Muslim Others
religion and response
GR MR PR
Table. No- 23 Showing the Incidence of Occupation and Response Sl.no. occupation
No.of.pts.
%
GR
%
MR
%
PR
%
1
Sedentary
25
83.33
13
52
9
36
3
12
3
Labour
05
16. 66
-
-
4
80
1
20
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
131
Results
4
Others
-
-
-
-
-
-
-
-
In occupation status, 25 patients were sedentary (83.33%) and 5 patients were
labors (16.66%).
Among the sedentary category 13 patients (52%) responded well, 9 patients
(36%) responded moderately and 1 patient (12%) showed poor response.
Among labors 4patient’s (80%) responded moderately, and 1 patient (20%)
showed poor response.
Graph no-7
0
5
10
15
Sedentary Labour others
Occupation and Response
GR MR PR
Table. No- 24 Showing the Family History and Response Sl.no. Family
History No.of.pts. % GR % MR % PR %
1
Present
19
63.33
8
42.10
09
47.36
2
10.52
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
132
Results
2
Absent
11
36.66
4
36.36
5
45.45
2
18.18
Among 30 patients, 19 patients’ (63.33%) had family history and in that 8 patients
i.e. (42.10%) responded well, 9 patient responded moderately and 2 patient’s showed
poor response.
Other 11 patients (36.66%) had no family history and in that 4 patient’s (36.36%)
responded well, 5 patients (45.45%) responded moderately and 2 patients (18.18%)
showed poor response.
Graph no-8
0
5
10
Present Absent
Family history and response
GRMRPR
Table. No-25 Showing the Treatment History and Response Sl.no Treatment
History No.of.pts. % GR % MR % PR %
1
Allopathy
24
80
11
45.83 10
41.66 3
12.5
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
133
Results
2
Ayurveda
04
13.33
1
25
3
12.5
-
-
3
No treatment
02
6.66
-
-
1
50
1
50
Among 30 patients, 24 patients (80%) had undergone allopathic treatment, 4
patients (13.33%) had taken Ayurvedic treatment and 2 patients (6.66%) had no treatment
history.
Among the patients those who had taken allopathic treatment, 11 patients
(45.83%) responded well, 10 patients (41.66%) responded moderately and 3 patients
(12.5%) showed poor response.
In Ayurvedic treatment group, 1 patient’s (50%) responded well and 3 patient’s
(50%) responded moderately.
In the no treatment history group, one patient (50%) responded moderate and 1 patient
showed poor response.
Graph no-9
0
5
10
15
GR MR PR
Treatment history and response
Allopathy Ayurveda No treatment
Table. No-26 Showing the Habits of the Patient and Response
Sl.no. Habits No.of.pts % GR % MR % PR % 1 Smoking 06 20.00 2 33.33 3 50 1 16.66 2 Alcohol 14 46.66 5 35.71 7 50 2 14.28
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
134
Results
3 Tobacco 02 6.66 1 50 - - 1 50 4 No habbit 08 26.66 4 50 4 50 - -
Among 30 patients, 06 patients (20%) had the habit of smoking and in them, 2 patients (33.33%) responded well, 3 patients (50%) responded moderately and 1 patient (16.66%) showed poor response.
14 patients (46.66%) had the habit of drinking alcohol and in them 5 patients
(35.71%) responded well, 7 patients (50%), responded moderately and 2 patient’s
(14.28%) showed poor response.
2 patients (6.66%) had the habit of tobacco chewing, one patient responded good
and one patient showed poor response.
8 patients (26.66%) had the no habit, in that 4 patients (50%) responded well and
4 patient’s (50%) responded moderately.
Graph no-10
0
5
10
15
Smoking Tobacco
Food habbits and Response
No.of.pts GR MR PR
Table. No- 27 Showing the Nature of Malapravrithi and Response
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
135
Results
Sl. no.
Malapravritti
No. of.pts.
%
GR
%
MR
%
PR
%
1
Free
11
36.66
4
36.36
4
36.36
3
27.27
2
Constipation
19
63.33
8
42.10
10
52.63
1
5.26
Among 30 patients, 11 patients (36.66%) had free bowel and in that 4 patients
(36.36%) responded well, 4 patients (36.36%) responded moderately and 3 patients
showed poor response.
19 patients had constipation (63.33%) and in that 8 patients (42.10%) responded
well, 10 patients (52.63%) responded moderately and 1 patient (5.26%) showed poor
response.
Graph no-11
Free
GR37%
MR36%
PR27%
GR MR PR
C o n s t i p a t i o n
G R4 2 %
M R5 3 %
P R5 %
G R M R P R
Table. No – 28 Showing the Nidana Status and Response
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
136
Results
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
137
Among 30 patients, all of
them used to indulge in general
aharaja nidanas, like snigdha atyupayoga (100%) and guru ahara atyupayoga (100%).
Sl.no. Nidana No.of.pts.
% %
1 Snigdha 30 100 2 Guru 30 100 3 Asya Sukha 22 73.33 4 Swapna Sukha 20 66.66 5 Alpavyayam 24 80.00 6 Alpa Chinta 09 30.00
22 patients (73%) used to indulge in the vihara asyasukham.
20 patients (66.66%) indulge in more swapna sukham vihara
24 patients (80%) indulge in alpavyayama and 12 patients (40%) indulge in
alpachinta
Graph no-12
Types of Nidana
Swapna Sukha15%
Asya Sukha16%
Guru22%
Alpa Chinta7%
Snigdha22%Alpavyayam
18%
Results
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
138
Table. No – 29 Showing the Nature of Koshta and Response Sl.no.
Kostha
No.of.pts.
%
GR
%
MR
%
PR
%
1
Mrudu
08
26.66
4
50
3
37.5
1
12.5
2
Madhyama
19
63.33
7
36.84
9
47.36
3
15.78
3
Kroora
03
10
1
33.33
2
66.66
-
-
Among 30 patients, 8 patients (26.66%) had mrudu koshta, 19 patients had
(63.33%), madhyama koshta and 3 patient’s (10) had krura koshta.
In mrudu koshta patients, 4 patient’s (50%) response was well, 3 patients
responded moderately and one patient showed poor response.
Among madhyma koshta patients, 7 patients (36.84%) responded well, 9 patients
(47.36%) responded moderately and 3 patients (15.78%) showed poor response.
In 3 krura koshta patients one patient (33.33) responded well and 2 patients
(66.66%) responded moderately
Graph no-13 .
Results
0
2
4
6
8
10
Mrudu Madhyama Kroora
NATURE OF KOSHTA
GRMRPR
Table. No- 30 Showing the Status of Agni and Response
Sl.no.
Agni
No.of.pts.
%
GR
%
MR
%
PR
%
1
Mandagni
07
23.33
2
28.57
4
57.14
1
14.28
2
Teekshnagni
20
66.66
8
40
10
50
2
10
3
Samagni
03
10
1
33.33
1
33.33
1
33.33
Among 30 patients 7 patients (23.33%) had Mandagni and in that 2 patients
(28.57%) responded well. 4 patients (57.14%) responded moderately and one patient
(14.28%) showed poor response.
In 20 Teekshanagni, 8 patients (40%) responded well. 10 patients (50%)
responded moderately and 2 patients (10%) showed poor response.
In 3 Samagni, one patient well responded, one patient responded moderately and one patient showed poor response.
Graph no-14
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
139
Results
0
2
4
6
8
10
Mandagni Samagni
Nature of Agni and Response
GR
MR
PR
Table. No – 31 Showing the Prakruiti of the Patient and Response
Sl. no.
Prakruiti
No.of. pts.
%
GR
%
MR
%
PR
%
1 Kapha Pitta
15
50
6
40
7
46.66
2
13.33
2 Kapha Vata
09
30
3
33.33
5
55.55
1
11.11
3
Vata Pitta
06
20
3
50
2
33.33
1
16.66
Among 30 patients, 15 patients (50%) came under kapha pitta, 9 patient’s kapha-
vata prakriti and 6 patient of vata pitta prakruti.
In first group 6 patients (40%) responded well, 7 patients (46.66%) responded
moderately and 2 patients’ (13.33%) showed poor response.
Among kapha-vata prakriti patients, 3 patients (33.33%) responded well, 5 patients
(55.55%) responded moderately and 1 patient (11.11%) response was poor.
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
140
Results
Graph no-15
0
2
4
6
8
Kapha Pitta Kapha Vata Vata Pitta
Prakruti and response
GR
MR
PR
Table. No- 32 Showing the Statastical data of the Study
Individual study of the parameters showing the significance effect before and after the treatment.
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
141
Results
Sl.no.
Parameters Mean S.D S.E T-Value P- Value Remarks
1
Prabhoota Mutrata
1.4
0.563
0.102
13.72
< 0.001
HS
2
Pipasadhikya
1.16
0.592
0.108
10.74
< 0.001
HS
3
Kshudhadikya
1.133
0.628
0.114
9.938
< 0.001
HS
4
Karapada Daha
0.733
0.583
0.106
6.915
< 0.001
HS
5
Atisweda
0.333
0.479
0.087
3.827
< 0.001
HS
6
FBS
21.766
15.31
2.795
7.787
< 0.001
HS
7
PPBS
45.43
26.234
4.789
9.486
< 0.001
HS
8
Urine Sugar
0.4
0.242
0.044
9.090
< 0.001
HS
9
Body Weight
1.316
0.793
0.144
9.138
< 0.001
HS
Conclusion on the statistical data.
All the parameters show highly significant, (as P<0.05). The subjective parameters
orderly prabhoota mutrata,pipasadhikya and kshudadhikya, shows highly significant than
karapada daha and atisweda,(by comparing t-values). The parameter prabhoota mootrata
shows net mean effect more,there atisweda shows low net mean effect. Similarly the
parameter kshudadhikya shows more variations and the parameter atisweda shows low
variations, (by comparing, mean and S.D).
The objective parameters orderly PPBS, Body weight, urine sugar shows highly
significant than FBS, (by comparing t-value) the PPBS shows high net mean effect with
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
142
Results
“Evaluation of efficacy of Madhutailika Bastikarma in the Management of Madhumeha’
143
more variations, where as the parameter urine sugar shows low net mean effect with low
variation (by comparing, mean and S.D)
The parameter PPBS, shows high mean effect and urine sugar shows low mean effect
after the treatment. There is a more variation in PPBS and low variation in urine after the
treatment; the parameter body weight shows uniform effect on the patients, by comparing
mean, S.D, and C.V.
Discussion
DISCUSSION
Discussion part is divided into five sections.
1. Discussion on Madhumeha and diabetes mellitus.
2. Discussion on role of bastikarma in the management of Madhumeha.
3. Discussion on clinical study and over all response.
4. Discussion on importance of Madhutailik basti in Madhumeha.
5. Discussion on probable mode of action and mechanism of Madhutailik basti
Bastikarma and Madhumeha
Basti is a major shodhana therapy among panchakarmas. In the present study, the first
point to be discussed is how basti is helpful in sthooola Madhumehi.
In the classics samshodhana, shamanaushadhis and also pathyahara viharas are
mentioned for modhumehi among them, basti karma was taken here for the study.
Though it is kapha pradhana vyadhi, due the involvement of vata dosha, some
specific bastis are indicated in madhumeha, madhutailika basti is also one among
them. In the context of Basti yogya and ayogya it is contraindicated in madhumeha as
it is a kledajanya vyadhi, in the same time basti is indicated in bala, varna and mamsa
kshaya condition; so basti can be given in madhumeha where the bala of the patient is
detoriated and it is very difficult to Performa other shodhana procedures. The factors,
which help in the pacification of Madhumeha by madhumehara bastis are as follows,
Basthi causes shodhana of malas from all parts of the body
Madhumeha is a kapha vata vyadhi, Basti will help in normalizing the vata by
removing avarana, it helps in eliminating an amount of vitiated kleda, malas and
doshas from the body, which is very much helpful to clear or check the
dhathuparinama and there by helps in the reduction or pacification of the disease.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
142
Discussion
As a result fat metabolism is checked and hence undigested and unutilized fat
will be excreted out.
Restriction of diet during basti will help in normalizing the digestion metabolism.
In the treatment of sthoolamehi reduction of weight is also have a role. Above-
mentioned factors are very much helpful in the reduction of weight, when there is
reduction of weight, then insulin resistance will be reduced and as a result relative
insulin deficiency will also get corrected.
Obesity is an extremely important factor in the formation of type –II diabetes.
Approximately 80% of type II diabetic patients are obese. In this impaired
binding is a result of decrease in the number of insulin receptors. Basti therapy
helps in diminishing the insulin resistance by the reduction of weight and
obviously it reduces the stress over beta cells.
.
Madhumeha v/s diabetes mellitus:
Madhumeha Richmans disease, since Vedic period it is familiar to mankind. It is
documented as one among the twenty obstinate urinary disorders. It abhishagaja vyadhi,
at the same time it is also explained that, when the other pramehas are left untreated,
these lead to the condition called Madhumeha. So Madhumeha can also be considered as
an advanced condition or stage of Pramehas are Nidanarthakara rogas of Madhumeha.
Traditionally, Madhumeha has been equated with diabetes mellitus. Madhumeha
is a disease in which certain pathological changes in urine are noted along with some
other changes, the most important being the presence of madhuryata ( glucose). Since the
disease is connected with the urinary system with the presence of sugar in urine. Apart
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
143
Discussion
from this, tanu madhuryata also mentioned, which can be taken as blood sugar. Like this
the equation of Madhumeha with diabetes mellitus is justifiable.
Also in view of the similarity in signs and symptoms Madhumeha has been
equated, with diabetes. Among them, some correlations are given below.
Obesity is mentioned as a major causative factor for diabetes mellitus, as it causes
insulin resistance. In Ayurveda Sthoulya is mentioned as a nidanarthakara roga for
Madhumeha and is included under santarpanajanya vyadhis.
Madhura, snigdha bhojana are mentioned as nidanas for madhumeha. In modern
science over eating and sedentary lifestyles are the predisposing factors for diabetes
mellitus. Those food articles and overeating, causes obesity and which may cause
Diabetes mellitus.
Prabhoota avila mootrata is considered as a pratyatma lakshana of madhumeha.
In this the bahudrava kapha along with other dooshyas mainly kleda pradhana dooshyas
in the basti is the cause for prabhoota avila mootrata. The same reason has been given in
modern science for Polyurea that is the osmotic diuretic effect of glucose in the kidney
tubules.
Glycosuria explained in the modern science can be taken as madhusama mootra.
The reason for this Madhusama mootra is bahudrava kapha or ojus, which is excreted
through mootra.
Pipasa or polydipsia mentioned in both sciences. Depletion of intracellular water
triggering the more receptors of thirst center of brain and thirst is noted, which is similar
to pipasa of Ayurvedic Science and here due to excessive loss of the urine, pipasa is
noted.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
144
Discussion
In modern science the condition weakness is due to lack of glucose utilization,
loss of electrolyte and proteins. In Ayurveda this same condition is due to aparipakwa,
dhatu i.e. lack of proper nourishment.
Kulaja dosha and beeja dosha have been mentioned in the causative factors of
Sahaja Prameha type I diabetes mellitus Such patients are said to be weak, emaciated,
suffering from thirst, loss of appetite and are required to be treated with a nourishing diet.
In diabetes also genetic and hereditary factors are mentioned as causative factors.
In such patients weakness and emaciation are noted. The above-mentioned patients are
Juvenile diabetics and require a nourishing diet. Therefore Sahaja Pramehi and Juvenile
diabetes may be correlated.
Apathyanimittaja Madhumeha explained by sushruta, in such patients, atikshudha,
atinidra and aalasya are noted. And it is caused due to excessive intake of madhura
snigdha ahara and vihara, which favours kapha medovridhi. Maturity onset diabetes tend
to occure in people indulging in over eating and are lazy in nature, while explaining
chikitsa charaka have explained sthoola and krisha classification. The same type of
classification can be seen in modern science as obese and non-obese type.
Upadravas of Ayurveda can be correlated to some of the complications of modern
science. For Example Trishna, bhrama, shoola, tama pravesha and swasa can be
correlated to diabetic Ketoacidosis, in which thirst, weakness, blurred vision, abdominal
pain, air hunger etc are seen.
Insulin resistance and relative insulin deficiency are the main phenomenon in the
pathogenesis of the diabetes mellitus on obese individuals. Some recent ayurvedic
scholars have correlated medodhatwagni with insulin.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
145
Discussion
In the normal state sthiratwa, dardya, utsaha, vrishata, budhi, etc are contributed
by kapha, which is also known as bala or oja. By seeing this, we can correlate this kapha
with glucose. In madhumeha, the kapha, which is vitiated and which is in bahudravata
flacid form travels all over the body in rasa produces tanu madhuryata, which can be
taken as hyperglycemia, i.e. increased blood glucose condition.
Discussion on Observation
All the trial cases of madhumeha were reported to OPD & IPD of Shri D.G.M.
Ayurvedic Medical College by pre-set inclusion and exclusion criteria. Special medical
camps were also conducted in the college for selecting the patient. Data of 30 patients
who had satisfied the diagnostic criteria, underwent the treatment and reported for the
follow-up are discussed here. There is no dropout in the study and all the 30 patients were
appeared for the assessment of results.
These observational findings are discussed below.
Age
Because of decrease in beta cells the Risk of diabetes increases as age advances;
especially after 40 years. It is well recorded fact that, the NIDDM occurs only after 3rd
decade of life. In this study, the above factors were proved, as all the patients were
between the age group of 30 to 60. It is also noted that maximum number of patients;
were between the age of 40 to 60 Years.
Sex
Acharya Sushruta had said that women wouldn’t get Madhumeha; because their
body gets cleaned every month by the raja pravrutti. But it is considered as a
controversial dialogue as women also getting madhumeha and they are also at high risk
of getting diabetes compared to men after 30 Years. From Sushruta’s statement we can
understand the importance of shodhana. But in this study majority of the patients were
male when compared to females i.e. 25 male patients and 5 female patients.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
146
Discussion
Food Habits
In the manifestation of madhumeha, food habits had great importance. If we
check the nidana aspects we can see the importance of food habits. At the same time lot
of foods are also mentioned which are helpful in controlling madhumeha.
In the present study 13 Patients were vegetarians and 17 patients were non-
vegetarian’s (mixed). From these we can see that high calorie intake is the main risk
factor for diabetes and sthoulya. Food items, which increase the sleshma, medas and
mamsa, are the main reason behind madhumeha. Similar types of aharaja nidna are seen
in sthoulya.
Religion
In the present study majority of the patients were Hindus (25%), but it does not
mean that Hindus are more prone to this disease. This may be due to the local ratio of
difference religion. The patients were selected incidentally.
Occupation
Maximum numbers of patients were with sedentary type of occupations. In
sedentary type of occupations physical activities are very less and in both Ayurveda and
modern science, it is clearly mentioned that people with sedentary life styles are more
prone to diabetes mellitus or Madhumeha. In present study 25 patients were recorded
with sedentary life style.
Socioeconomic Status
Majority of the patients belongs to upper middle and high class. In these classes,
the people indulge in very less activities and ultimately with sedentary life styles and
such persons are more prone to diabetes.
Family History
In the present study 19 patients had family history and rest of the 11 the patients
had no family history of madhumeha. It is a well-proven factor that family history had a
main role in the manifestation of sthoola madhumeha.
Chronicity
In the present study only mild and moderate type of diabetes mellitus were taken
for the study and in this study 6 patients were newly diagnosed. In the remaining patients,
20 patients were suffering from this disease since 1-2 years, 11 patients below 2 year and
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
147
Discussion
9 patients were there in the above 3 years and 4 patients are above 3 year category. As it
is a chronic, relapsing type of disease, only mild and moderate types of cases were taken
for the study.
Deha Prakriti
Even though madhumeha is a disease with the involvement of 3 doshas, here an
attempt was made in this study to find out the doshik involvement based on the
symptoamatology dealt in classics. The study observed that involvement of both vata and
kapha was the most predominant feature 16 patients were with kapha pitta prakriti and
9patients were with kapha vata Prakriti, 6 patient were vata pitta prakruti From this we
can understand the involvement of Kapha and vata as a main dosha in the manifestation
of madhumeha.
Agni
Majority of the patients (20 patients) were with teekshnaagni followed by
Samagni (7 patients) and samagni (3patient). In this study the incidence of teekshnagni
justifies the significance of role of Agni in the pathogenesis of the disease madhumeha.
Nidanas
Most of the nidanas mentioned in the classics were elicited in this study by
detailed questioning. Among general nidanas, all patients used to take snigdha aharas and
guru aharas excessively. Among the viharas, asya sukham (27 patients), swapna sukham
(25 patients), alpa vyayama (26 patients) and alpa chinta (12 patients) were also noted.
From this we can say that snigdhadi ahara dravyas and asya sukhadi viharas had key role
among the nidanas.
Basavarajiyam a 16th century physician of Andhrapradesh has included the
excessive indulgence in alcoholic beverages as one of the nidana of prameha roga. In the
present study 14 patients had the habit of taking alcoholic drinks.
Lakshanas
In all the patients’ prabhoota mootrata was noted. Other symptoms like
pipasadhikya, kshudadhikya, karapada daha, atisweda, etc. were also seen in most of the
patients. Gayadasa says kara pada daha is due to vyadhi prabhava and other symptoms
like snigdha pichila guruta and madhurata shukla mootrata are due to kapha only.
Regarding other symptoms discussions were done already.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
148
Discussion
Importance of mixing of bastidravya
In ayurveda many formulations have been explained for preparation of medicine
under the heading of panchavidha kashayakalpana. almost all different preparations of
modern science arebased on these formulations, vagbhata and other acharyas are
mentioned specific formulations in the form of mixing of basti dravyas in proper order
viz .Makshikam, lavanam, sneham, kalkam, kwatham. Here an attempt made to know the
rationality behind this
Makshika
Honey bee drinks the florescence’s of the different nectars. This nectar is
nothing but secretion of plants which contains mainly flavonoides, it is vomits. The
vomited substance of the honey bee contains bile products like bile pigment and bile salt,
this bile resembles as that of the pittantya as we commonly seen in samyaka vamana.
Basically bile salt rich in emulsification and bile pigments (sodium glycocolic acid) are
rich in saphonification.
Saidhava
By adding and churning with saindhava (NaCl2) the mixture becomes light and
liquid, it reduced surface tension of honey helps in increasing the dravya prasarana. The
sookshma srotogami property of madhu and saindhava makes biodegradable of micro
particles and it leads to precise amount of drug delivery at a local area. The main aim of
using saindhava is to increase the emulsification.
Sneha
By adding of sneha in to this mixture the sneha gets emulsification due to affinity
of sodium hydroxide towards fat. Here the saphonification helps in solubility of drug that
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
149
Discussion
is water in oil emulsification (one molecule of fat binds with the two molecules of water),
the whole sneha dravya converts in to water soluble and it will enhance the absorption of
drug.
Kalka
It makes whole mixture in to suspension form; the fine powder helps in uniform
molecule binding.
Kwatha
By adding and churning the kwath it will become same state without sedimentation, it
gives the selective permeability to mixture and helps in crossing the Blood brain barrier
(BBB), similar explanations also available in classics i.e.Charaka siddisthana 3/23.
Madhutalika vasti and madhumeha
This yoga has been selected for the study because of the direct indication
of madhutailika vasti by vagbhata, he has considered this under niroohabasti. The
treatment given to all the 30 patients includes abhyanga with moorchita tila taila,
swedana locally and madhutailika vasti 8 days. In this particular context
prabhootavilamootrata, pipasadhikya etc are the main symptoms and the aim of
management is to control it, as madhumeha is kapha pradhana vatavyadhi, along with
kleda and meda, as it is considered under sidda and yapana basti, the unique combination
of this basti is Makshikam, lavanama, taila ( moorchita tila taila ), shatapushpi and
Erandamoola.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
150
Discussion
Shatapushpi and Eranda are having the vata shamaka, vatanulomaka and prameha hara
property. In madhumeha vata gets alleviated by basti along with this some amount of
kapha also expelled out.
The present work is aimed to evaluate the efficacy of madhutailika vasti only.
Hence, other shodhana karmas where not done. No specific pathya pathya has been
advised to be followed.
Probable mode of action of basti in madhumeha
Honey is rich dietary supplement and it is alkaline media, generally alkalines
(kshara) are beneficial in kapha dosha treatment, the antibiotic property of honey helps in
formation of healthy bacterial flora in the intestine it is very much needed for drug
absorption. Rectum is the moola for sharera as chakrapani explained “gudamoolam
shareerasya” and most of the capillaries are presentment in guda helps in absorption of
medicinal property and helps to enters in to the systemic circulation, as smaller channels
of the root absorbs the water and these are merge in large stream or channels and
nourishes the body, lavana (sodium chloride) is a integral part of body constituent, this
will inhibit thirst by maintains the electrolyte balances. Sookshma srotosravka property
acts as a vehicle for the chief ingredient. Tila is best remedy for vata vyadhi and
alleviates the kleda if it is administer internally, the ushna property of tila taila normalize
the kapha and vata, as it possesses both brihmana and karshna effect, shatapushpi
contains some amount of anti-oxidants these helps in the cellular nourishment. Eranda
having a tikta and madhura rasa with ushna veerya will nullify the vata and kaph. It is
rasayana, medhya and shoola hara. It contains anti-oxidants like gallic, skimmic, ellagic,
ferulic and coumarinic these are reduses the endoneural hypoxia which is the main factor
in the pathology.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
151
Discussion
CONCLUSION
A close perusal of the observation and inference that can be drawn leads to the
following conclusions.
• Madhutailika basti is an effective treatment in the management of Madhumeha
and it shows long lasting result.
• Madhutailika basti can be administered without prior other procedures like
snehapana, swedana or virechana.
• Complications are rarely occurring during and after the course of bastikarma.
• It is easy to constitute, less time consuming and gives least discomfort to both
patient and physician.
• It is cheap compared to other conventional methods of management of
Madhumeha.
• Madhumeha can be undoubtedly compared with that of Diabetes mellitus on its
etiopathogenesis and symptomatologies etc.
• In mild and moderate type of sthoola madhumeha, Madhutailika basti alone is
enough to control it.
• Along with bastikarma, administration of pathya ahara viharas may give more
effect.
Suggestions for future study
1. Study is better to be conducted on a large sample.
Study has been conducted in yoga basti Sankhya and facts revealed in the study suggest
that the results will be more encouraging if the Vaitharanabasti is administered in the
Sankhya of kalabasti or karmabasti.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
153
Summary
SUMMARY
The Panchakarma therapy is an important part of Ayurveda. The procedures of
Panchakarma therapy have thrown new light on the management of disease and have
provided effective weapons against them. The entire group of purification procedures is
based up on promoting the body’s natural methods of elimination of unwanted
substances. Among the Panchakarmas, the vasti is an important one, which had great
importance and at the same time it is highly effective therapy. It is a process by which
the doshas are made to pass through the guda marga. It is a specific treatment for vata
dosha, and vata associated with pitta as well as kapha doshas. Based on the property
Madhutalika vasti is fall under mrudu vasti, with a synonym of sidda vasti, yapana vasti,
vasti, though it is the type of nirooha patients are not much restricted.
Management of madhumeha is perhaps one of the most important and interesting
subject in the clinical practice considering its high prevalence as well as profound impact
the treatment has on long term morbidity and mortality of the patient. Increasing
urbanization industrialization and due to increased sedentary life styles seems to be
contributing to increasing prevalence of madhumeha.
Like the disease, the treatment of madhumeha is also prolonged one. Since the
patient of madhumeha have been divided in to the sthoola and krisha varities, the separate
methods of treatments are mentioned in classics, and from that vasti therapy was taken as
a choice of treatment in the present study and is adopted in sthoola madhumeha patients.
Keeping in mind, the objectives of this study was, “Evaluate the efficacy of
madhutailika vasti in the management of madhumeha (NIDDM)”. During 8 days basti
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
155
Summary
course 3 niroohas prepared with madhu,saindhava,morchita tila taila, shatapuspi kalka
and eranda moola kwath were administered along with 5 anuvasana vasti by using
morchita tila taila. Madhutalika vasti was selected for the study as its efficacy is
explained by vagbhata in astanga hridaya kalpa sthana 4/27-28.
The present work covered the following areas-
Introductory part regarding the present work and the objectives.
Historical aspect of basti, madhumeha and also the mile stones and previous
research works in the field of diabetes mellitus.
Basti karma in detail along with its modern concepts, anatomical and
physiological aspects.
Modern description regarding the diabetes mellitus along with the physiological
and anatomical descriptions of glands involved in it.
Nidana panchakas of madhumeha, simultaneously explanation of dibetes mellitus
in modern counterpart has been done along with the comparison and description
in the same context.
Description regarding the materials and methods used in the present study.
Observations of the present study, results, discussion, summery, conclusion and
finally bibliography and references.
The study was conducted in a single group and all the patients received classical.
The effect of the therapy was assessed statistically by using student t-test.
It was found that Basti shows long-termi effect. But, it was also noted that due to
food and activities of the patient there is gradual variation in sugar levels after Basti. So
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
156
Summary
after Basti if the person follows strict diet, sugar levels and other associated complaints
can be controlled. A significant response was obtained in majority of the cases, higher
percentage of reduction in the symptoms and FBS, RBS, PPBS and urine sugar level and
increase in general sense of well being shows that madhutalika vasti has significant role
in the management of madhumeha.
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
157
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
158
Bibliography
1. Agnivesa, Charakasamhitha Sutrasthana chapter 16-34, 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 2002. p. 686 (Rashtriya Sanskrit Samsthana).
2. Agnivesa, Charakasamhitha Sutrasthana chapter 16-20, 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 2002. p. 682 (Rashtriya Sanskrit Samsthana).
3. Ashtangasangraha Suthrasthana chapter 28/3 Prof.K.R.Shrikhantamurthy, editor. Varanasi: Chaukhambha Orientalia; 1996. p. 485, (Jaikrishnadas Ayurvedic series 79).
4. Agnivesa, Charakasamhitha Siddisthana chapter 1. sloka 40. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 712. (Kasi Sanskrit series 228).
5. Sushrutha, Sushruthasamhitha,Chikitsasthana, chapter 35. sloka 34. Varanasi: Krishnadas Academy; 1980. p. 509. (Krishnadas Ayurveda series 51).
6. Agnipurana adhyaya sankhya 229. sloka 63. Second edition. Acharya Baladeva
Upadhyaya, editor. Varanasi Sanskrita University, Varanasi p.335
7. Agnipurana adhyaya sankhya 289. sloka 46. Second edition. Acharya Baladeva Upadhyaya, editor. Varanasi Sanskrita University, Varanasi p.429
8. Agnipurana adhyaya sankhya 289. sloka 46. Second edition. Acharya Baladeva
Upadhyaya, editor. Varanasi Sanskrita University, Varanasi p.419
9. Vrudhajeevaka, Kashyapasamhita Khilasthana chapter 8 sloka 54. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1988. p. 289. (Kasi Sanskrit series 154).
10. Kashyapa Samhitau Sutrasthana Chapter25 sloka22. Ed Prof Premavati Tivari
Chaukhambha vishwabharati Varanasi 2002. p.58 11. Bhela.Samhita.Nidanasthana chapter 6 sloka 1.ed. Dr.K.H.Krishnamurthy
Chaukhambha vishwabharati Varanasi 2005. p.155
12. Haritha Samhita chapter 28. sloka 23. Varanasi: Krishnadas Academy; 1980. p. 364. (Krishnadas Ayurveda series 51).
13. Amarasimha, Amarakosha Manushyavarga 6 sloka 73. Pundit Vishwanath Jha, editor. Delhi: Motilal Banarasi Das; 1976. p. 139.
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
159
14. Arunadatta, Ashtangahridaya Suthrasthana chapter 19 sloka 1. Varanasi: Krishnadas Academy; 1982. p. 270. (Krishnadas academic series 4).
15. Sharangadhara, Sarngadharasamhitha Utharakhanda chapter 5 sloka 1. 3rd ed.
Varanasi: Chaukhambha Orientalia; 1983. p. 319. (Jaikrishnadas Ayu. Granthamala 53).
16. Vagbhata, Ashtangahridaya .Sutrasthana chapter 9. sloka 1. Vaidhya Haridas
paradkar Chaukhambha Sanskrit Sansthan;2002 p.169
17. Sushrutha, Sushruthasamhitha.Uttarasthana chapter 5. sloka 1. Varanasi:
Krishnadas Academy; 1980. p. 1005. (Krishnadas Ayurveda series 51). 18. Agnivesa, Charakasamhitha Siddisthana chapter 1. sloka 40. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 712. (Kasi Sanskrit series 228).
19. Sushrutha, Sushruthasamhitha Nidanasthana chapter 2 sloka 5. Varanasi:
Krishnadas Academy; 1980. p. 272. (Krishnadas Ayurveda series 51). 20. Sushrutha, Sushruthasamhitha Nidanasthana chapter 2 sloka 6-7. Varanasi:
Krishnadas Academy; 1980. p. 272. (Krishnadas Ayurveda series 51).
21. Agnivesa, Charakasamhitha Shareerasthana chapter 7 sloka 10. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 338. (Kasi Sanskrit series 228).
22. Vagbhata, Ashtangahridaya Shareerasthana chapter 3 sloka 13. Varanasi:
Krishnadas Academy; 1982. p. 388. (Krishnadas academic series 4).
23. Agnivesa, Charakasamhitha Shareerasthana chapter 7 sloka 9. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 338. (Kasi Sanskrit series 228).
24. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 10. Varanasi:
Krishnadas Academy; 1980. p. 364. (Krishnadas Ayurveda series 51).
25. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 24. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 899.
26. Sushrutha, Sushruthasamhitha Shareerasthana chapter 5 sloka 8. Varanasi:
Krishnadas Academy; 1980. p. 364. (Krishnadas Ayurveda series 51).
27. Vagbhata, Ashtangahridaya Shareerasthana chapter 3 sloka 10-11. Varanasi: Krishnadas Academy; 1982. p. 387. (Krishnadas academic series 4).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
160
28. Vagbhata, Ashtangahridaya Shareerasthana chapter 3 sloka 10-11. Varanasi: Krishnadas Academy; 1982. p. 387. (Krishnadas academic series 4).
29. Agnivesa, Charakasamhitha Shareerasthana chapter 7 sloka 10. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 338. (Kasi Sanskrit series 228).
30. Vagbhata, Ashtangahridaya Shareerasthana chapter 3 sloka 12. Varanasi: Krishnadas Academy; 1982. p. 387. (Krishnadas academic series 4).
31. Sharangadhara, Sarngadharasamhitha Poorvakhanda chapter 5 sloka 9. 3rd ed.
Varanasi: Chaukhambha Orientalia; 1983. p. 44. (Jaikrishnadas Ayu. Granthamala 53).
32. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 24. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 900.
33. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 18. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 621-622.
34. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 18. 4th ed. New
Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 601-602.
35. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 18. 4th ed. New Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 614-615.
36. Martini.F.H, Fundamentals of Anatomy and Physiology chapter 24. 4th ed. New
Jersey: Prentice Hall Inc. Simon & Schuster; 1998. p. 891-892.
37. Bjornstorp P, Sjostrom L: Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism 27 (Suppl. 2):1853-65, 1978.
38. Katz LD, Glickman MG, Rapaport S, Ferrannini E, De Fronzo RA: Splanchnic
and peripheral disposal of oral glucose in man. Diabetes 32:675-79, 1983.
39. Karem JH, Forsham PH: Pancreatic hormones and diabetes mellitus. In Basic and Clinical Endocrinology. 4th edition. Greenspan FS, Baxter JD, Eds. Norwalk, Conn., Appleton and Lange, 1994, p. 571-634.
40. McGilvery RW, Goldstein G: Biochemistry: a Functional Approach. 2nd edition.
Philadelphia, Pa., W.B. Saunders, 1979.
41. Agnivesa, Charakasamhitha Siddhisthana chapter 10 sloka 4. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 724. (Kasi Sanskrit series 228). 42. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 116. Varanasi:
Krishnadas Academy; 1980. p. 548. (Krishnadas Ayurveda series 51).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
161
43. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 1. Varanasi: Krishnadas Academy; 1982. p. 270. (Krishnadas academic series 4).
44. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 86. Varanasi:
Krishnadas Academy; 1982. p. 285. (Krishnadas academic series 4).
45. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 36 sloka 6. Varanasi: Krishnadas Academy; 1980. p. 529. (Krishnadas Ayurveda series 51).
46. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 87. Varanasi:
Krishnadas Academy; 1982. p. 286. (Krishnadas academic series 4).
47. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 525. (Krishnadas Ayurveda series 51).
48. Agnivesa, Charakasamhitha Siddhisthana chapter 1 sloka 27-28. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 682. (Kasi Sanskrit series 228).
49. Vrudhajeevaka, Kashyapasamhita Khilasthana chapter 8 sloka 54. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1988. p. 289. (Kasi Sanskrit series 154).
50. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 18. Varanasi:
Krishnadas Academy; 1980. p. 526. (Krishnadas Ayurveda series 51).
51. Kasture VG, Ayurvediyapanchakarmavigyan chapter 6. 6th ed. Nagpur: Shree Baidyanath Ayurved Bhavan Ltd.; 1998. p. 373.
52. Sushrutha, Sushruthasamhitha Nidanasthana chapter 35 sloka 18. Varanasi:
Krishnadas Academy; 1980. p. 812. (Krishnadas Ayurveda series 51). 53. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 18 Varanasi:
Krishnadas Academy; 1980. p. 526. (Krishnadas Ayurveda series 51).
54. Ashtangasangraha Suthrasthana chapter 28 sloka 4. Prof.K.R.Shrikhantamurthy,
editor. Varanasi: Chaukhambha Orientalia; 1996. p. 485. (Jaikrishnadas Ayurvedic series 79).
55. Agnivesa, Charakasamhitha Siddhisthana chapter 1 sloka 49-50 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 684. (Kasi Sanskrit series 228).
56. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 17. Varanasi:
Krishnadas Academy; 1980. p. 526. (Krishnadas Ayurveda series 51).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
162
57. Agnivesa, Charakasamhitha Siddhisthana chapter 4 sloka 54. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 409. (Kasi Sanskrit series 228). 58. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 18. Varanasi:
Krishnadas Academy; 1980. p. 541. (Krishnadas Ayurveda series 51). 59. Vagbhata, Ashtangahridaya Suthrasthana chapter 28. sloka 9.Varanasi:
Krishnadas Academy; 1982. p. 586. (Krishnadas academic series 4). 60. Ashtangasangraha Suthrasthana chapter 28 sloka 9. Prof.K.R.Shrikhantamurthy,
editor. Varanasi: Chaukhambha Orientalia; 1996. p. 492. (Jaikrishnadas Ayurvedic series 79).
61. Sushrutha, Sushruthasamhitha Chikitsasthana, chapter 38. sloka 18. Varanasi:
Krishnadas Academy; 1980. p. 541. (Krishnadas Ayurveda series 51). 62. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 19. Varanasi:
Krishnadas Academy; 1980. p. 526. (Krishnadas Ayurveda series 51).
63. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 61. Varanasi: Krishnadas Academy; 1982. p. 282. (Krishnadas academic series 4).
64. Sharangadhara, Sarngadharasamhitha Utharakhanda chapter 5 sloka 19-22. 3rd ed.
Varanasi: Chaukhambha Orientalia; 1983. p. 323. (Jaikrishnadas Ayu. Granthamala 53).
65. Agnivesa, Charakasamhitha Siddhisthana chapter 8. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 713-715. (Kasi Sanskrit series 228).
66. Agnivesa, Charakasamhitha Siddhisthana chapter 1 sloka 47-48. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 684. (Kasi Sanskrit series 228). 67. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 37 sloka 39. Varanasi:
Krishnadas Academy; 1980. p. 533. (Krishnadas Ayurveda series 51).
68. Agnivesa, Charakasamhitha Siddhisthana chapter 8 sloka 2-14. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 713. (Kasi Sanskrit series 228).
69. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 118. Varanasi:
Krishnadas Academy; 1980. p. 548. (Krishnadas Ayurveda series 51).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
163
70. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 36 sloka 3. Varanasi:
Krishnadas Academy; 1980. p. 528. (Krishnadas Ayurveda series 51).
71. Agnivesa, Charakasamhitha Siddhisthana chapter 4 sloka 53. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 701. (Kasi Sanskrit series 228).
72. Agnivesa, Charakasamhitha Siddhisthana chapter 4 sloka 54. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 701. (Kasi Sanskrit series 228).
73. Agnivesa, Charakasamhitha Siddhisthana chapter 12 sloka 15. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 731. (Kasi Sanskrit series 228).
74. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 116. Varanasi:
Krishnadas Academy; 1980. p. 548. (Krishnadas Ayurveda series 51).
75. Vangasena, Vangasenasamhitha Bastikarmaadhikara sloka 170. Jain Sankarlalji Vaidya editor. Mumbai: Khemnath Srikrishnadas publishers; 1996. p. 999.
76. Vangasena, Vangasenasamhitha Bastikarmaadhikara sloka 186-190. Jain
Sankarlalji Vaidya editor. Mumbai: Khemnath Srikrishnadas publishers; 1996. p. 1000.
77. Chakrapanidatta, Chakradatta chapter 73 sloka 29-31. 2nd ed. P.V.Sharma editor.
Varanasi: Chaukhambha Publishers; 1998. p. 628. (Kasi Ayurveda series 17).
78. Chakrapanidatta, Chakradatta chapter 73 sloka 23-26. 2nd ed. P.V.Sharma editor. Varanasi: Chaukhambha Publishers; 1998. p. 627-628. (Kasi Ayurveda series 17).
79. Vagbhata, Ashtangahridaya Chikitsasthana chapter 9 sloka 72-76. Varanasi:
Krishnadas Academy; 1982. p. 661. (Krishnadas Academic series 4).
80. Agnivesa, Charakasamhitha Siddhisthana chapter 6 sloka 83. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 708. (Kasi Sanskrit series 228).
81. Vangasena, Vangasenasamhitha Bastikarmaadhikara sloka 182-185. Jain
Sankarlalji Vaidya editor. Mumbai: Khemnath Srikrishnadas publishers; 1996. p. 999.
82. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 45. Varanasi:
Krishnadas Academy; 1982. p. 279. (Krishnadas Academic series 4).
83. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 23. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 693. (Kasi Sanskrit series 228).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
164
84. Ashtangasangraha Suthrasthana chapter 28 sloka 28. Prof.K.R.Shrikhantamurthy editor. Varanasi: Chaukhambha Orientalia; 1996. p. 492. (Jaikrishnadas Ayurvedic series 79).
85. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 30. Varanasi:
Krishnadas Academy; 1980. p. 542. (Krishnadas Ayurveda series 51).
86. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 26-28. Varanasi: Krishnadas Academy; 1980. p. 541. (Krishnadas Ayurveda series 51).
87. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 30. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 694. (Kasi Sanskrit series 228).
88. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 29-30. Varanasi: Krishnadas Academy; 1980. p. 542. (Krishnadas Ayurveda series 51).
89. Ashtangasangraha Suthrasthana chapter 28 sloka 60, 61.
Prof.K.R.Shrikhantamurthy, editor. Varanasi: Chaukhambha Orientalia; 1996. p. 534. (Jaikrishnadas Ayurvedic series 79).
90. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 29-30. Varanasi:
Krishnadas Academy; 1980. p. 542. (Krishnadas Ayurveda series 51).
91. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 115. Varanasi:
Krishnadas Academy; 1980. p. 592. (Krishnadas Ayurveda series 51). 92. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 100 and 101.
Varanasi: Krishnadas Academy; 1980. p. 579. (Krishnadas Ayurveda series 51).
93. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 38 sloka 102. Varanasi:
Krishnadas Academy; 1980. p. 580. (Krishnadas Ayurveda series 51).
94. Ashtangasangraha Kalpasthana, chapter 5. sloka 15-17. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 2002. p. 823 (Rashtriya Sanskrit Samsthana).
95. Ashtangasangraha Kalpasthana, chapter 5. sloka 18. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 2002. p. 824 (Rashtriya Sanskrit Samsthana).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
165
96. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 7. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 691. (Kasi Sanskrit series 228).
97. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 10-14. Varanasi:
Krishnadas Academy; 1982. p. 273-274. (Krishnadas Academic series 4). 98. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 8-9. 4th ed. Varanasi:
Chaukhambha Sanskrit Sansthan; 1994. p. 691. (Kasi Sanskrit series 228) 99. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 7-9. Varanasi:
Krishnadas Academy; 1980. p. 525-526. (Krishnadas Ayurveda series 51). 100. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 11.
Varanasi: Krishnadas Academy; 1980. p. 526. (Krishnadas Ayurveda series 51) 101. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 14. Varanasi:
Krishnadas Academy; 1982. p. 274. (Krishnadas Academic series 4).
102. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 10-12. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 692. (Kasi Sanskrit series 228).
103. Agnivesa, Charakasamhitha Siddhisthana chapter 5 sloka 4-6. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 702. (Kasi Sanskrit series 228).
104. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 36 sloka 8-11.
Varanasi: Krishnadas Academy; 1980. p. 529. (Krishnadas Ayurveda series 51).
105. Vagbhata, Ashtangahridaya Chikitsasthana chapter 19 sloka 4, 5, 6. Varanasi: Krishnadas Academy; 1982. p. 271-272. (Krishnadas Academic series 4).
106. Agnivesa, Charakasamhitha Siddhisthana chapter 2 sloka 14-15. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 688-689. (Kasi Sanskrit series 228).
107. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 21.
Varanasi: Krishnadas Academy; 1980. p. 527. (Krishnadas Ayurveda series 51).
108. Agnivesa, Charakasamhitha Siddhisthana chapter 6 sloka 83. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 708. (Kasi Sanskrit series 228).
109. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 5.
Varanasi: Krishnadas Academy; 1980. p. 525. (Krishnadas Ayurveda series 51).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
166
110. Vagbhata, Ashtangahridaya Chikitsasthana chapter 19 sloka 2-3. Varanasi: Krishnadas Academy; 1982. p. 271. (Krishnadas Academic series 4).
111. Agnivesa, Charakasamhitha Siddhisthana chapter 2 sloka 19. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 689. (Kasi Sanskrit series 228).
112. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 6. Varanasi:
Krishnadas Academy; 1982. p. 272. (Krishnadas Academic series 4).
113. Agnivesa, Charakasamhitha Siddhisthana chapter 2 sloka 18-19. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 689. (Kasi Sanskrit series 228).
114. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 8. Varanasi:
Krishnadas Academy; 1982. p. 272. (Krishnadas Academic series 4).
115. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 22. Varanasi: Krishnadas Academy; 1980. p. 527. (Krishnadas Ayurveda series 51).
116. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 6. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 691. (Kasi Sanskrit series 228).
117. Vagbhata, Ashtangahridaya Suthrasthana chapter 19 sloka 17-19.
Varanasi: Krishnadas Academy; 1982. p. 274. (Krishnadas Academic series 4).
118. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 35 sloka 9. Varanasi: Krishnadas Academy; 1980. p. 526. (Krishnadas Ayurveda series 51).
119. Agnivesa, Charakasamhitha Siddhisthana chapter 3 sloka 31. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 695. (Kasi Sanskrit series 228).
120. Ashtangasangraha Suthrasthana chapter 28 sloka 19.
Prof.K.R.Shrikhantamurthy editor. Varanasi: Chaukhambha Orientalia; 1996. p. 491. (Jaikrishnadas Ayurvedic series 79).
121. Agnivesa, Charakasamhitha Siddhisthana chapter 4 sloka 26-30. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 699-700. (Kasi Sanskrit series 228).
122. Agnivesa, Charakasamhitha Siddhisthana chapter 7 sloka 4-62. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 709-712. (Kasi Sanskrit series 228).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
167
123. Agnivesa, Charakasamhitha Siddhisthana chapter 5 sloka 16. 4th ed. Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 702. (Kasi Sanskrit series 228).
124. Raja Radhakantha Deva Bahadur, Shabdakalpadruma vol 3, 3rd ed.
Varanasi: Chaukambha Sanskrit Series; p. 421.(Chaukambha Samskrita Granthamala-93).
125. Agnivesa, Charakasamhitha Nidana sthana, chapter 4. sloka 44. 4th ed.
Varanasi: Chaukhambha Sanskrit Sansthan; 1994. p. 179. (Kasi Sanskrit series 228).
126. Vagbhata, Ashtangahridaya nidanasthana, chapter 10. sloka 18.
Prof.K.R.Shrikhantamurthy, editor. Varanasi: Chaukhambha Orientalia; 1996. p. 178. (Jaikrishnadas Ayurvedic series 79).
127. Kahn Ronald C MD, Weir GC, Joslin’s Diabetes Mellitus. Chapter 1. 13th ed. USA. Lea & Febiger; 1994.p. 36.
128. Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal
implications of the diabetes epidemic. Nature, 414, 782–787
129. Rosenbloom, A.L., Joe, J.R., Young, R.S. and Winter, W.E. (1999) Emerging epidemic of type 2 diabetes in youth. Diabetes Care, 22, 345–354
130. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic
complications. Nature, 414, 813–820
131. Jensen, C.C., Cnop, M., Hull, R.L., Fujimoto, W.Y. and Kahn, S.E. (2002) ß-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes, 51, 2170–2178
132. UKPDS Group (1995) UK Prospective Diabetes Study 16. Overview of 6
years' therapy of type II diabetes: a progressive disease. Diabetes, 44, 1249–1258
133. Gerich, J.E. (1998) the genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev., 19, 491–503
134. Foulis, A.K. and Stewart, J.A. (1984) the pancreas in recent-onset type 1
(insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia, 26, 456–461
135. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A. and Butler,
P.C. (2003) ß-cell deficit and increased ß-cell apoptosis in humans with type 2 diabetes. Diabetes, 52, 102–110
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
168
136. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 11 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 451. (Krishnadas Ayurveda series 51).
137. Agnivesa, Charaka samhitha Shareerasthana chapter 3 sloka 17. 4th ed.
Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 350. (Krishnadas academic series vol 4).
138. Agnivesa, Charaka samhitha Nidanasthana chapter 4 sloka 5. 4th ed. Varanasi:
Chaukhambha Kasi Sanskrit series; 1994. p. 212. (Krishnadas academic series vol 4).
139. Agnivesa, Charaka samhitha Nidanasthana chapter 04 sloka 24. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 214. (Krishnadas academic series vol 4).
140. Agnivesa, Charaka samhitha Nidanasthana chapter 04 sloka 36. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 215. (Krishnadas academic series vol 4).
141. Agnivesa, Charaka samhitha Sutrasthana chapter 17 sloka 79. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 203. (Krishnadas academic series vol 4).
142. Sushrutha, Sushruthasamhitha Chikitsasthana chapter 11 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 451. (Krishnadas Ayurveda series 51).
143. Cotran SR, Pathologic Basis of Disease chapter 20. 6th ed. Philadelphia:
Saunders; 2003. p. 913. Davidson Stanley Sir, Principles and Practice of Medicine chapter 12. CRW Edwards ,editor. London: Churchill Livingston 1995. p. 728.
144.Agnivesa, Charaka samhitha Nidanasthana chapter 04 sloka 47. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 215. (Krishnadas academic series vol 4).
Sushrutha, Sushruthasamhitha Chikitsasthana chapter 6 sloka 5. Varanasi: Krishnadas Academy; 1980. p. 290. (Krishnadas Ayurveda series 51). Vagbhata, Ashtangahridaya Nidanasthana chapter 10 sloka 38. Varanasi: Krishnadas Academy; 1982. p. 505. (Krishnadas academic series 4).
145. Vagbhata, Ashtangahridaya Nidanasthana chapter 10 sloka 7. Varanasi: Krishnadas Academy; 1982. p. 502. (Krishnadas academic series 4).
Sushrutha, Sushruthasamhitha Chikiitsasthana chapter 6 sloka 6. Varanasi: Krishnadas Academy; 1980. p. 290. (Krishnadas Ayurveda series 51).
146. Vagbhata, Ashtangahridaya Nidanasthana chapter 10 sloka 7. Varanasi: Krishnadas Academy; 1982. p. 502. (Krishnadas academic series 4).
Sushrutha, Sushruthasamhitha Chikiitsasthana chapter 6 sloka 6. Varanasi: Krishnadas Academy; 1980. p. 290. (Krishnadas Ayurveda series 51).
References
“Evaluation of efficacy of Madhutailika basti In the management of Madhumeha”
169
147.Agnivesa, Charaka samhitha Nidanasthana chapter 04 sloka 29-34. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 214. (Krishnadas academic series vol 4).
148.Agnivesa, Charaka samhitha Nidanasthana chapter 04 sloka 41-45. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 215. (Krishnadas academic series vol 4).
149.Sushrutha, Sushruthasamhitha Nidanasthana chapter 6 sloka 25. Varanasi: Krishnadas Academy; 1980. p. 294. (Krishnadas Ayurveda series 51). 150. Cotran SR, Pathologic Basis of Disease chapter 20. 6th ed. Philadelphia: Saunders; 2003. p. 913-916 151. Agnivesa, Charaka samhitha Nidanasthana chapter 04 sloka 4. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 212. (Krishnadas academic series vol 4). 152. Sushrutha, Sushrutha samhitha Chikitsasthana chapter 11 sloka 3. Varanasi: Krishnadas Academy; 1980. p. 451. (Krishnadas Ayurveda series 51). 153. Vagbhata, Ashtangahridaya Nidanasthana chapter 10 sloka 18. Varanasi: Krishnadas Academy; 1982. p. 504. (Krishnadas academic series 4). 154. Agnivesa, Charaka samhitha Chikitsasthana chapter 6 sloka 15-16. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 446. (Krishnadas academic series vol 4). 155. Cotran SR, Pathologic Basis of Disease chapter 20. 6th ed. Philadelphia: Saunders; 2003. p. 913. 156. Agnivesa, Charaka samhitha Nidanasthana chapter 4 sloka 48. 4th ed. Varanasi:
Chaukhambha Kasi Sanskrit series; 1994. p. 250. (Krishnadas academic series vol 4).
157. Agnivesa, Charaka samhitha Sutrasthana chapter 17 sloka 105-106. 4th ed. Varanasi: Chaukhambha Kasi Sanskrit series; 1994. p. 105. (Krishnadas academic series vol 4).
158. Sushrutha, Sushrutha samhitha Nidanasthana chapter 6 sloka 14. Varanasi: Krishnadas Academy; 1980. p. 292. (Krishnadas Ayurveda series 51). 159. Cotran SR, Pathologic Basis of Disease chapter 20. 6th ed. Philadelphia: Saunders; 2003. p. 913.
Davidson Stanley Sir, Principles and Practice of Medicine chapter 12. CRW Edwards, editor. London: Churchill Livingston 1995. p. 754-757.
SPECIAL CASESHEET FOR MADHUMEHA
Post Graduate Studies And Research Center (Panchakarma) Shree DGM Ayurvedic Medical College, Gadag.
Guide : Dr. G.Purushothamacharyalu, PG Scholar : MD (Ayu) D.S.Swami
Co- Guide : Dr. Shashidhar.H. Doddamani. MD (Ayu) 1. Name of the patient : Sl. No :
170
2. Father’s / Husband’s Name : OPD No : 3. Age : IPD No : 4. Sex : 5. Religion :
M F
Hindu Muslim Christian Others
Poor Middle Upper middle class High class
Sedentary Active Labor Others 6. Occupation : 7. Economical Status : 8. Diet : 9. Address :_____________________________ Phone No : ____________________________ Email ID :
_____________________________ Pin
Veg Mixed
10. Date of Schedule Initiation :
Date of Schedule Completion :
11. Result : 12. Consent : I here by agree that, I have been fully educated with the disease and
Good Response Moderate Response
Poor Response
No Response
treatment, here by satisfied whole heartedly, and accept the medical trial over
me
Investigator’s Signature Patient’s Signature
13. COMPLAINTS WITH DURATION :-
Chief Complaints P/A Duration Prabhuta Mutrata Kshudadhikya Ati Sweda Pipasadhikya Karapada daha Other complaints P/A Duration Anga Saidhilyam Sareera ghanatwam Seeta Priyatwam Hrut-Netra-Jihwa Shravana upadeha Shareeradurgandha Chikkanata dehe
14. HISTORY OF PRESENT ILLNESS :- >Appearance of similar complaints before :
Yes No 15. HISTORY OF PAST ILLNESS Present Absent 16. TREATMENT HISTORY :- Modern Medicine :- If Yes :- Duration Drug Ayurvedic medicine :- If Yes :-
Drug
Duration Relief with previous
Yes No treatment :- 17. FAMILY HISTORY :- Present Absent
171
18. PERSONAL HISTORY
Mrudu Madhya Kroora Koshta
Veg Mixed Diet Poor Moderate Good Appetite Bowels Free Constipated Urine Normal Abnormal
Day Night
Number of times
Sleep Normal Loss More Disturbed
Habit Smoking Alcohol Tobacco
chewing No
Habits
Duration Of Habits :-
19. ASHTASTHANA PAREKSHA
a. Nadee Dosha Gati Poornata Spandana Kathinya
b. Mootra : c. Malam : Constipation Loose Normal d. Jihwa : e. Sabdam : f. Sparsham : g. Drink :
Sthoola Krisha h. Akrithi :
172
20. GENERAL EXAMINATION : - Appearance
Healthy Unwell Nutrition
Obese Moderate Poor
Orientation Good Poor
Memory Normal Medium Poor
Height in cms:- Weight in kg :- BMI :- Temperature in degree Farenheit:- Pulse Rate:- Heart rate:- Respiratory Rate:- Bloodpressure:- mmHg. 21. DASAVIDHA PAREEKSHA :-
A) Prakruthi Vata Pitha Kapha Vatapitha Vatakapha Pithakapha Sannipatha
B) Vikruthi
Hetu
Dosha
Dushya
Bala
Prakruthi
Desa
Kala
Linga
173
C) Sara Pravara Madhyama Avara
D) Samhanana Susamhatha Madhyasamhata Asamhata
E) Pramana Sama Heena Adhika
F) Satmya Ekarasa Sarvarasa Vyamishra
Rooksha satmya Snigdha satmya
G) Satva Pravara Madhya Avara
H) Ahara shakthi
Abhyavahara Pravara Madhyama Avara
Jaranashakti Pravana Madhyama Avara
Pravara Madhyama Avara I) Vyayama shakthi
Bala Madhya Vruddha J) Vayaha
22. SROTOPAREEKSHA :-
Srotas Observed Lakshanas
Pranavaha
Annavaha
Udakavaha
Rasavaha
Rakthavaha
Mamsavaha
Medovaha
Asthivaha
Majjavaha
Shukravaha
Pureshavaha
Mutravaha
Swedovaha
Arthavavaha
174
175
23. NIDANA PANCHAKA :-
a. Nidana> General :- Ahara Vihara > Vataja Nidana :-
Ahara Vihara
> Pithaja Nidana :-
Ahara Vihara
Kaphaja Nidana :-
Ahara Vihara
b. Poorva roopa : c. Roopa :
d. Upashaya / Anupashaya : e. Samprapthi
24. OTHER INVESTIGATIONS. Blood-Hb- TC- DC- ESR- SERUM CHOLESTROL-
25. TREATMENT PROTOCOL :-
Deepana pachana Abhyanga & Mruduswedana :- Pradhanakarma :- Total 5 Anuvasana Basti and 3 Madhutailika Basti Paschathkarama- Basti nirgamana kala
176
Observation Before Bastikarma
During Bastikarma
After Bastikarma
Pulse Blood Pressure Respiratory Rate Temperature
26.ASSESSMENT OF RESULTS A. Subjective Parameters
Symptoms Before
treatmentAfter
Bastikarma15th day of follow-up
30th day of follow-
up Prabhuthamutratha Kshudadhikya Pipasadhikya Karapada daha Ati Sweda
B. Objective Parameters
Body Weight
27. INVESTIGATORS NOTE :- Signature of Co-Guide Signature of Guide
177
SCORE-SHEET A) Prabhuthamutratha : Grade O - 2-3 times/day time ; 0-1 times/night Grade 1 - 4-5 times/day time ; 2-3 times/night Grade 2 - 6-7 times/day time ; 4-5 times/night Grade 3 - > 7 times/day time ; >5 times/night B) Pipasadhikya: Grade O - Normal Grade 1 - Slightly Increased Grade 2 - Severely Increased C) Kshudadhikya: Grade O - Normal Grade 1 - Increased, but can tolerate Grade 2 - Increased, but cant tolerate without consuming food D) Karapada daha: Grade O - Absent Grade 1 - Slightly present Grade 2 - Present E) Ati Sweda: Grade O - Absent Grade 1 - Present